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A capacidade de um organismo sentir e reagir a estímulos ambientais, 
mantendo a homeostasia num meio em constante mudança, é fundamental 
para a sua sobrevivência. Nas plantas, a SnRK1 (SNF1-related protein kinase 
1) é um sensor energético central e um regulador metabólico que integra vários 
sinais para equilibrar os níveis de energia celular. Ao fazê-lo, a SnRK1 participa 
na resposta da plantas ao stresse (privação de energia), mas também no 
crescimento normal e decisões do desenvolvimento da planta. A SnRK1 está 
conservada em todos os eucariotas. Funciona como um complexo 
heterotrimérico constituído por uma subunidade catalítica (!) e duas 
subunidades reguladoras (" e !). No entanto, apesar da sua importância, a 
regulação da SnRK1 é ainda pouco compreendida. Em contraste com os 
homólogos em mamíferos e leveduras, a fosforilação/ desfosforilação da T-loop 
na subunidade catalítica SnRK1! é necessária, mas não suficiente, para 
determinar a sua activação/ inactivação, sob stress e uma vez restaurada a 
homeostasia. Com base em várias evidências, colocámos a hipótese de que 
outras modificações pós-tradução, nomeadamente sumolização, possam estar 
envolvidas na regulação da SnRK1. 
Mostramos que a SnRK1 interage com a enzima E2 de conjugação do 
SUMO em ensaios de dois híbridos em levedura, e é sumolizada num sistema 
heterólogo em E. coli. Demonstramos, por imunoprecipitação, que a 
sumolização da SnRK1 também ocorre na planta, possivelmente como um 
evento coordenado ao nível do complexo da SnRK1, uma vez que tanto a 
subunidade catalítica como as reguladoras estão sujeitas a esta modificação. 
Além disso, identificamos SIZ1 como a enzima E3 de ligação de SUMO 
responsável pela sumolização da SnRK1 por SUMO1, em Arabidopsis. 
A sumolização pode afectar a atividade, estabilidade e/ ou a localização 
subcelular dos substratos, principalmente através da modulação de interações 
! XXII 
proteicas intra- e intermoleculares. Demonstramos que a sumolização regula 
negativamente a sinalização da SnRK1. No mutante siz1-2, a ausência da 
enzima E3 de ligação de SUMO, SIZ1, conduz a uma maior ativação da via da 
SnRK1, que pode ser revertida para níveis basais por complementação 
transiente com SIZ1, mas não com a variante cataliticamente inativa, SIZ1C379A. 
Além disso, a expressão de um constructo que mimetiza a sumolização, 
através da fusão de SUMO1 e SnRK1!1, restaura os níveis normais de 
sinalização da SnRK1, reforçando que a sobreativação observada em siz1-2 é 
causada pela ausência de sumolização da SnRK1. Observamos também uma 
maior estabilidade e acumulação de várias subunidades da SnRK1 em siz1-2, 
sugerindo que a sumolização da SnRK1 promove a sua degradação, 
restringindo assim a sinalização da SnRK1. Com efeito, a activação excessiva 
da via da SnRK1 em siz1-2 não é causada por alterações na atividade catalítica 
intrínseca da quinase, mas sim por uma acumulação da SnRK1 neste mutante. 
Mostramos ainda que a SnRK1 é ubiquitinada na planta e encaminhada para 
degradação pelo proteosoma. Nos imunoprecipitados da SnRK1 são co-
purificados conjugados de SUMO e de ubiquitina. No entanto, em siz1-2, os 
conjugados de ubiquitina associados à SnRK1 estão bastante reduzidos, 
sugerindo uma interação cooperativa entre a sumolização e a ubiquitinação no 
direcionamento da SnRK1 para degradação. Este processo poderá envolver a 
ação de ligases de ubiquitina dirigidas para SUMO (STUbLs), responsáveis 
pela ubiquitinação de substratos multi- ou polisumolizados. Adicionalmente, 
temos resultados preliminares que sugerem que a sumolização poderá afectar 
a composição do complexo da SnRK1 e, possivelmente, a organização das 
subunidades da SnRK1 em complexos heterotriméricos e putativamente 
oligoméricos. 
Finalmente, mostramos que os variantes inativos da SnRK1, SnRK1K48M e 
SnRK1T175A,  se acumulam em níveis mais elevados e são mais estáveis do que 
a proteína ativa, sugerindo uma ligação entre a atividade e a estabilidade da 
quinase. Para além disso, os variantes inativos SnRK1K48M e SnRK1T175A podem 
! XXIII 
ser destabilizados se co-transfectados com SnRK1 ativa, ou se expressos 
como proteínas em fusão com SUMO1, reforçando que a atividade da quinase 
é essencial para a sua degradação, e sugerindo que a deficiente degradação 
dos variantes inativos da SnRK1 é causada pela ausência de sumolização. O 
trabalho aqui descrito revela um mecanismo de feedback negativo pelo qual a 
atividade da SnRK1 desencadeia a sua própria degradação pelo proteosoma, 
mediada por sumolização e ubiquitinação, para evitar os efeitos nocivos 
resultantes de uma sinalização excessiva da SnRK1 na planta. Além disso, 
mostramos que a SnRK1 fosforila a enzima E3 de ligação de SUMO, SIZ1, in 
vitro. Propomos que esse mecanismo poderá ser o elo de ligação entre o 
stresse e consequente ativação da SnRK1 e a sua  sumolização/ubiquitinação, 
que resulta na sua subsequente degradação na planta. A apertada regulação 
da ativação da via da SnRK1, e da acumulação da quinase em condições de 
privação de energia, poderá estar conservada evolutivamente e ser essencial 
para o equilíbrio entre respostas ao stresse e defesa, com as atividades 
biossintéticas, de crescimento e desenvolvimento da planta. 
 


















The ability of an organism to sense and react to environmental stimuli, 
maintaining homeostasis under ever-changing conditions, is key for survival. 
The plant SnRK1 (Snf1-Related protein Kinase 1) is a central energy sensor 
and metabolic regulator that integrates multiple inputs to balance cellular energy 
levels. In doing so, it takes part in the plant stress (energy deprivation) response 
but also on normal plant growth and developmental decisions. The SnRK1 
kinase is conserved in all eukaryotes. It functions as a heterotrimer composed of 
!-catalytic and "- and #-regulatory subunits. However, despite its importance, 
SnRK1 regulation is still poorly understood. In contrast to its mammalian and 
yeast homologues, SnRK1! T-loop phosphorylation/dephosphorylation is 
required but insufficient to determine its activation under stress and subsequent 
inactivation once homeostasis is restored. Based on several lines of evidence, 
we hypothesized that additional posttranslational modifications, like SnRK1 
sumoylation, may be involved.  
We show that SnRK1 interacts with the E2 SUMO conjugating enzyme in 
yeast two-hybrid assays and undergoes sumoylation in a heterologous E. coli 
system. Importantly, immunoprecipitation experiments demonstrate that 
sumoylation of SnRK1 also occurs in planta, seemingly as a coordinated event 
at the whole-complex level, as both catalytic and regulatory subunits undergo 
this modification. Moreover, we identify SIZ1 as the E3 SUMO ligase 
responsible for SnRK1 sumoylation by SUMO1 in Arabidopsis. 
Sumoylation can affect substrate activity, stability and/or subcellular 
localization, mainly through modulation of intra- and intermolecular protein 
interactions. We demonstrate that SnRK1 signaling is negatively regulated by 
sumoylation. In the siz1-2 mutant, the absence of the E3 SUMO ligase SIZ1 
leads to enhanced SnRK1 pathway activation that can be reverted to wild-type 
(WT) levels by transient complementation with SIZ1, but not with the 
! XXVI 
catalytically inactive SIZ1C379A variant. Furthermore, a translational fusion of 
SUMO1 to SnRK1!1 mimics sumoylation and restores normal SnRK1 signaling 
in siz1-2, supporting that the overactivation of the SnRK1 pathway in this mutant 
is caused by the lack of SnRK1 sumoylation. We observed increased stability 
and accumulation of several SnRK1 subunits in siz1-2, suggesting SnRK1 
sumoylation promotes its degradation and thereby restrains SnRK1 signaling. 
Indeed, the higher activation of SnRK1 signaling in siz1-2 was not caused by 
changes in SnRK1 intrinsic activity, but rather by an enhanced accumulation of 
the kinase in this mutant background.  
We further show that SnRK1 is ubiquitylated in planta and targeted for 
proteasomal degradation. SUMO and ubiquitin conjugates co-purify in SnRK1 
immunoprecipitates. However, in the siz1-2 background, SnRK1-ubiquitin 
conjugates are greatly reduced, suggesting a cooperative interplay between 
sumoylation and ubiquitylation in targeting SnRK1 for degradation. This process 
is likely to involve the action of SUMO-targeted Ubiquitin Ligases (STUbLs), 
responsible for the ubiquitylation of multi- or polysumoylated substrates.  
Additionally, preliminary results suggest sumoylation may also affect SnRK1 
complex composition, and possibly SnRK1 complex assembly and its putative 
oligomerization. 
Finally, we show that the inactive SnRK1 variants SnRK1K48M and SnRK1T175A 
accumulate to a greater extent and are more stable than the active WT SnRK1 
protein, underpinning a connection between kinase activity and stability. 
Importantly, inactive SnRK1K48M and SnRK1T175A can be destabilized if co-
transfected with active SnRK1!1 or if expressed as translational protein fusions 
with SUMO1, further supporting that kinase activity is essential for its 
degradation and suggesting the impaired turnover of inactive SnRK1!1 variants 
is caused by lack of sumoylation. The work here described has uncovered a 
negative feedback loop by which SnRK1 activity triggers its own SUMO-
mediated proteasomal degradation, to prevent deleterious effects derived from 
overly high SnRK1 signaling. Furthermore, we show that SnRK1 phosphorylates 
! XXVII 
the E3 SUMO ligase SIZ1 in vitro, and hypothesize that such mechanism may 
couple stress and SnRK1 activation to its sumoylation/ubiquitylation, and 
subsequent turnover in planta. A tight regulation of SnRK1 pathway activation 
and kinase accumulation in energy deprivation conditions may be evolutionary 
conserved and essential for balancing stress and defense responses with 
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Posttranslational modifications (PTMs) allow a sensitive, rapid and reversible 
response to internal or external stimuli, allowing cells to adapt to programmed or 
unpredicted changes (1, 2). The expansion in proteome diversity prompted by 
PTMs is crucial for an organism plasticity, adaptation and ultimately survival. 
 
1.1 | Posttranslational regulation by members of the Ubiquitin 
family 
 
Ubiquitin (Ub) was discovered in the mid 1970s and is the founding member 
and the most prominent one (ubiquitous) of a broad family of protein modifiers 
(Ubiquitin-like, UBL). Ub an UBLs are transiently conjugated to other proteins, 
expanding the diversity and versatility of the proteome in eukaryotes (3). 
However, they can also modify prenyl groups or lipids, as it is the case for the 
membrane-anchored ubiquitin-fold protein (MUB) and the UBL-protein 
autophagy 8 (ATG8), respectively. The transient conjugation of ATG8 to the 
autophagosomal membrane is essential for autophagy (4). 
All members of the ubiquitin family share a robust "-grasp structure, derived 
from the folding of a conserved ""!""" secondary motif, with some N- and C-
terminal variations or extra helixes/folds, specific to each UBL member (3, 5, 6) 
(Figure 1.1). The compact structures of UBLs result in fast assembling and 
highly stable proteins resistant to harsh environmental conditions. Despite the 
reduced conservation of the primary structure amongst different UBLs, each 
UBL member shares a highly conserved sequence, structure, and possibly 
regulation and regulatory role across different organisms (3). UBL modifiers are 
encoded in the genome and therefore, have been targets of duplication and 
diversification events during evolution (7). Insight regarding the origins of the 
Ub/UBL family came from the prokaryotic ThiS and MoaD proteins, involved in 




are structurally related to the "-grasp structure and display surprising 
mechanistic parallels with the UBL conjugation pathway. Moreover, the 
eukaryotic UBL ubiquitin-related modifier 1 (URM1), implicated both in sulfur 
donation to transfer RNAs (tRNAs) and in covalent protein attachment to target 
proteins, could represent an ancestral bridge between sulfur chemistry and 
protein conjugation (1, 3, 5). 
Several proteins have evolved as translational fusions with N-terminal 
Ub/UBL domains, in a stable association that overcomes the need for 
subsequent modification. These UBL domains have lost the characteristic C-
terminal end and are thus resistant to deconjugation, providing enduring 
features in protein-protein interactions or folding properties to the whole protein 
(3, 5). 
In plants, besides Ub, the UBL family includes the small ubiquitin-like 
modifier (SUMO), related to ubiquitin (RUB), ATG8 and ATG12, MUB, URM1, 
ubiquitin-fold modifier 1 (UFM1), and homology to ubiquitin1 (HUB1), whereas 
other UBL modifiers like the interferon-stimulated gene 15 (ISG15) or HLA-F 
adjacent transcript 10 (FAT10) are only present in metazoans (1, 3, 8).  
The biological processes regulated by PTMs of the UBL family, and the 
specificities associated to each member, have been the focus of intense 
research and at present, Ub and UBLs are considered major regulators of 
growth, development, and survival in eukaryotes.  
 
This thesis will focus on posttranslational modification by SUMO, given its 
prominent role in Snf1-Related protein Kinase 1 (SnRK1) regulation and due to 
the limitations of covering the entire UBL family here. SUMO regulation of 
SnRK1 signaling in plants will be addressed in detail in the experimental 
chapters, while the following introductory sections will provide an overview of 
the SUMO system and of the SnRK1 pathway. 
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1.2 | SUMO 
 
SUMO stands for Small Ubiquitin-like Modifier and was discovered in 1996, 
when a peptide sequence analysis retrieved a protein with two N-termini but just 
one C-terminal end (9). The Ran-GTPase-activating protein 1 (RanGAP1) was 
the first SUMO substrate described, and the outcome of this modification was a 
change in the subcellular localization of RanGAP1 (10). Since then, a burst in 
the UBL research area allowed the identification of a myriad of SUMO targets 
and implicated SUMO in the regulation of crucial biological processes elevating 
it, together with Ub, as one of the most prominent UBL members. 
 


















Figure 1.1 | Schematic and three-dimensional ribbon diagrams of mature Ubiquitin and 
SUMO, evidencing the Ub/UBL "-grasp fold.  
A. Schematic arrangement of the !-helix and "-strand secondary structures in the Ub/UBL "-
grasp fold. B. Avena sativa Ub [PDB accession number 1UBQ; (11)]. C. Human SUMO1 [PDB 
accession number 1AR5; (12)]. D. Superimposed structures of Ubiquitin (orange, from B) and 
SUMO (yellow, from C). Arrows point to the hydrophobic groove between the "2-strand and !1-
helix of Ub/SUMO. In A, B, and C, colors represent different secondary structures (red- helix; 
yellow- sheet; green- loop). Adapted from (3). 
 
 
SUMO and Ub share only ~18% amino acid (aa) sequence identity and their 
overall surface-charge distribution is different (6, 12-14). A specific feature of 
SUMO is an N-terminal unfolded extension that provides unique binding 
properties to this modifier and precedes the conserved hallmark "-grasp 
structure of the UBL class (Figure 1.1). SUMO is synthesized as a precursor (as 
most of the UBL members) and is processed to expose a di-Glycine (GG) C-
terminal motif through peptide cleavage (6). Due to its N-terminal extension, 
mature SUMO has a few more amino acids (~100 aa) than Ub (76 aa). SUMO 
protein is around 12KDa but, when conjugated, it contributes to an increment of 
~20KDa on the target protein molecular mass. The corresponding delay in 
migration in SDS-PAGE of the modified protein will also depend on where in the 
substrate the SUMO conjugation takes place and, for instance, on the 
occurrence of branching effects (15-18). 
 
1.2.2 | SUMO isoforms  
 
Whereas lower eukaryotes possess only one SUMO isoform (Smt3 in S. 
cerevisae or Pmt3 in S. pombe), higher eukaryotes express several SUMO 
variants possibly with distinct functional properties (19-21). In mammals, four 
SUMO paralogs (SUMO1 to SUMO4) exist, although SUMO4 has been 
suggested to be a pseudogene (only its mRNA is detected but not the protein), 
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and its ability to undergo maturation and conjugation even if expressed, has 
been questioned (20, 22).  
In Arabidopsis thaliana, eight genes are putatively attributed to SUMO 
isoforms (6, 23, 24), but only 4 SUMO variants are highly, although differentially, 
expressed: SUMO1, SUMO2, SUMO3 and SUMO5 (6, 25, 26). SUMO1 and 
SUMO2 are much more abundant (~7 fold) than SUMO3 and SUMO5 
transcripts (25, 27). The transcriptional profile of SUMO isoforms is mostly 
unchanged in different tissues and developmental stages. Nevertheless, 
SUMO3 and SUMO5 transcripts might be specifically enriched in roots and 
flowers, respectively, reflecting isoform-specific roles in these tissues (27). 
However, at the protein level there is an enrichment of free SUMO1/2 and of the 
respective SUMO conjugates, in flowers and siliques (27). The SUMO1 and 
SUMO2 genes are constitutively expressed, whereas SUMO3 can be strongly 
and widely induced by salicylic acid (SA) and by the defense elicitor Flg22 (21). 
At the cellular level, most of the SUMOs are present in the nucleus as the 
majority of proteins involved in sumoylation, despite some may display distinct 











Figure 1.2 | Primary sequence alignment of Arabidopsis thaliana (At) SUMO and Ubiquitin 
precursors. 




(www.ebi.ac.uk/Tools/msa/clustalo/). A red box highlights the C-terminal di-glycine motif exposed 
during precursor maturation, and a black box evidences the variable amino acids important for 
deconjugation rate, at position -4 from the mature isoform C-terminus. Underlined residues 
represent identified sumoylation (black) and ubiquitylation (red) sites. Additional putative 
ubiquitylation (blue) and acetylation (green) sites are based on the detection of the respective 
modification in conserved residues of human SUMO1 and/or SUMO2. Below the alignment, 
asterisks (*) indicate amino acid residues conserved in all aligned sequences, colon (:) indicates 
conservation between groups of strongly similar properties, and period (.) indicates conservation 
between groups of weakly similar properties. The Delta (%) symbol in front of AtUbiquitin5 and 




There is a high sequence similarity between SUMO1 and SUMO2 proteins 
(93%) (7) and probably functional equivalence (21, 23, 27). Accordingly, a single 
functional allele of SUMO1 or SUMO2 is sufficient for cell viability, whereas 
double mutants blocking the accumulation of both SUMO1 and SUMO2 are 
embryo lethal, underpinning an essential role for SUMO conjugation (21, 27). At 
the protein level, SUMO1 and SUMO3 share 53% sequence identity and the 
more divergent SUMO5 shares only 44% sequence identity with SUMO1 (7). 
Sequence alignment of the different isoforms revealed differences at a 
glutamine (Q) residue, conserved in most organisms, four amino acids distant 
from the mature C-terminus. SUMO1, SUMO3 and SUMO5 display Q, 
methionine (M) or leucine (L) at that position, respectively, and differences in 
deconjugation between SUMO isoforms in vitro were attributed to the identity of 
this amino acid (Q causing the fastest deconjugation) (Figure 1.2). Such type of 
regulation could result in a different half-life for the different SUMO-specific 
conjugates in vivo, and in diverse roles for the different paralogs (7, 25, 29). 
Besides SUMO proteases that can preferentially desumoylate specific SUMO 
conjugates (7), the SUMO paralog specificity also relies on E3 SUMO ligases 
and/or substrate interaction surfaces that may favor the binding of one SUMO 
isoform.  
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Whereas SUMO1 and SUMO2 can be further modified by SUMO in specific 
lysine (K) residues [K10, K23 and K42 in SUMO1 (30, 31) and K10 in SUMO2 
(7, 25)], and feature chain assembly, SUMO3 does not share this property or is 
sumoylated to a much minor extent (Figure 1.2). SUMO1/2 chain formation is 
functionally important in plants, for instance in the crosstalk with the ubiquitin 
proteasome system (UPS), when Ub and SUMO cooperatively target a protein 
for degradation (32), as similarly reported in yeast and animals (33, 34). In 
plants, there is a free pool of SUMO1/2 protein that is rapidly diminished by 
conjugation to substrates upon exposure to a diversity of stresses like heat 
shock, H2O2, ethanol and to the aminoacid analog canavanine, whereas the 
SUMO3 profile does not seem to change in these conditions (23).  
The differences observed in plant SUMO isoforms occur also in animals, 
although in this case SUMO2/3 are the highly similar and chain-forming 
isoforms, more abundant in vivo and massively conjugated as part of an early 
stress response (35, 36). Interestingly, mixed-chain formation between all 
SUMO family members was detected in mammals (37). SUMO1 mRNA levels 
increase in response to hypoxia in animals (38, 39), and higher SUMO2 
transcripts are an indicator of malignancy in human hepatocellular carcinomas 
(40). In animals, a number of lysine residues (K11, K20, K32, K41 and K44) 
have been identified in SUMO2, as acceptor sites for ubiquitylation (41). Some 
of these residues are conserved in Arabidopsis SUMO isoforms (Figure 1.2). 
SUMO2 monoubiquitylation at its N-terminus primes its polyubiquitylation (42) 
through K63-linked ubiquitin chains that might target SUMO conjugates to 
insoluble protein inclusions (41). Ubiquitylation of AtSUMO1 on K23 was 
detected in heat stressed plants (30). SUMO can also be phosphorylated (43, 
44) and acetylated (45) (Figure 1.2). Acetylation of K37 in SUMO1 and K33 in 
SUMO2 neutralizes a positive charge on SUMO and inhibits its interaction with 
some SUMO interacting motifs (SIMs), whereas it promotes the interaction of 
SUMO2 with the bromodomain in p300, indicating that acetylation of SUMO can 




1.2.3 | SUMO pathway 
 
As for other UBLs, the SUMO pathway engages an E1-E2-E3 (and E4) 
enzymatic cascade that initiates with an inactive precursor processed by 
specific proteases, and terminates with the covalent attachment of the mature 
SUMO to a target substrate. The subsequent removal of the modifier by specific 
proteases confers a transient and versatile nature to the posttranslational 
modification of substrates by SUMO (Figure 1.3). SUMO conjugation requires 
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Figure 1.3 | SUMO and Ubiquitin conjugation pathways.  
Both SUMO (S, bottom, yellow) and Ubiquitin (Ub, upper, orange) pathways share an E1 
(activating), E2 (conjugating), E3 (ligase) and E4 (ligase, involved in chain formation) enzymatic 
cascade. After processing, the modifier is covalently attached through its C-terminal glycine (G) 
residues to the &-amino group of lysine (K) residues in the substrate (red). Modifiers can target 
single or multiple lysines in the substrate (mono-/multiubiquitylation/sumoylation) and 
subsequently form chains through different lysine residues of the modifiers 
(polyubiquitylation/sumoylation). There are diverse outcomes of these modifications that 
essentially modulate protein-protein interactions. SUMO-targeted ubiquitin ligases (STUbLs) can 
ubiquitylate SUMO conjugates, and ubiquitin chains with K48 topology target substrates for 
proteasomal degradation. Modifications can be reversed by Proteases, also involved in the 
processing of the respective precursors, which control the free pool of the modifier. The enzymes 
involved are specific for each pathway and there are striking differences in their number (the 
numbers of enzymes encoded in Arabidopsis are in parentheses). Adapted from (47). 
 
 
1.2.3.1 | SUMO maturation 
 
Most of the newly synthesized UBL isoforms need to be processed to expose 
a conserved di-glycine motif involved in the covalent attachment to the 
substrate. SUMO proteases fulfill this role through endopeptidase cleavage of 
carboxyl-terminal extensions from SUMO inactive precursors (6). SUMO 
proteases can perform both SUMO maturation and SUMO deconjugation, or be 
specifically engaged in only one of these functions (48).  
The proteolytic activity of SUMO proteases can target SUMO-specific 
isoforms (7, 25, 29). In fact, in vitro pre-SUMO processing activity of the 
Arabidopsis SUMO proteases ESD4, OTS1 and OTS2, as well as yeast ULP1 
and X. campestris XopD, was shown to be specific to AtSUMO1 and AtSUMO2 
precursors. In this assay AtSUMO3 could only be processed by XopD, whereas 
AtSUMO5 was not processed at all, suggesting the enrollment of other SUMO 
proteases in precursor processing in Arabidopsis. The five cysteine proteases 




SUMO2 conjugates (7).  
 
 
1.2.3.2 | SUMO conjugation/deconjugation 
 
SUMO conjugation follows the same chemistry as Ub conjugation, however 
significant differences make E1, E2 and E3 enzymes specific for each UBL (3). 
One exception occurs for ATG8 and ATG12 modifiers that are activated by the 
same E1 (ATG7) but subsequently transferred as thioester intermediates to 
separate E2s (3, 5). E1 SUMO activating enzymes function as heterodimers 
(SAE1 and SAE2) and activate mature SUMO with the consumption of one 
ATP. Activated SUMO is transferred to the active site cysteine of SAE2 with the 
formation of a thioester bond and release of AMP (SAE2~SUMO). A 
transthiolation reaction allows the transfer of SUMO from SAE2 to the active site 
cysteine of E2 SCE1 (SCE1~SUMO). SUMO-loaded SCE1 will directly bind the 
target and conjugate SUMO through an amide (isopeptide) bond to a lysine 
residue on the substrate. It may modify a single lysine (monosumoylation) or 
multiple lysine residues (multisumoylation) on the substrate, and it may also 
result in the formation of SUMO chains (polysumoylation). E3 SUMO ligases 
facilitate SUMO conjugation and improve specificity either by bringing SCE1 and 
the substrate together, or by orienting SCE1~SUMO in a way that promotes 
SUMO transfer (32, 49). SUMO-substrate conjugates can be rapidly and 
specifically deconjugated through the isopeptidase activity of SUMO proteases 
that replenish the pool of free SUMO and release the substrate from its 





































Figure 1.4 | SUMO conjugation reactions.  
SUMO precursors are processed by SUMO proteases that expose a C-terminal glycine (Gly) 
in the SUMO modifier. Mature SUMO is activated with ATP by E1 SAE1, that adenylates the C-
terminal carboxyl group of SUMO, forming a high-energy (~) AMP adduct. This intermediate is 
attacked (red arrow) and covalently bound by the sulfhydryl group of the E1 SAE2 catalytic 
cysteine, creating a thioester bond and releasing AMP. SUMO is subsequently transferred to the 
catalytic cysteine of the E2 SCE via a transthiolation reaction. SUMO can thereafter be ligated to a 




lysine near the E2-SUMO thioester, catalyzing the transfer of SUMO to the substrate. Following 
this, SUMO proteases can remove SUMO from substrates, recycling the modifier. Adapted from 
(50). 
1.2.4 | SUMO Enzymology 
 
Unlike ubiquitylation, which in Arabidopsis involves 2 E1s, 37 E2s and over 
1500 different E3s that provide substrate specificity, the SUMO machinery 
comprises only two different E1 heterodimers, a single E2, and just two E3s. 
Therefore, distinct features of the sumoylation process, such as the recognition 
of specific motifs by the E2 on the target, and a tight regulation must be key to 
attain specificity. The SUMO conjugation and deconjugation machinery is target 
of such regulation at the transcript level, protein amount and distribution, as well 
as through posttranslational modifications (3, 28). 
 
 
1.2.4.1 | E1 SUMO activating enzymes (SAE1 and SAE2) 
 
The yeast Saccharomyces cerevisiae has a single E1 enzyme that 
coordinates the activation of Ub (Uba) while the SUMO activation in the same 
organism requires an E1 heterodimer (Aos1/Uba2). In Arabidopsis, the 
heterodimeric complex of E1 SAE is composed of a small subunit (SAE1a or 
SAE1b; encoded by two genes), and a big subunit (SAE2), that functionally 
resemble the N- and C-terminal domains of E1 in the Ub system, respectively 
(6, 7, 27). SAE1a and SAE1b share high amino acid sequence identity (81%) 
and have similar expression patterns in plants, suggesting functional 
redundancy. Accordingly, a potentially null mutant affecting SAE1a is viable, 
probably due to redundancy with SAE1b (27). SAE1 activates SUMO through 
the formation of a SUMO adenylate between the carboxyl group of SUMO C-
terminal glycine (G) and the !-posphate group of ATP, with the subsequent 
release of pyrophosphate (PPi). The activated intermediate is then transferred 
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to the sulfhydryl group of the SAE2 active site cysteine, forming a highly 
energetic thioester linkage (SAE2~SUMO). Null T-DNA insertion mutants of the 
single gene encoding SAE2 in Arabidopsis are embryonic lethal, with arrest 
occurring early in embryo development (27). 
In Arabidopsis, there is little variation in the mRNA profiles of SAE1a, SAE1b 
or SAE2 across different tissues and developmental stages, despite some 
differences at the protein level, for instance with SAE1 levels slightly elevated in 
flowers (27). Regulation at the transcriptional level was described in other 
organisms, with increased accumulation of SAE1/Aos1 transcripts in a variety of 
tissues (e.g., testis and thymus) (51, 52), in the S phase of the cell cycle (52), as 
well as during embryogenesis in Drosophila (53). On the other hand, high 
SAE2/Uba2 and SUMO2 transcript levels were correlated with malignancy in 
human hepatocellular carcinomas (40).  
At the protein level, sumoylation of both SAE subunits has been observed in 
mammals. Sumoylation of SAE2 is thought to be more common and derived 
from auto-sumoylation or mediated by E2 SCE (54, 55). SUMO conjugation on 
the active site of SAE2 inhibits the transfer of SUMO from E1 to E2 (56), 
whereas sumoylation on the SAE2 C-terminus is important for SAE nuclear 
retention (57). AtSAE2 is also sumoylated in vivo (30). SAE1 and SAE2 are 
ubiquitylated and downregulated upon viral infection in the presence of the 
adenovirus protein Gam1 (58). Reversible oxidation, on the other hand, has also 
been shown to regulate sumoylation. In response to low concentrations of ROS, 
mammalian E1 SAE2 and E2 SCE1 form a disulfide bond between their 
catalytic cysteines, preventing SUMO thioester formation (59). 
 
 
1.2.4.2 | E2 SUMO conjugating enzyme (SCE1) 
 
In Arabidopsis, the SUMO machinery comprises a single E2 enzyme (SCE1), 




relaxed substrate specificity to conjugate all SUMO substrates (and all SUMO 
isoforms) in vivo (7). SCE1 is crucial in SUMO conjugation since it binds directly 
the target on a consensus motif, through a patch surrounding the active site (60, 
61). The SUMO moiety is then transferred from the thioester bond with SCE1 to 
the &-amino group of a target lysine, establishing a covalent amide bond via the 
SUMO C-terminal glycine carboxyl group. This feature of SCE1 allows 
sumoylation in in vitro systems even in the absence of E3 SUMO ligases, 
despite co-expression of the latter might increase the efficiency of the reaction. 
SCE1 activity is modulated by the non-covalent binding of E1 (determinant for 
SCE1~SUMO formation) and of SUMO on a multifunctional binding site on 
SCE1 (6, 62). The consensus motif recognized by SCE, and ultimately the 
SUMO attachment site (SAS) in the target is 'KxE/D, where ' is a bulky 
hydrophobic amino acid (mainly valine (V), leucine (L), Isoleucine (I)), x is any 
amino acid, and where aspartate (D) can also replace the preferable glutamate 
(E) residue. There are several variations of this classic motif and also inverted 
motifs (63). The negatively charged amino acid-dependent sumoylation motif 
(NDSM) 'KxE(x)2-3(E/D)n comprises acidic residues downstream of the core 
motif that enhance the binding affinity with the positively charged patch of SCE1 
(64). The same increase in affinity is seen in the phosphorylation-dependent 
sumoylation motif (PDSM) 'KxExxS/T, when phosphorylation of the serine (S)/ 
threonine (T) triggers sumoylation (65). A third sumoylation motif, hydrophobic 
cluster-containing sumoylation motif (HCSM), clusters N-terminal hydrophobic 
residues upstream of the core motif, 'nKxE.  Inverted sumoylation motifs have 
also been described, E/DxK' (66). 
The variation on SAS motifs contributes to the efficiency and specificity of 
SUMO conjugation at the substrate level in response to varied signaling cues 
(63). There are several algorithms that score the probability of a SAS to become 
modified by SUMO according to the hydrophobicity and acidity of the amino 
acids at given positions (e.g., SUMOplot, www.abgent.com; sumosp, 
http://sumosp.biocuckoo.org/; JASSA v4). Despite not all consensus motifs are 
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bona fide SUMO targets and sumoylation also occurs outside of canonical high 
probability SUMO attachment sites (hpSAS), there seems to exist a correlation 
between hpSAS enrichment and SUMO conjugation. Proteomic analysis of 
putative SUMO targets reveals that 70% (25, 67) or even 80% (30) of these 
proteins contain hpSAS [defined with an arbitrary cutoff value of hpSAS (91% 
(67)], compared to the presence of hpSAS in ~40% of the Arabidopsis 
proteome. Interestingly, in a recent proteomic study, whereas more than half of 
the identified sumoylation sites matched the SUMO consensus motif in 
untreated cells, the adherence to the consensus motif dropped moderately for 
sumoylation sites mapped exclusively after heat-shock treatment, and more 
drastically after proteasome or SUMO/ubiquitin protease inhibitors treatment 
(37). However, besides the substrate primary sequence, SUMO attachment will 
also depend on the 3D context of the consensus motif, since it has to be 
exposed on the surface of the protein and thereby accessible to the sumoylation 
machinery (7). Furthermore, suitable modification sites are frequently outside of 
functional domains, within flexible regions not conserved, as described for 
protein group modification events (addressed in a later section) (47, 60). 
SCE1 is essential not only in plants but in all organisms tested, with the 
exception of S. pombe, in which the mutant lacking the SUMO E2 grows poorly 
and has severe defects in genome maintenance (with the same phenotypes as 
S. pombe mutants lacking SUMO or E1 subunits) (6, 27, 68-74). In Arabidopsis, 
SCE1 is the most highly expressed gene of all SUMO conjugation components 
and there is little variation in its mRNA profile across different tissues and 
developmental stages, despite its relative enrichment at the protein level in 
flowers and siliques (27). The transcription of SCE1 can be modulated by 
temperature, as revealed by its induction by heat and repression by cold shock 
in rice (75). SCE is regulated by several posttranslational modifications with an 
impact on its efficiency and specificity towards different targets. Auto-
sumoylation of the mammalian E2-conjugating enzyme Ubc9 at K14 leads to a 




interaction with RanGAP1, while not altering its activity towards other targets 
(76). On another report in budding yeast, E2 sumoylation at K153, and its 
subsequent interaction with the non-sumoylated SUMO-charged E2, promoted 
SUMO chain formation (77). Recently, SUMO conjugation to SCE1 at K15 was 
shown to be essential for SUMO chain formation in Arabidopsis (31). E2s can 
also be acetylated at K65 and this acetylation selectively reduces sumoylation of 
NDSM-containing proteins, such as the ETS-domain transcription factor ELK1 
(28, 45). In response to oxidative stress, mammalian SAE2 (UBA2) and E2 SCE 
form a disulfide bond between their catalytic cysteines preventing SUMO 
thioester formation (59), whereas ubiquitylation and downregulation of E2 
occurs in response to viral infections (58, 78, 79).  
 
 
1.2.4.3 | E3 SUMO ligases 
 
In the Ub system more than one thousand E3 Ub ligases were identified and 
coupled with specific substrates, whereas few E3 ligases exist in the SUMO 
pathway (3). E3 SUMO ligases are not required for SUMO conjugation in in vitro 
systems but increase the rate and substrate specificity of sumoylation in vivo 
(32). SCE1~SUMO and the target substrate can be brought together through 
binding interfaces in E3 ligases, that by this mean influence SUMO isoform and 
substrate specificity. This might be particularly relevant in cases when a 
consensus SAS motif is absent in the substrate, compromising a direct binding 
of SCE1 that needs to be recruited via an interaction with the ligase (47). On the 
other hand, E3 SUMO ligases may interact only with SCE1 and thus orient 
SCE1~SUMO in such a way to favor the SUMO transfer (49). A known SCE 
interaction domain present in most E3 ligases is the SP-RING domain (80), in 
which a zinc ion is coordinated via a set of conserved cysteine and histidine 
residues (32, 81, 82). The intracellular localization of E3 SUMO ligases is also 
critical for their function and substrate specificity, and since they possess SUMO 
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interacting motifs (SIMs) they can concentrate upon sumoylation and trigger a 
sumoylation chain reaction (47). 
E3 SUMO ligases are grouped in several distinct types. The best 
characterized is the SIZ/PIAS (SAP and MIZ/ protein inhibitor of activated STAT) 
(83-86) that displays conserved SAP, PINIT, SP-RING, SUMO binding, and NLS 
domains (87). The PINIT and SP-RING domains are both required for SUMO 
ligase activity and the SP-RING is determinant for SCE binding (80, 87, 88). The 
SAP domain is composed of a helix-extended loop-helix structure and interacts 
with DNA (89). In the plant homologs of SIZ/PIAS, there is an additional specific 
Zn-finger domain, the plant homeodomain (PHD), associated with chromatin 
remodeling complexes (90) and contributing to SCE1 binding as well (91). 
Additional types of SUMO E3s include the non-SMC element/methyl 
methanesulfonate sensitive (NSE2/MMS21) that also belongs to the family of 
SP-RING ligases, and other structurally unrelated SUMO ligases like RanBP2 
(92) or Pc2 (6, 93). In plants, SIZ1 (23, 24, 94) and HPY2/MMS21 (95, 96) are 
the only two E3 SUMO ligases identified and contain the hallmark SP-RING 
domain (32). 
 
1.2.4.3.1 | SIZ1 
 
Arabidopsis SIZ1 was the first SUMO E3 identified in plants, belonging to the 
SP-RING family, SIZ/PIAS type of SUMO ligases. AtSIZ1 is encoded by a single 
gene, and several orthologs are predicted in other plant species (32). In rice, 
two paralogs OsSIZ1 and OsSIZ2 have been described (97, 98). As determined 
for other components of the SUMO machinery in Arabidopsis, the relative 
expression of SIZ1 mRNA shows little variation across different tissues and 
developmental stages (27). Nevertheless, a relative enrichment of SIZ1 mRNAs 
was observed in root compared to shoot (94) and in female organs compared to 
anthers or pollen (99). At the cellular level, AtSIZ1 protein localizes 




for PIAS ligases in other organisms (94, 100). Despite its predominant role, null 
mutants of SIZ1 are still viable but have severe and pleiotropic phenotypes. On 
the other hand, the siz1-2 and hpy2-1 double mutant is embryonic lethal (82) 
showing that the combined role of the two ligases is essential for plant 
development, and questioning the physiological relevance of direct sumoylation 
by SCE1 via E3-independent mechanisms (27, 82).  
SIZ1 is implicated in plant vegetative growth and developmental processes, 
as well as in the response to several biotic and abiotic stresses. Under control 
conditions, SIZ1 regulates the expression of important sets of genes (101). The 
siz1 mutants accumulate salicylic acid (SA) to a higher extent (~28 fold) than 
wild-type (WT) plants (102, 103), and many of the phenotypes caused by the 
absence of SIZ1 are SA-dependent. The siz1 mutations cause dwarfism and 
reduced leaf size (101) due to a decrease in cell size and number (SA-
dependent) (104), an early flowering phenotype in short days (SD) (SA-
dependent), and reduced fertility, probably due to defects in the female 
gametophyte (99), but also due to anther dehiscence (98). SIZ1 sumoylates and 
represses Flowering Locus D (FLD) activity, required for proper expression of 
the floral repressor Flowering Locus C (FLC) (105, 106). SIZ1 also modulates 
abscisic acid (ABA) signaling through sumoylation of the transcription factors 
ABI5 (107, 108) and MYB30 (109) that operate in parallel pathways to 
coordinate germination in response to ABA. Consequently, siz1 mutations 
cause ABA hypersensitivity with an inhibition of germination and of seedling 
primary root growth. Plants cope with nutrient imbalance through several 
molecular mechanisms in which SIZ1 is key. These include the response to Pi 
starvation, through sumoylation of the transcriptional activator PHR1 and the 
control of auxin distribution-induced root architecture (94, 110), as well as the 
regulation of copper homeostasis and tolerance (111), and sodium sensitivity 
(94, 112). In addition, SIZ1 sumoylates the nitrate reductases NIA1 and NIA2, 
stimulating their activity and favoring nitrogen assimilation (113) and an increase 
in alternative respiratory bypass pathways (114). SIZ1 mediates the 
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accumulation of SUMO1/2 conjugates required for basal thermotolerance (94, 
115) and for cold acclimation. Sumoylation-dependent stabilization of the 
transcription factor ICE1 inhibits MYB15 and activates CBF3/DREB1A 
downstream responses to low temperature (in a SA-dependent process) (116-
118). SIZ1 accumulates in response to drought stress, increasing SUMO1/2 
conjugation, and thereby inducing transcriptional changes that promote 
tolerance to water scarcity (101). However, a subsequent study reported an 
decreased stomatal aperture and increased tolerance to drought in the siz1 
mutant, mediated by SA-induced ROS accumulation (119). Besides its role in 
abiotic stress, SIZ1 is also involved in biotic stress responses. siz1 plants have 
a constitutive systemic-acquired resistance (SAR), characterized by increased 
SA accumulation, increased expression of pathogenesis-related (PR) genes and 
increased resistance to the pathogen Pseudomonas syringae pv. tomato (Pst) 
DC3000 (102, 103). 
Interestingly, several of the siz1 mutant phenotypes could be attributed to 
specific domains of the E3 ligase protein, through complementation of siz1-2 
knockout mutants with SIZ1 alleles harboring point mutations in the predicted 
domains (120). The SP-RING is the most important domain for sumoylation, for 
the proper nuclear localization of SIZ1, crucial for its activity, and for the control 
of SA levels. Alterations in the PHD and PINIT domains of SIZ1 had a negative 
impact on SUMO conjugation and sugar and light perception, whereas 
mutations in the SAP or SXS domains did not influence the level of SUMO 
conjugates. The SXS domain, on the other hand, has been implicated in SA-
mediated ABA signaling at the level of cotyledon greening and expansion (120). 
Several posttranslational modifications regulate the SIZ1 E3 ligase and can 
impact its localization, activity and/or specificity. Different SIZ1 phosphopeptides 
were retrieved in phosphoproteomic studies (121-125), but the role of 
differentially phosphorylated SIZ1 remains unclear in plants. In other systems, 
phosphorylation was shown to directly modulate the activity of the human E3 




the yeast Siz1 during mitosis (84), or to target human PIAS1 to downstream 
effectors in response to pro-inflammatory stimuli (28, 127). In response to 
environmental stresses, AtSIZ1 is sumoylated in specific lysine residues [K100 
(H2O2, heat), K479 (H2O2), K488 (H2O2, heat)] (30). Sumoylated SUMO ligases 
RanBP2 and Siz2 were also detected in Xenopus egg extracts and in yeast, 
respectively, but the relevance of these modifications requires further 
clarification (128, 129). Several mammalian SUMO ligases are targeted for 
ubiquitin-dependent proteasomal degradation (130-132) and a SUMO-targeted 
ubiquitin ligase (STUbL) was recently implicated in the degradation of the 
nuclear pool of the Siz1 ligase in yeast (133). 
 
 
1.2.4.3.2 | HPY2/ MMS21 
 
The role of yeast and mammalian MMS21 is well documented in DNA repair, 
chromosome segregation and other cellular processes (134), but the 
Arabidopsis SUMO ligase HPY2⁄MMS21 was recently identified and is less 
characterized than SIZ1. HPY2⁄MMS21 belongs to the family of SP-RING, 
MMS21-type of E3 SUMO ligases and except for SP-RING, it lacks all the 
domains characteristic of the SIZ/PIAS-type E3s. Orthologs of HPY2 were 
identified in several plants, mostly as single copy genes (32). The expression 
pattern of HPY2 is distinct and more restricted even if partially overlapping with 
that of SIZ1. Moreover, ectopic expression of SIZ1 driven by the HPY2 promoter 
is unable to rescue the dwarf phenotype of hpy2, revealing that the two ligases 
have independent functions (82). At the cellular level, HPY2 localizes in the 
nucleus like the core of SUMO machinery and SUMOs (95), although 
cytoplasmic localization has also been reported (96). HPY2 functions primarily 
in development and may also contribute to stress tolerance since the hpy2 
mutant accumulates less SUMO1/2 conjugates in response to heat stress than 
WT plants (but more than siz1-2). HPY2 modulates cell cycle progression and 
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meristem development in the PLETHORA1 (PLT1) and PLT2-dependent 
signaling pathway (95), and impacts root development (96). HPY2 acts 
downstream of the auxin pathway to promote cell proliferation (82), and 
negatively modulates cytokinin signaling to control primary root development 
(96). Reported hpy2 phenotypes are independent of SA signaling, as opposed 
to SIZ1 (82). 
 
 
1.2.4.4 | E4 SUMO ligases 
 
Besides SIZ1 and HPY2, the Arabidopsis genome encodes two other 
proteins with a SP-RING domain, PIAS Like1 (PIAL1) and 2 (PIAL2) (31, 32), 
that also possess SUMO interacting motifs (SIMs). They show SUMO ligase 
activity in vitro and promote the formation of SUMO chains through SUMO-
SUMO isopeptide bonds on already mono or multisumoylated substrates. 
Extension of the SUMO chains occurs through modification of K10, K23 and 
K42 on SUMO1, and occurs less efficiently with SUMO3. Unmodified SUMO 
substrates are not sumoylated by PIAL1 and PIAL2, but these ligases seem to 
promote the sumoylation of SCE1 on K15, which strongly favors 
polysumoylation, as previously described (129). Accordingly, in the presence of 
the mutated and unmodified SCE1K15R, PIALs enhance SUMO chain formation 
to a lesser extent. By analogy with the E4 Ubiquitin ligases that extend 
polyubiquitin chains in a protein that has been already modified by one or more 
ubiquitins (8), these ligases were designated as E4 SUMO ligases (31). Several 
plants analyzed have at least one homolog of PIAL, more similar to PIAL2 than 
to PIAL1 (32). The analysis of single and double mutants suggests a role for 
PIAL1 and PIAL2 in the salt and osmotic stress responses, and in sulfur 
metabolism. PIAL1 and PIAL2 (both with polysumoylation activity) seem to be 
redundant and do not overlap functionally with SIZ1 (with 




accumulate SUMO conjugates to the same extent or even more than WT (and 
siz1-2) under normal and heat stress conditions. Since SUMO does not target 
directly substrates to the proteasome, this unexpected observation led to the 
proposal that E4 SUMO ligases (through extension of polySUMO chains), 
together with SUMO-targeted Ubiquitin Ligases (STUbLs) (through recognition, 
binding, and ubiquitylation of polySUMO chains - or direct ubiquitylation of the 
sumoylated substrate) (135), may target poly- and/ or multisumoylated 
substrates to proteosomal degradation, attributing a physiological role to SUMO 
chains in substrates (31).  
 
 
1.2.4.5 | SUMO Proteases 
 
A delicate balance between SUMO conjugation and deconjugation confers 
precision and reversibility to SUMO signaling and its regulatory mechanisms. 
SUMO proteases are required for deconjugation of SUMO (or SUMO chains) 
from modified substrates, through cleavage of the scissile peptide bond 
between the terminal glycine of mature SUMO and the lysine on the substrate, 
and for processing SUMO precursors into mature forms. SUMO proteases can 
edit SUMO chains by removal of just some SUMO moieties (136). The pool of 
free-SUMO will vary in accordance with both proteolytic outcomes of SUMO 
recycling and maturation. SUMO proteases are cysteine proteases with a 
papain-like proteinase fold belonging to three distinct classes, based on 
structural and functional characteristics (32, 136). The diversification of SUMO 
proteases resembles the diversification seen for deubiquitylating enzymes 
(DUBs). In Arabidopsis, around 70 DUBs have been identified, compared to less 
then 10 SUMO proteases (3, 32). However, the high number of SUMO 
proteases if compared to SUMO activating (SAE) and conjugating (SCE) 
enzymes, suggests an important modulation of SUMO signaling at the level of 
desumoylation (29, 137). 
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The catalytic domain in SUMO proteases contains the triad (sometimes 
dyad) catalytic residues (Histidine-Aspartate-Cysteine), whereas non-catalytic 
regions can display one or more SUMO interacting motifs, and have described 
roles on subcellular localization (138), substrate recognition (139) and paralog 
specificity (140). The substrate specificity of SUMO proteases, though, is 
strongly influenced by their subcellular localization (138). AtESD4 localizes to 
the nuclear periphery and interacts with the Nuclear Pore Anchor (NUA) protein 
to regulate flowering time and other developmental processes (141-143). The 
related SUMO protease ELS1/AtULP1a has extra-nuclear localization and is 
functionally distinct from ESD4, as shown by distinct mutant phenotypes (48). In 
vivo, the SUMO protease ELS1 is predominantly engaged in SUMO maturation 
and ESD4 in SUMO deconjugation. esd4 accumulates high levels of SUMO 
conjugates and its early flowering and pleiotropic shoot development 
phenotypes are even worsened by supplying mature SUMOs, as opposed to 
els1 (7, 48, 141, 142). Accordingly, ELS1 (but not ESD4) complements an ulp1-
ts yeast mutant impaired in SUMO precursor processing, and ESD4 (but not 
ELS1) complements an ulp2Δ yeast mutant impaired in SUMO deconjugation. 
Recently, it was described that the Ulp2 protease trims SUMO chains with a 
minimum of three SUMO moieties and from the distal end, since attachment to 
the N-terminus of the distal SUMO moiety reduces cleavage efficiency (144). 
Belonging to another group of SUMO proteases, OTS1/AtULP1d and 
OTS2/AtULP1c are nuclear localized, in association with speckle-like bodies 
(OTS2) or diffused in the nucleoplasm (OTS1), and act redundantly in the 
response to salt-stress (137). ots1 and ots2 single and double mutants 
accumulate high levels of SUMO1/2 conjugates in basal conditions, and even 
more in response to salt stress, showing a role for SUMO deconjugation in vivo. 
The ots1 ots2 double mutant exhibits an early flowering phenotype but has an 
overall growth similar to WT plants (137). Other potential plant SUMO proteases 




vitro deconjugation generally lacks SUMO paralog specificity, Arabidopsis 
SUMO-specific conjugates, with distinct residues four amino acids upstream of 
the glycine attached to the substrate, can influence the deconjugation rate by 
SUMO proteases (7). In vivo, SUMO paralog specificity relies very often on the 
accessibility of SUMO proteases to the modified substrate, depending on its 
localization and competitive binding of other proteins (136). In SUMO precursor 
processing, variable peptide extensions of the immature forms are thought to 
determine the affinity of specific SUMO proteases (136).  
An important role for sumoylation in plant-pathogen interactions was 
uncovered by the SUMO protease activities of plant pathogen virulence factors, 
like XopD from Xanthomonas campestris, towards plant nuclear proteins, 
leading to deactivation of important biotic stress responses (7, 145, 146). 
Regulation of SUMO proteases can occur at the transcript level, e.g., through 
binding of hypoxia stress signaling components to response elements located at 
the promoter region (147), or through differential splicing like in human SENP2 
mRNA, with an impact on its localization (148). SUMO proteases are also 
regulated by posttranslational modifications like phosphorylation (149) and 
ubiquitylation, with subsequent proteolytic cleavage (150). AtESD4 is 
sumoylated in oxidative stress conditions (30). In response to salt stress, 
despite no detectable changes at the mRNA level, OTS1 protein levels 
decrease in a proteasome-dependent manner, suggesting a regulatory negative 
feedback mechanism (137). Some SUMO proteases can be inactivated 
transiently, through a disulfide bond between the catalytic cysteine of two 
proteases in response to oxidative stress (151), or irreversibly by heat shock-
promoted denaturation (152). Interestingly, a crosstalk between SUMO 
proteases and SUMO targeted ubiquitin ligases (STUbLs) has been reported. 
Depletion of SUMO proteases [ULP2 in yeast (153) or SENP6, in human cells 
(154)] rescues the defects caused by depletion of STUbLs (SLX5 or SLX8 in 
yeast; or RNF4 in human cells, respectively). This was an unexpected 
observation, since SUMO modification is reversed primarily through 
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deconjugation by SUMO proteases and, alternatively, by STUbL activity, and 
suggests that there might exist in vivo antagonism between these two players.  
Furthermore, a putative metalloproteinase expected to cleave a covalent 
bond between SUMO and ubiquitin, as suggested for the yeast protein Wss1 
(155), has been predicted in Arabidopsis (32). Such protease might have an 
important role in the cleavage of mixed SUMO-Ubiquitin chains.  
 
 
1.2.5 | Molecular consequences of sumoylation 
 
Downstream effects of sumoylation occur primarily through modulation of 
interactions of the modified substrate with other proteins, since SUMO 
attachment alters the properties and binding surface of the target.  
 
 
1.2.5.1 | Promotion of interactions/ Recruiting factors 
 
The most common outcome of sumoylation is to promote protein-protein non-
covalent interactions. The molecular basis for this relies on the increased affinity 
of a specific surface groove of the SUMO moiety on the conjugate, towards a 
SUMO interacting motif (SIM) present in another protein.  
 
 
SUMO interacting motifs (SIMs) 
 
SUMO interacting motifs are short sequence elements (less than 10 amino 
acids) with a hydrophobic core of 3 to 4 amino acids (usually I or V) in the 
vicinity of acidic amino acids (E or D), or phosphorylated S or T residues. The 




and !1-helix of SUMO (Figure 1.5). The acidic residues of SIM bind a basic 
patch on SUMO, and are determinant to strengthen the interaction, to define the 
orientation of the SIM (parallel or antiparallel to the "2 strand), and to modulate 
its specificity towards distinct SUMO isoforms (8, 136, 156-158). All SIMs dock 
onto the same site on SUMO and thus belong to a single group, contrasting with 
over 16 structurally distinct Ub recognition motifs, that bind ubiquitin at several 
surface sites (3, 8, 159-161). According to different consensus sequences, SIMs 
can be classified in several types: SIMa, ''x'AcAcAcAcAc, characterized by 
four consecutive hydrophobic residues (') (the third hydrophobic residue is not 
conserved, though) immediately followed by a mixed cluster of acidic (Ac) D/S/E 
residues; SIMb, ''DLT, with a better conservation, and can have a downtream 
non-crucial acidic region; and SIMr, AcAcAcAcAc'x'', that resembles SIMa 
but in a reversed orientation (162). Despite recent advances, a better insight 
into biologically active SIMs awaits further criteria, since the residues contacting 
SUMO are still poorly defined and lead to ambiguous identifications of SUMO-
interacting proteins (135, 157, 163). SIM-associated S and T residues can be 
phosphorylated, adding a negative charge that can act as a switch for efficient 
recognition of SUMO (158). This is the case, for example, for PIAS1, PML and 
PMSCL1, whose SIMs are phosphorylated by CK2, allowing efficient recognition 
of human SUMO1/2 (164). A cluster of multiple SIMs is found in some proteins 



























Figure 1.5 | Non-covalent (NC) and covalent (C) interactions between SUMO and substrates.  
Shown are ribbon diagrams of SUMO interactions with substrates. A. Diagram of the SIMb 
from PIASx (red) bound to human SUMO1 (yellow) (based on structure PDB: 2ASQ) (157). The 
SIM "-strand sits in the SUMO hydrophobic groove (marked with a black arrow). B. Covalent (blue 
arrowhead) and non-covalent (SUMO-SIM, arrow) contacts between TDG (red) and SUMO1 
(yellow) induce a conformational change essential for the release of TDG from the product DNA 
(based on structure PDB: 1WYW) (165). In the SUMO-SIM interaction, the SIM "-strand from 
TDG sits in the SUMO hydrophobic groove. C. Covalent attachment (blue arrowhead) of SUMO to 
Ubc9 creates new binding interfaces that can provide a gain in Ubc9 affinity towards specific 
targets (based on structure PDB: 2VRR) (76). In this structure, the SUMO on sumoylated Ubc9 
does not participate in any SUMO-SIM non-covalent interaction, and consequently the SUMO 
hydrophobic groove is free. TDG, thymine/uracil DNA glycosylase; PIAS, protein inhibitor of 
activated STAT.  
 
 




are also crucial to regulate the activity and specificity of sumoylation per se. SIM 
motifs are found on the SUMO machinery and in sumoylation substrates (166). 
SCE1 has 2 SIMs (1 SIMa and 1 SIMb), and SIZ1 has 2 SIMs type a located in 
the SAP, PINIT and SP-RING domains. Both SCE1 and SIZ1 were retrieved, 
together with 6 STUbLs and 6 histone or DNA methyltransferases or 
demethylases, in large-scale yeast two-hybrid (Y2H) screens to identify 
Arabidopsis proteins that interact with SUMO isoforms (167). A predicted SIMa 
also exists in the OTS2 SUMO protease. On the other hand, SUMO-SIM non-
covalent interactions can be required for the covalent attachment of SUMO to 
targets. A SIM in Sp100 is required for its enhanced sumoylation, likely through 
specific recruitment of sumoylated E2 (76).  
 
 
Protein Group sumoylation 
 
When several sumoylated proteins that also have SIMs are in proximity, this 
can lead to complex assembly and formation of a net of SUMO-SIM connected 
proteins. Sites of DNA damage, telomeres, promyelocytic leukemia (PML) 
nuclear bodies (NBs), and ribosome biosynthesis at the nucleolus, are 
described hot spots of sumoylation in mammalian and yeast cells. For instance, 
sumoylation of PML promotes the formation of PML NBs and recruitment of 
associated proteins with SIMs, like Sp100 and the transcriptional repressor 
Daxx, followed by sumoylation of associated proteins and additional 
recruitments. E3 SUMO ligases, that also have SIMs, could be enrolled in this 
wave of sumoylation reactions, crucial in signaling pathways. Still, active and 
functional complexes could pre-assemble and be further stabilized by 
sumoylation that would act as “glue" between the different elements/ subunits. 
The Arabidopsis co-repressors TOPLESS (TPL) and LEUNIG bind to gene-
specific repressors and recruit components involved in histone deacetylation. 
Both TPL and LEUNIG are sumoylated, as almost all of the additional 
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components of these two transcriptional regulatory circuits (including SEUSS, 
HDA19, GCN5, and ADA2a and b), suggesting that the entire process is under 
SUMO control (30). When such a web of cooperative bonds is established, 
individual SUMO-SIM interactions may be redundant or additive, and justify 
some of the absent or weak phenotypes observed with single SAS or SIM 
mutations. In the case of protein group sumoylation, specificity is attained 
through co-localization with the SUMO ligase in the presence of a specific 
trigger of sumoylation (6, 47, 168). 
 
 
1.2.5.2 | Inhibition of interactions 
 
Besides promoting interactions, the SUMO moiety in a substrate can act as a 
"repellent", blocking the access of binding partners to the same residue or to a 
close binding site. A bulky SUMO moiety conjugated to K236 of human SAE2 
leads to steric hindrance and interferes with the proper interaction between E1 
and E2, and with overall SUMO conjugation to target proteins (56). SUMO and 
ubiquitin can compete for the same residue (K21) on I)B!. SUMO1-modified 
I)B! cannot be ubiquitylated and is resistant to proteasome-mediated 
degradation (169), constituting an example of antagonism between SUMO and 
ubiquitin pathways. In Arabidopsis, sumoylation of the transcription factors 
ICE1, ABI5, and MYB30 results in their stabilization, possibly through reduced 
ubiquitin-mediated degradation (108, 109, 117). However, different 
modifications of the same residue on a substrate do not necessarily mean 
competition between PTMs, since they can be sequential and cooperative, or 
occur in different times, conditioned by distinct stimuli.  
 
 






Finally, substrate sumoylation can lead to a change in its conformation due to 
the establishment of intramolecular SUMO-SIM interactions with relevant 
functional consequences. The base excision repair protein uracil/ thymine DNA 
glycosylase (TDG) is sumoylated after base excision. A subsequent non-
covalent intramolecular interaction of the conjugated SUMO with a SIM in TDG 
(VQEV) induces a conformational change and steric hindrance, with the release 
of TDG from DNA (165, 170). More recently, the same type of mechanism was 
shown to regulate the Sucrose non-fermenting 1 (Snf1) kinase in yeast. Snf1 is 
sumoylated and inhibited in response to sugar supply. The non-covalent 
interaction of the conjugated SUMO with a SIM near the Snf1 active site 
prompts a conformational change and the rapid inhibition of the kinase (171). 
 
1.2.6 | SUMO Enigma  
 
Usually only a minor fraction of a protein pool is sumoylated at a given time 
point, providing however a global effect. This phenomenon is referred as the 
SUMO enigma and can be understood if a cycle of sumoylation and 
desumoylation, rather than persistent attachment of SUMO to the substrate, is 
required for a functional outcome. In the abovementioned example of TDG, the 
sumoylation and desumoylation steps are required for each catalytic cycle. 
SUMO conjugation induces a conformational change in TDG, crucial for its 
removal from DNA after base-excision repair. Released TDG is rapidly 
desumoylated and can again bind with high affinity to mismatches in DNA (14, 
172). On the other hand, the sumoylation-mediated effects may persist after 
SUMO deconjugation, for instance if sumoylation drives translocation of a 
substrate to a different subcellular compartment, where it is subsequently 
desumoylated. In neurons, the SUMO modification of glutamate receptor 
subunit 6 (GluR6) leads to its endocytosis at the plasma membrane. A large 
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fraction of GluR6 undergoes SUMO-mediated endocytosis but only a small 
proportion of sumoylated GluR6 can be detected at a given time point, probably 
due to its rapid deconjugation after endocytosis (20, 173). However, SUMO 
modification could still act stoichiometrically and correspond to one state 
whereas desumoylation would restore the original state. In this case, SUMO 
would get attached to only a minor fraction of structurally and/ or functionally 
engaged proteins, of a larger total pool (6, 20). 
 
1.2.7 | Biological consequences of sumoylation 
 
Through the modulation of protein intra- and intermolecular interactions, 
sumoylation can have an impact on substrate stability, activity and/or subcellular 
localization. As previously mentioned, in most organisms the SUMO pathway is 
essential for viability. The lethality of E1 (SAE2), E2, and double SUMO1/2 
mutants, and the severity of E3 SUMO ligase and of some SUMO protease 
mutants’ phenotypes in Arabidopsis, is a corollary of such an essential role in 
plants. Studies of SUMO pathway mutants implicated SUMO in the regulation of 
flowering (105, 142) and other development processes (82, 95, 110, 174), in the 
cell cycle (95), and in signaling through abscisic acid (107-109, 175) and other 
hormones (110, 176). A prominent role was also established in nitrogen and 
sulfur metabolism (113, 177) (31), in phosphate homeostasis (94) and copper 
tolerance (111), as well as in the response to biotic stress (30, 102, 103), and 
the response to heat (23, 115), cold (116-118), drought (101, 119, 178) and 
salinity (112, 137). Despite the importance of sumoylation established by 
genetics, only recent proteomic approaches have provided detailed insight on 
the identity of SUMO substrates and their associated processes in Arabidopsis 
(25, 30, 67, 167, 179). Such studies have retrieved sumoylated proteins from a 
myriad of cellular processes, with an enrichment for SUMO machinery 




remodeling/repair factors (e.g. Histone 2b, GCN5 histone acetyltransferase, 
HDA19 histone deacetylase, and UBP26 deubiquitylating enzyme), suggesting 
a role for sumoylation in the plant histone code and chromatin accessibility (30). 
Sumoylation also plays a role in transcription, with transcription factors (TFs) 
being the most represented elements in the Arabidopsis sumoylome, and with 
several co-regulators [TPL and LEUNIG] also being sumoylated (30). Other 
categories enriched in SUMO substrates are RNA metabolism, cell cycle 
regulators (6, 28), and nuclear–cytoplasmic shuttling (6). Such categories are 
also enriched in yeast and human sumoylomes and highlight predominant 
SUMO-regulated processes in a far-reaching SUMO regulatory landscape (180-
183). Despite the enrichment of SUMO, sumoylation machinery components, 
and SUMO conjugates in the nuclear compartment, sumoylation occurs also 
outside the nucleus and sumoylated proteins are found throughout the cell. The 
Arabidopsis sumoylome responds strongly to biotic and abiotic stress with 
several types of stress triggering a rapid increase in SIZ1-mediated SUMO1/2 
conjugation (179). On the other hand, distinct factors, like the ESD4 SUMO 
protease, WRKY72 transcription factor and LINC1 are specifically sumoylated in 
response to oxidative stress, heat or basal conditions, respectively (30), 
altogether revealing a pervasive role for SUMO in the plant stress response. 
 
1.2.8 | Crosstalk with other posttranslational modifications  
 
An increasing body of evidence points to an active and dynamic interplay 
between SUMO and other posttranslational modifications (PTMs), such as 
phosphorylation, ubiquitylation and acetylation, to coordinately regulate protein 
function in response to multiple cues (63). One layer of crosstalk occurs when 
the posttranslational modifier (and/or machinery) is itself subjected to 
posttranslational regulation. As described in previous sections, SUMO itself and 
the SUMO machinery are modulated through phosphorylation, acetylation, 
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ubiquitylation and sumoylation. Conversely, sumoylation may intervene in the 
regulation of other posttranslational modifiers (and/or machinery). Interplay 
between PTMs can also occur at the substrate level. Frequently, SUMO 
attachment sites have flanking regions that are also subject to PTMs, dictating 
the efficiency of sumoylation (e.g., phospho-dependent sumoylation occurs 
upon phosphorylation of PDSMs). The co-regulation of a given target by SUMO 
and other modifiers can be competitive or cooperative, and occur in a sequential 
or simultaneous manner. Since the biological outcomes of sumoylation are 
mostly transduced via SUMO-SIM interactions, the modification of SIMs by 
PTMs introduces another variation to the theme [e.g., SIM-associated S and T 
residues can be phosphorylated, adding a negative charge that can act as a 
switch for efficient recognition of SUMO (158)]. The interplay between SUMO 
and other posttranslational modifications occurs at different levels of the 
sumoylation cascade and gives rise to a robust and versatile regulation (63, 
184, 185). 
 
 1.2.8.1 | SUMO and Ubiquitin 
 
SUMO (and SUMO machinery) regulation by mono, multi and 
polyubiquitylation has been addressed in previous sections.  The 
deubiquitylating enzyme UBP26, which removes Ub bound to histone 2b, is 
sumoylated in response to oxidative stress, whereas Ub13 is increasingly 
sumoylated from basal, to oxidative and to heat stress conditions in Arabidopsis 
(30). The biological meaning of such modifications needs further elucidation. At 
the target level, sumoylation is thought to attenuate HOS1 mediated 
polyubiquitylation of the transcription factor ICE1. SUMO or ubiquitin 
conjugation to ICE1 results in either transcription factor activity or degradation, 
respectively. In response to low temperatures, ICE1 is sumoylated and 
stabilized, promoting CBF3/DREB1A expression and plant acclimation (117). 




the case of the ABI5 transcription factor. Sumoylation protects ABI5 from 
proteasomal degradation mediated by AFP and KEG E3 ubiquitin ligase, but 
renders the transcription factor inactive, negatively modulating ABA signaling 
(108, 186, 187).  
 
 
SUMO-targeted Ubiquitin ligases 
 
A new class of ubiquitin ligases with a cluster of SIMs and affinity to multi- or 
polysumoylated substrates was recently described in yeast, animals and plants 
(32, 167, 188, 189). SUMO targeted Ubiquitin ligases (STUbLs) bind poly and/ 
or multisumoylated substrates through a cluster of SIMs. RING domains on 
STUbLs recruit the E2 ubiquitin conjugating enzyme, and ubiquitin is directly 
transferred to the substrate and/or to the attached SUMO moieties (155, 190). 
Consequently, STUbL activity results in proteins that are modified both by 
SUMO and ubiquitin. Ubiquitylation of sumoylated proteins can target them to 
proteasomal-mediated degradation (and in fact, STUbL mutants accumulate 
more SUMO conjugates) or to non-proteolytic fates (33, 135). PML protein is 
ubiquitylated by the STUbL RNF4 in a SUMO-dependent manner and degraded 
by the proteasome, in response to arsenic treatment (34, 191). This crosstalk 
opens new questions such as whether the conjugated SUMO(s) could fulfill 
other biological functions prior to SUMO targeted ubiquitylation and signal 
termination, whether this discrimination could be based on the length and/or 
topology of the attached SUMO chains, and whether SUMO proteases could still 
deconjugate SUMO on proteins simultaneously sumoylated and ubiquitylated 
(136). The recently uncovered role of the USP11 ubiquitin protease in removing 
ubiquitin polymers attached to SUMO chains (counteracting RNF4) (192), as 
well as the described mechanism of SUMO chain trimming by the SUMO 
protease Ulp2 (144), suggest that the modifiers are gradually removed from the 
distal N-terminus of ubiquitin-SUMO hybrid chains. The processing of such 
CHAPTER 1 | 
! 36 
modified substrate would predict the existence of a protease that cleaves a 
covalent bond between SUMO and ubiquitin, and this role has been attributed in 
yeast to the metalloproteinase Wss1 (155). An ortholog of Wss1 has been 
predicted in Arabidopsis (32). Arabidopsis STUbLs share a conserved RING 
domain with S. pombe Rfp1/Rfp2 and human RNF4 STUbLs, and contain SIMs 
of type b and/or type a. Both the RING domain and SIMs are required to 
complement to various degrees the phenotypes of S. pombe rfp1/rfp2 mutant. 
The complementation analysis suggests that AtSTUbL1, 3, and 6 are most 
similar to S. pombe Rfp1/Rfp2, whereas STUbL2 and 4 probably evolved plant-
specific functions. All characterized STUbLs localized to the nucleoplasm, but 
whereas STUbL1, 3 and 4 were strongly localized in the nucleolus, STUbL4 
also localized to speckles, and STUbL2 and 6 were excluded from the 
nucleolus. STUbL4 reduces the protein levels of Cycling DOF Factor 2 (CDF2) 
with a consequent increase on the CONSTANS transcript and the promotion of 
flowering transition (167). 
Proteasome inhibition studies show an increased accumulation of both 
SUMO and ubiquitin conjugates (surprisingly K63 polyubiquitylated substrates 
are particularly enriched) and underpin an interplay between SUMO and 
ubiquitin modifiers not only in SUMO-targeted degradation through the UPS, but 
also in the formation of protein inclusions, as a quality control mechanism for the 




1.2.8.2 | SUMO and Phosphorylation 
 
SUMO (and the SUMO machinery) can be regulated by phosphorylation. 
Conversely, sumoylation modulates several kinases, phosphatases and signal 
transduction pathways (28, 63). In response to oxidative stress, there is a 




kinase 2 (HIPK2) (194), whereas phosphorylation triggers the sumoylation of 
phosphatase PTEN (phosphatase and tensin homolog) (195, 196). As 
previously mentioned, phosphorylation can trigger SUMO covalent attachment 
through PDSMs on the substrate, and SUMO-SIM non-covalent interactions 
through phosphorylation of S and T residues associated with SIMs on 
interacting proteins. Phospho groups add negative charges and increase the 
affinity of PDSMs with the positively charged patch of SCE1 (64), or the affinity 
of phosphorylated SIMs with a positive patch on SUMO (158). Besides the 
cooperative interplay between phosphorylation and sumoylation, these PTMs 
can impose opposite fates on a substrate. ABI5 is phosphorylated and activated 
by SnRK2.2 and SnRK2.3 kinases in response to ABA, whereas SIZ1-mediated 




1.2.8.3 | SUMO and Acetylation 
 
SUMO (and the SUMO machinery) can be regulated by acetylation. 
Acetylation neutralizes positive charges on SUMO and E2, and thereby 
decreases their affinity for negatively charged SIMs or target NDSMs, 
respectively. Acetylation of K37 in SUMO1 and K33 in SUMO2 decreases the 
affinity towards some SUMO interacting motifs (SIMs), but promotes the 
interaction of SUMO2 with the bromodomain in p300 (28, 46, 63). The GCN5 
histone acetyltransferase and the HDA19 (HD1) histone deacetylase, together 
with HAC1, ADA2A and ADA2B elements, are some of the factors involved in 
chromatin modification that are sumoylated in Arabidopsis (30). It has been 
previously mentioned that sumoylation and acetylation cooperate in the 
regulation of HIPK2 in response to oxidative stress. Oppositely, sumoylation of 
the tumor suppressor p53 on K386 has a negative impact in the acetylation of 
K382 by p300/CBP, presumably due to steric hindrance (63, 197). 





1.2.8.4 | SUMO and Methylation 
 
Several proteins involved in DNA methylation like the SUVR chromatin 
methylase family and related elements (SUVR1, SUVR2, SUVH2, SUVH9, 
KTF1, IBM1) are sumoylated in Arabidopsis (30). A functional crosstalk between 
SUMO and methylation probably occurs at the level of several histone or DNA 
methyltransferases (MT) or demethylases (DMT) that were retrieved as SUMO-




Posttranslational modifications are often combined at the substrate level, 
generating unique regulatory codes that reflect specific physiological contexts or 
signaling cues. The tumor suppressor p53 can be heavily modified in its C- 
terminal regulatory domain by sumoylation, ubiquitylation, neddylation, 
phosphorylation, acetylation, and methylation (63). Phosphorylation of the 
human flap endonuclease (FEN1) induces SUMO conjugation, leading to a 
subsequent SUMO-dependent ubiquitylation and proteasomal degradation at 
the end of S phase (184, 185). Sumoylation of ABI5 stabilizes the protein in an 
inactive state, while phosphorylation induces transcriptional activity, and 
subsequent ubiquitylation and degradation (108). Such intricate networks have 
tight regulatory roles in fundamental biological processes. Thus, a toolbox of 
PTMs allows swift molecular switches, enabling sensing, signaling, and 







1.2.9 | Challenges and strategies for the identification of sumoylation 
substrates and SUMO interactors in Arabidopsis 
 
The low levels of sumoylated proteins and the labile nature of SUMO 
conjugates due to high SUMO protease activity associated with cell lysis, have 
hampered until recently the large-scale identification of SUMO substrates in 
Arabidopsis and other organisms. Several strategies have been developed for 
enrichment, purification and identification of SUMO substrates and their 
acceptor sites. These approaches included interactome studies using the 
Arabidopsis E2 SCE1 and the ESD4 desumoylating protease as baits in Y2H 
screens, combined with computational analysis of hpSAS on the Arabidopsis 
proteome (167), in vitro sumoylation reactions of candidate proteins (94, 108, 
117), and reconstitution of the Arabidopsis SUMO machinery in E. coli (198). 
Despite the enormous advances made with such approaches, they provide low 
level confidence regarding the in vivo sumoylation of the identified targets and 
its biological relevance (199). High confidence analysis of SUMO conjugates 
employed cells expressing epitope tagged SUMO isoforms, both in transient 
protoplast assays (106, 108, 109, 117) or using genetically modified Arabidopsis 
(30, 179), followed by (tandem) affinity purification and immunoblot detection. In 
human cells, other alternative approaches have been used, including the use of 
monoclonal SUMO antibodies for immunoprecipitation and epitope-specific 
peptides for elution (54), and affinity purification with peptides containing SUMO 
interaction motifs [also called SUMO Binding Entities (SUBEs)] to specifically 
enrich for polysumoylated proteins (55, 199-202). Bona fide mass spectrometry 
identification of sumoylated sites is challenging, since SUMO leaves a large 
footprint on the modified lysine residue after tryptic digestion (196). Several 
strategies to interpret complex Mass Spectrometry (MS) data (66, 203, 204), 
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modified protease digestion protocols (205-208), or the use of SUMO variants 
mutated in their C-terminal amino acids have proven useful in such task. In 
Arabidopsis, a stringent three-step purification procedure to enrich for SUMO 
conjugates, and a Histidine (H) tagged SUMO1-H89 mutated to arginine (R) 
variant that generates a smaller footprint (K-QTGG) compared to WT SUMO 
footprint (K-25 amino acids), allowed the identification of 357 SUMO substrates, 
although only for 14 of them the SUMO attachment sites were determined (30).  
Recently, isobaric tag for relative and absolute quantification (iTRAQ) MS 
allowed the quantitative study of sumoylation dynamics in intact Arabidopsis 
seedlings subjected to stress, and revealed that stress mostly increases the 
abundance of existing conjugates as opposed to modifying new targets (179). 
The rapid breakdown of SUMO conjugates can be minimized by adding N-
ethylmaleimide (NEM) (175) that irreversible alkylates and inhibits the active 
cysteine of SUMO proteases, or through the usage of strong denaturants (e.g., 
7 M guanidine chloride or 8 M urea) (30), in the cell lysis. The latter approach 
also avoids that proteins non-covalently bound to SUMO via SUMO-SIM 
interactions are retrieved in such screens. However, a global insight into the 
functional and biological outcomes of sumoylation has to integrate both covalent 
and non-covalent SUMO binding partners. The use of mild conditions in the 
extraction buffer allows the identification of both type of SUMO interactions, 
whereas a Y2H screen using a SUMO variant that lacks the terminal di-glycine 
motif and thus can not be conjugated, identified only proteins non-covalently 
attached to SUMO (209). Arabidopsis SUMO1, 2 and 3 were used as baits in 
large-scale Y2H screens for identifying SUMO interacting proteins. Fourteen 
proteins that interacted with SUMO through regions spanning putative SIMs 
were retrieved, and unraveled predominant nuclear functions for these SUMO 
interactors. The E2 SCE1 and E3 SIZ1 were identified, together with six histone 







In the next section, I will describe the central role of the SNF1/AMPK/SnRK1 
family of protein kinases in energy signaling in yeast, mammals and plants, 
respectively. Common and particular features will be analyzed with a special 
focus on the SnRK1 pathway, in plants. Moreover, the dissection of 
SNF1/AMPK/SnRK1 regulatory mechanisms will give further insight on these 
systems, but also reveal the very scarce knowledge on the regulation of the 
plant counterpart. The activation of the SnRK1 kinase in response to energy 
stress will be shown to rely on distinct features from the regulatory mechanisms 
occurring in yeast and mammals in activating conditions. This discloses the 
need for additional regulatory mechanisms such as posttranslational 
modifications, namely sumoylation, in the tight regulation of the SnRK1 energy 
sensor in plants.  
!
!
1.3 | Energy sensing and signaling in eukaryotes 
 
All organisms need to tightly balance the energy levels of the cell in 
accordance with the surrounding available resources. The yeast SNF1 (Sucrose 
non-fermenting 1), mammalian AMPK (AMP-activated protein kinase), and plant 
SnRK1 (Snf1-related protein kinase 1) are conserved kinases with homologs in 
almost all eukaryotes. These kinases sense the energy levels of the cell and 
undergo activation in response to energy depletion, turning off energy-
consuming processes and mobilizing energy reserves in an attempt to restore 
homeostasis (210). SNF1/AMPK/SnRK1 are heterotrimeric complexes 
composed of an !-catalytic subunit (SnRK1!1/!2 in Arabidopsis, also called 
AKIN10/11 or KIN10/11) and two regulatory subunits, " and # (211).  
Genetic studies firstly identified a central role for SNF1 in carbohydrate 
metabolism in the budding yeast Saccharomyces cerevisiae (212, 213). Mutants 
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of the catalytic subunit, snf1", failed to grow in the absence of glucose due to 
their inability to induce genes required for metabolizing alternative carbon 
sources, or to switch from fermentative to a more energy efficient oxidative 
metabolism (diauxic shift) (212-214). In more complex multicellular organisms, 
the role of SNF1/AMPK/SnRK1 kinases evolved beyond a conserved cell 
autonomous regulation of energy homeostasis, to integrate additional metabolic 
and hormonal cues, balancing energy at the whole body level. In mammals, 
AMPK activation is crucial for metabolic adaptation to fasting and exercise, 
when the cellular ATP levels decline (and the AMP/ATP and ADP/ATP ratios 
increase). In response to peripheral hormones, AMPK activation in the 
hypothalamus increases appetite and food intake (215). The AMPK homolog in 
the nematode Caenorhabditis elegans, AAK, is required for the response to 
starvation and to other stresses, and promotes lifespan extension (216, 217). 
Similarly, in plants, SnRK1 is important for balancing energy use and storage, 
and for growth under low energy conditions. The moss Physcomitrella patens 
snf1a snf1b null mutant is deficient in starch accumulation and is only viable if 
grown under high energy conditions, either in the form of constant illumination or 
exogenous sugar supply (210). Furthermore, it displays altered sensitivity to 
several phytohormones and premature senescence (210). Conversely, 
SnRK1!1/AKIN10 overexpression in Arabidopsis thaliana allows plants to better 
tolerate conditions of limited photosynthesis and carbohydrate supply, whereas 
it delays flowering and the onset of senescence under long-day conditions 
(218). 
 
1.4 | SnRK1 in the core of plant energy homeostasis 
 
The early identification of a Snf1-related protein kinase in the endosperm of 
rye, RKIN1 (219), and the remarkable sequence similarity amongst the plant, 




belong to an evolutionarily conserved family of protein kinases (220). The 
characterization of AKIN10 in Arabidopsis thaliana revealed a 65% identity to 
the catalytic domain of yeast Snf1, and showed its ubiquitous expression (221). 
Rye RKIN1 (219), as well as tobacco NPK5 (222), complemented the yeast snf1 
mutant, suggesting a conserved function for the plant kinases in the control of 
carbon metabolism. The first in vivo evidence for such role came from the 
antisense-mediated silencing of SnRK1! in potato (223, 224) and wheat 
embryos (225), which resulted in decreased expression of the sucrose synthase 
(SUS4, sucrose-inducible), and !-amylase (!-AMY2, glucose-repressible) 
genes, respectively.  
Overtime, different biochemical studies showed the phosphorylation and 
inactivation of the key metabolic enzymes 3-hydroxy-3-methylglutaryl CoA 
(HMG-CoA) reductase (HMGR), sucrose phosphate synthase (SPS) and nitrate 
reductase (NR), in cauliflower (226, 227), spinach (228, 229) and Arabidopsis 
(228). However, only later it was realized that the kinases responsible for these 
different phosphorylation events belonged to the same SnRK1 family (230). 
Consequently, besides the abovementioned gene expression regulation, the 
SnRK1 kinases were also implicated in the control of fundamental metabolic 
processes through direct enzyme phosphorylation (HMGR, isoprenoid 
biosynthesis; SPS, sucrose synthesis; and NR, nitrogen assimilation), and in a 
clear analogy with the SNF1 and AMPK kinases that regulate metabolism in 
yeast and mammals (224). Furthermore, SnRK1, SNF1 and AMPK share similar 
substrate recognition motifs (231) and can phosphorylate several substrates 
from their counterparts in different organisms. For instance, SnRK1 
phosphorylates and inactivates the mammalian HMGR and acetyl-CoA 
carboxylase (ACC, involved in lipid biosynthesis) in the same sites as AMPK. 
However, SnRK1 does not phosphorylate the plant ACC, where possibly 
different regulatory mechanisms have evolved (226). 
The Arabidopsis SnRK superfamily comprises the SnRK1, SnRK2 and 
SnRK3 groups (232). Whereas the SnRK1 group (with 3 members, SnRK1!1, 
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!2 and !3) is closely related to the yeast Snf1 and mammalian AMPK, SnRK2 
(with 10 members) and SnRK3 (with 25 members) are more divergent plant-
specific groups that cannot functionally replace SnRK1, and have been 
implicated in the osmotic and salt stress responses (233). 
The identification and characterization of " and # regulatory subunits 
associated with SNF1 (234)/ AMPK (235-238)/ SnRK1 (239-241) complexes, 
and their regulation through different metabolites and through phosphorylation 
of a conserved threonine residue on the T-loop of the !-subunit (242-248), were 
progressively unraveled as well as the crosstalk with novel metabolic, 
developmental, and stress response pathways.  
Importantly, subsequent studies in Arabidopsis thaliana uncovered an 
unexpectedly wide role for SnRK1 in transcriptional reprogramming, impacting 
more than a thousand genes in response to energy deprivation (218, 249). 
KIN10 and KIN11 [SnRK1!1 and !2, respectively; SnRK1!3 or KIN12 is poorly 
expressed in most plant tissues (218)] were shown to be activated by energy 
deprivation caused by unpredicted darkness and other stresses that impair 
photosynthesis and/or respiration, such as DCMU herbicide treatment and 
hypoxia. However, the induction of these kinases by stress was blocked by 
glucose or sucrose supply (218). The massive transcriptional changes triggered 
by SnRK1 activation occurred partly through the S-class of basic region/leucine 
zipper motif (bZIP) transcription factors (TFs) (250). Activation of SnRK1 
signaling induced genes related to major catabolic pathways, including cell wall, 
starch, sucrose, amino acid, lipid, and protein degradation, as well as autophagy 
and trehalose metabolism genes. Conversely, it repressed genes related to 
anabolic pathways such as amino acid and protein synthesis, or ribosome 
biogenesis genes. TFs, chromatin remodeling factors, and signal transduction 
components were also regulated at the transcript level by SnRK1 (218). 
Furthermore, the transcriptional profile induced by SnRK1 activity largely 
overlapped with the profiles obtained under a variety of dark and starvation 




sucrose or glucose were fed (inhibiting SnRK1) (255, 256). Recently, miRNAs 
were also implicated in the regulation of specific mRNA targets of the SnRK1 
pathway, possibly tuning down particular cellular processes during the stress 
response (257).  
Overall, SnRK1 emerged as a global regulator of gene expression in 
response to energy deprivation, that coupled with direct enzyme regulation, 
favors energy production and represses energy consuming processes to 
achieve homeostasis.  
 
 
SnRK1 appears to be at the interface of several stress, hormone, and 
metabolic signaling pathways, promoting survival and long-term responses for 
plant adaptation, growth and development (218, 233, 249) (Figure 1.6). The 
next sections will address the centrality of the SnRK1 system and the intricate 
crosstalk between SnRK1 and other signaling pathways. Furthermore, recent 
studies highlighting the impact of SnRK1 on plant growth and developmental 
decisions will be discussed.  
 
 







Figure 1.6. | SnRK1 in the interface of Stress, Metabolic, Hormonal, and Developmental 
signaling pathways.  
Several types of biotic and abiotic stresses, as well as nutrient deprivation conditions, 
converge as an energy deficit signal that triggers SnRK1 activation, alike other hormonal and 
developmental signals. Upon activation, SnRK1 triggers a vast transcriptional reprogramming that 
together with direct enzyme regulation promotes energy homeostasis. Through an increase in 
catabolism and repression of anabolic processes, SnRK1 promotes stress response and survival, 
growth and development, throughout the plant life cycle. Adapted from (218, 249). 
 
1.4.1 | Stress  
 
SnRK1 intervenes in plant responses to abiotic and biotic stress that disrupt 
energy homeostasis. As previously mentioned, many adverse conditions that 
interfere with carbon assimilation and/or respiration, such as drought, extreme 
temperatures, extended darkness, pollutants or flooding, are decoded as energy 
deficit signals that trigger SnRK1 activation (218, 249). One of the first 
observations connecting environmental stress and SnRK1 was the increased 
salt sensitivity of potato plants silenced for the SnRK1# subunit (258). SnRK1 
promotes tolerance to submergence stress in rice (259) and Arabidopsis (260), 
at least partly because it mediates the induction of important stress genes. The 
calcineurin B–like (CBL)–interacting protein kinase 15 (CIPK15) acts through 
the SnRK1A-MYBS1 axis to regulate carbohydrate catabolism and fermentation, 
allowing rice to grow under floodwater. Furthermore, SnRK1A plays a role in 
source-sink communication during seedling growth in rice and this contributes to 
seedling vigor during stress (259, 261). Consistent with this, SnRK1 was 
recently identified as a central hub required for signal integration from multiple 
stress, hormone and metabolic pathways in rice (262). Additionally, SnRK1 has 
been implicated in the response to Pi starvation in Arabidopsis (263) and its 
ability to interact with and phosphorylate the barley heat shock protein 17 
(HSP17), suggests it may also be important for the heat stress response (264). 
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An increasing number of reports highlight a role for SnRK1 also in the biotic 
stress response. The metabolic status of the host influences the inherent 
susceptibility to pathogen attack, and in some cases SnRK1 was shown to be a 
component of the plant resistance to infection. On the other hand, pathogens 
can hijack host resources and trigger metabolic and energy imbalances. In such 
scenario, SnRK1 activation triggered by pathogen attack can also elicit a 
defense response. In other cases, SnRK1 is specifically targeted upon infection, 
thereby participating in the evolutionary arms race between hosts and 
pathogens. Several examples are listed below.  
In N. benthamiana, the SnRK1 homolog AKIN1 increases resistance against 
tomato golden mosaic virus and beet curly top virus. On the other hand, AL2 
and L2 viral proteins interact and inactivate AKIN1, counteracting the plant 
defense response (265). AL2 viral proteins can also repress adenosine kinase 
(ADK) with a consequent decrease in AMP levels. This may increase the 
susceptibility of SnRK1 to dephosphorylation and inactivation, and may be an 
indirect mechanism for SnRK1 downregulation by AL2 (265, 266). Arabidopsis 
SnRK1!2 is inhibited by AC2/C2 geminivirus proteins, and the infection results 
in broad effects, namely on RNA silencing and autophagy, likely components of 
antiviral immunity (267). Begomovirus and curtovirus AL2/C2 proteins interact 
with the host geminivirus Rep-interacting kinases (GRIKs), which are upstream 
activating kinases of SnRK1 (268, 269). Moreover, SnRK1 phosphorylates the 
AL2/C2 proteins in vitro, suggesting this as a mechanism by which SnRK1 
delays viral DNA accumulation and symptom development during Arabidopsis 
thaliana infection (270). SnRK1 also interacts and phosphorylates the "C1 
protein encoded by a Geminivirus "-Satellite, as part of the host defense in 
tomato plants (271, 272).  
On the other hand, infection of sweet orange plants by Xanthomonas 
axonopodis pv. aurantifolii increased the expression of trehalose biosynthesis 
enzymes and SNF1-related kinases, likely associated with a defense response 




SnRK1 and suppresses the hypersensitive response (HR) elicited by the 
effector protein AvrBs1 in pepper. Intriguingly, SnRK1 is required for AvrBs1-
induced HR (274). In another case, the plant AvrPto-dependent Pto-interacting 
protein 3 (Adi3) interacts and phosphorylates the SnRK1" subunit Gal83, with a 
consequent suppression of SnRK1 activity. Adi3 is a cell-death suppressor with 
an important role in the resistance of tomato plants to Pseudomonas syringae 
pv tomato (275). Furthermore, the plant-specific SnRK1"# subunit interacts with 
HSPRO1/2 proteins involved in plant defense and possibly in the leaf 
senescence program (276). HSPRO was shown to participate in a whole-plant 
change in growth physiology associated with SnRK1 signaling, when Nicotiana 
attenuata seedlings interact with the fungus Piriformospora indica (277, 278). 
Interestingly, herbivore attack results in downregulation of SnRK1# transcripts in 
Nicotiana attenuata source leaves, and thereby in increased assimilate transport 
to the roots. Plants with enhanced root reserves prolong reproduction and 
tolerate better herbivory by allocating reserves to a less vulnerable location 
within the plant (279). 
 
1.4.2 | Hormones 
 
The SnRK1 pathway is intimately associated with plant hormone signaling 
and several hormones have been shown to control SnRK1 at various levels. 
In tomato, expression of the SnRK1#-regulatory subunit, LeSNF4, was 
induced in response to abscisic acid (ABA) or dehydration, and repressed by 
gibberellins (GA) or in seeds that had completed germination. In contrast, 
SnRK1! and #-subunit genes were constitutively expressed regardless of the 
developmental, hormonal, or environmental conditions (280). Consistent with 
this, an inhibitor of ABA synthesis repressed SNF4b gene expression (281) in 
Medicago. On the other hand, another study showed that auxin and ABA 
stimulated Vicia faba SnRK1 promoter activity in Arabidopsis and tobacco 
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protoplasts (282).  
Interplay between sugar and ABA signaling has been revealed through 
extensive connections (283), as exemplified by the requirement of GIN1/ABA2, 
involved in ABA synthesis, for the glucose hypersensitivity of SnRK1 
overexpressors (284). 
ABA controls SnRK1 activity also at a posttranscriptional level in a 2C-type 
protein phosphatase (PP2C)-dependent manner. Two known repressors of the 
ABA pathway, the PP2Cs ABI1 and PP2CA, interact, dephosphorylate and 
inactivate SnRK1!. ABA, in turn, inhibits PP2C action, thereby resulting in the 
activation not only of ABA signaling but also of the SnRK1 pathway (285). 
Consistent with this, SnRK1 and ABA induce largely overlapping transcriptional 
responses (285). On the other hand, SnRK1 repression via antisense 
expression causes an ABA insensitive phenotype in pea seeds, suggesting 
other levels of crosstalk between the two pathways downstream of PP2Cs (282, 
286).  
However, some studies report a negative regulation of ABA on SnRK1 
signaling, possibly due to the use of different (autotrophic vs. heterotrophic) 
plant material or conditions that may determine different SnRK1 complex 
composition. ABA counteracts SnRK1A signaling in rice seedlings by restricting 
SnRK1A-Interacting Negative Regulators (SKINs), SnRK1A and MYBS1 to the 
cytoplasm and thus preventing SnRK1A-MYBS1 nuclear localization and 
mobilization of nutrient reserves from source tissues (261). An antagonistic 
regulation of the two pathways was also suggested by another study in which 
SnRK1 repressed salt and ABA-inducible gene expression (287). On the other 
hand, the C-class bZIP63 TF that is phosphorylated by SnRK1 (288) and 
partially mediates SnRK1 transcriptional reprogramming, requires intact ABA 
signaling for its full repression in high sugar concentrations in Arabidopsis 
seedlings (289). Finally, ABA treatment promoted SnRK1 degradation overtime 
in wheat roots. However, the amount of phosphorylated SnRK1! remained 




Studies using pea seeds with reduced SnRK1 activity also highlighted a 
cooperative crosstalk between SnRK1 and other hormones, such as auxin and 
cytokinins, at early stages of seed development, cotyledon emergence and 
growth (282, 286, 291). On the other hand, transcripts related to GA and/or 
brassinosteroid (BR) synthesis were increased upon silencing of SnRK1 (286). 
In accordance, BR and jasmonate (JAZ) hormone metabolism genes are 
downregulated upon SnRK1 overexpression in Arabidopsis protoplasts (218). 
Finally, one of the downstream effectors of SnRK1 signaling, the S-class bZIP 
TFs bZIP11 (218), is able to trigger auxin-induced transcription through the 
recruitment of SAGA-like histone acetyltransferase complexes, via ADA2b. This 
role might be shared by other members of the S-class bZIPs (292). 
 
1.4.3 | Metabolism  
 
As early as its identification as part of the SNF1/AMPK/SnRK1 family of 
protein kinases, SnRK1 was implicated in sugar sensing and signaling pathways 
in plants. SnRK1 senses the metabolic status of the plant and regulates 
accordingly metabolism in a cell-autonomous manner, as well as at the whole 
plant level through crosstalk with hormonal and other signaling pathways.  
A first layer of metabolic regulation is exerted by the SnRK1 kinase through 
direct enzyme regulation of key metabolic components. The inhibitory 
phosphorylation by SnRK1 of SPS, NR and HMGR implicated this central 
kinase in the regulation of sucrose synthesis, nitrogen assimilation and 
sterol/isoprenoid metabolism, respectively (230). SnRK1 also phosphorylates 
the class II trehalose-6-phosphate synthase 5 (TPS5). Phosphorylated TPS5 
binds to 14-3-3 proteins but the functional outcome of this regulation needs 
further clarification (293). Further connections between SnRK1 and metabolism 
come from the phosphorylation of fructose-6-phosphate,2-kinase/ fructose-2,6-
biphosphatase (F2KP) by purified AMPK or by an Arabidopsis cell extract (294). 
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Arabidopsis F2KP generates and hydrolyzes fructose-2,6-biphosphate (fru-2,6-
P2), a signaling metabolite in photosynthetic carbon partitioning. Similarly to 
SPS (295), NR (296) and TPS5 (293), phosphorylation of F2KP causes its 
binding to 14-3-3 proteins, but whether and how this modifies F2KP function and 
carbon partitioning requires further investigation. Other examples of direct 
enzyme regulation come from the potato SnRK1 catalytic subunits PKIN1 and 
StubSNF1, which interact in yeast-two hybrid assays with the key enzyme of 
glycolysis, cytosolic pyruvate kinase (PKc). PKc has a consensus SnRK1 motif 
(230) that is phosphorylated by StubSNF1 but not by PKIN1. However, both 
PKIN1 and StubSNF1 silenced lines show diurnal changes in the intensity and 
periodicity of PKc activity in leaves, compared to WT plants (297). Another 
candidate metabolic target of SnRK1 is nonphosphorylating glyceraldehyde-3-
phosphate dehydrogenase (np-Ga3PDHase), a cytosolic unconventional 
glycolytic enzyme regulated by phosphorylation in heterotrophic tissues. 
Phosphorylated np-Ga3PDHase is subsequently bound to 14-3-3 proteins and 
inactivated. Partially purified SnRK1 from wheat endosperm phosphorylates np-
Ga3PDHase and impacts carbohydrate and reducing power partitioning and 
storage (298).  
Besides direct enzyme regulation, SnRK1 activation also triggers metabolic 
rearrangements through an extensive transcriptional reprogramming, with 
implications in primary and secondary metabolism (218, 249). The 
transcriptional regulation exerted by SnRK1 was first acknowledged through its 
positive impact on sucrose synthase (219) and !-amylase (225) gene 
expression. However, SnRK1 regulates the transcription of many other 
metabolism genes such as plant specific trehalose genes, for instance (218). 
Thus, plants manipulated in the SnRK1 pathway display altered metabolic 
profiles and changes in carbohydrate storage (223, 282, 286, 299, 300). 
Silencing of SnRK1 in pea embryos results in defects in sucrose utilization, 
impaired metabolic fluxes, lower levels of metabolites, and a consequent 




implications have been described for AMPK and SNF1 in their respective 
systems (233).  
Another example of an intricate SnRK1-carbohydrate regulatory network is 
the case of ADP-glucose pyrophosphorylase (AGPase), involved in starch 
synthesis and activated posttranslationally through redox modification. SnRK1 is 
required for the redox activation of AGPase in response to sucrose and 
trehalose-6-phosphate (T6P), whereas redox activation in response to glucose 
seems to involve a separate pathway that depends on hexokinase (301, 302). 
Conversely, diverse metabolic signals modulate the SnRK1 pathway, in order 
to adjust and optimize its downstream regulatory response. Several levels of 
regulation of the SnRK1 pathway by sugars have been reported. For example, 
sucrose deprivation stimulated Vicia faba SnRK1 promoter activity in 
Arabidopsis protoplasts (282), and glucose depletion induced SnRK1#1 
expression in germinating Medicago truncatula seeds (281). SnRK1#1 
expression was also induced by dark (303), or ammonia (304).  
Sugars can also regulate the expression of S-class bZIP transcription factors, 
downstream effectors of SnRK1 signaling (305-307). For example, bZIP11 
expression is induced by sugars, but its translation is repressed by sucrose 
through a so-called sucrose-induced repression of translation (SIRT) 
mechanism. Plants with dexamethasone (dex)-inducible nuclear localization of 
bZIP11 have low T6P levels, changes in trehalose metabolism genes, and 
altered carbohydrate metabolic profiles that resemble carbon starvation, 
suggesting a SnRK1-bZIP11-T6P regulatory circuitry that controls growth (308). 
As another example of a posttranscriptional regulation, mRNA decay was also 
reported as an important mechanism to downregulate bZIP63 in response to 
sugar and ABA signals (289). On the other hand, glucose deprivation activated 
SnRK1A posttranscriptionally in rice embryos and suspension cells, and this 
activation was dependent on the CIPK15 kinase (309). SnRK1A protein 
accumulation was higher after 24h of glucose deprivation, and in the absence of 
SnRK1A transcript changes, a two-fold increase in kinase activity was achieved 
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in comparison to glucose-fed conditions (310). It is important to note that sugar 
depletion can be the result of unfavorable environmental conditions, but also of 
an increased demand for photosynthate in other high-priority tissues or organs 
(249, 282). 
In an apparent contradiction, some studies have suggested a positive 
regulation of SnRK1 activity by sucrose (223, 224, 301, 311) or glucose (284). 
Potential explanations for this could be that high sugar concentrations, 
particularly in the light (where endogenous sugar levels are already elevated), 
may be perceived as a stress, with the consequent activation of SnRK1. In other 
studies, the use of heterotrophic tissues or organs (e.g. tubers) as experimental 
material as opposed to autotrophic mature leaves could explain an opposite 
mode of SnRK1 regulation (312).  
T6P is a precursor of trehalose and plays an important signaling role in plant 
carbohydrate metabolism, growth and development. Increased T6P 
accumulation generally occurs when sucrose levels are high, and is thus 
considered an indicator of the sugar status of the plant (313, 314). T6P 
represses SnRK1 activity in physiological amounts, and its inhibition of SnRK1 
is mediated by an unknown proteinaceous, heat labile factor, present in young 
actively growing tissues (315-323). Other sugars such as glucose-6-phosphate 
(G6P) and glucose-1-phosphate (G1P, alone or in synergism with T6P) also 
inhibit SnRK1, whereas the glycolysis-inhibitor, non-metabolizable sugar, 2-
deoxyglucose seems to activate it (293, 294, 324, 325).  
SnRK1 was also implicated in inositol signaling trough its in vitro interaction 
with the WD40 domain of a myoinositol polyphosphate 5-phosphatase 13 
(5PTase13) protein. 5PTase13 is a positive regulator of SnRK1 activity under 
low-nutrient or -sugar conditions, whereas in severe starvation conditions, it 
exerts a negative regulation (326). Another conserved WD protein, the 
pleiotropic regulatory locus 1 (PRL1) interacts and inhibits the activity of SnRK1 
in Arabidopsis (311), possibly through its ubiquitylation and proteasome- 




activity and exhibit glucose and sucrose hypersensitivity and transcriptional 
derepression of glucose responsive genes (328, 329). In comparison to WT 
plants, prl1 mutants have increased accumulation of isoprenoid products 
derived from the plastidial isoprenoid pathway, possibly as a consequence of 
the increased phosphorylation and inactivation of HMGR, the rate-limiting 
enzyme of the cytosolic pathway for isoprenoid biosynthesis (330).  
 
1.4.4 | Growth and Development 
 
SnRK1 energy sensing conveys environmental and metabolic signals 
towards important developmental decisions in vegetative and reproductive 
growth. In potato, antisense transcript repression of the !-subunit PKIN1 (331) 
or the "-subunit StubGAL83 (258) affected tuber and root development. On the 
other hand, engineered reduction of T6P levels in potato tubers activated 
SnRK1 and induced down-regulation of genes involved in cell proliferation and 
growth promotion, and up-regulation of an inhibitor of cell cycle progression 
(323). T6P and SnRK1-mediated signaling are also involved in the repression of 
new fruit growth by preexisting fruits in cucumber plants (332), whereas 
transgenic tomato plants overexpressing SnRK1 ripened earlier than the wild-
type (300). In Medicago truncatula seeds, repression of SNF4b resulted in 
reduced seed longevity (299). 
A developmental role for SnRK1 has been similarly shown in cereals. 
Antisense repression of SnRK1 in barley could never be transmitted to the T1 
generation (333), probably due to the developmental arrest of a starch-depleted 
pollen (334). Wheat SnRK1 marker genes showed different patterns of 
expression before and during the grain filling period, consistent with changes in 
T6P content (319). On the other hand, SnRK1A protein kinase was also shown 
to promote seed germination and seedling growth and modulate development in 
rice (260, 310). SnRK1A-Interacting Negative Regulators (SKINs) counteracted 
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SnRK1A function, inhibiting starch and nutrient mobilization from the endosperm 
and in consequence seed germination and growth (261).  
Antisense repression of SnRK1 in pea seeds caused defects in seed storage 
and maturation reminiscent of ABA-insensitivity. This included downregulation of 
genes related to cell proliferation, meristem maintenance and differentiation, leaf 
formation, and polarity, both through interaction with ABA-dependent and 
independent pathways (282, 286). In agreement with its described 
transcriptional reprogramming function, SnRK1!1 is predominantly localized to 
the nucleus in young organs, such as leaf primordia and meristematic zones of 
roots and shoots. In most other tissues throughout Arabidopsis development, 
SnRK1!1 is mainly in the cytoplasm and at the plasma membrane (335). 
Additionally, SnRK1 was identified as a very early marker gene of developing 
leaf primordia in tomato (336). 
In Arabidopsis, SnRK1 function in growth and development was assessed 
employing transient and systemic virus induced gene silencing (VIGS) of KIN11 
in a kin10 mutant background. This strategy was employed to circumvent the 
problem of redundancy in single !-subunit mutants, as well as potential lethality 
problems in stable double mutants. Plants depleted of both KIN10 and KIN11 
displayed dramatic growth defects, strong accumulation of anthocyanins and 
early senescence (218). Less severe silencing allowed the formation of 
inflorescences, although they were rudimentary and unviable. Unlike the snf1a 
snf1b double mutant in moss (210), the growth defects of the Arabidopsis 
SnRK1 loss-of-function plants could not be rescued by constant illumination or 
exogenous supply of sucrose, suggesting fundamental roles in normal 
vegetative and reproductive growth beyond a purely metabolic regulation (218). 
Conversely, SnRK1!1 overexpression in Arabidopsis altered inflorescence 
architecture, delayed flowering, and the onset of senescence under long-day 
conditions (218, 260). In agreement with the strong phenotypes resulting from 
altered SnRK1 levels, the previously described prl1 mutants display pleiotropic 




SnRK1 activity (328). Similarly, deficient myristoylation of the SnRK1"1 and "2 
subunits in the N-myristoyltransferase mutant nmt contributes to malformation of 
the shoot apical meristem and to developmental arrest (337). SnRK1 kinase 
activity was five fold increased in the nmt1-1 mutant, that also displayed glucose 
hypersensitivity (337).  
AMPK was shown to regulate fundamental cellular functions, such as cell 
polarity and cell division (338). Phosphorylation of the cyclin-dependent kinase 
inhibitor p27KIP1 by AMPK causes its stabilization, and thereby cell-cycle arrest, 
autophagy or apoptosis (339-341). Similarly, SnRK1 phosphorylates the 
Arabidopsis p27KIP1 homologs, KRP6 and KRP7, but this phosphorylation seems 
to promote cell division. This seemingly counterintuitive function of SnRK1 in 
promoting cell cycle progression could be unrelated to its energy sensing 
function, ensuring proper cell division in the absence of stress. It may also serve 
a coordinating function, allowing an orderly cell cycle arrest in the ensuing G1 
phase (342).  
Recently, SnRK1!1 was shown to interact, phosphorylate and stabilize 
FUSCA3 (FUS3) TF. SnRK1!1 and FUS3 interact genetically and functionally 
as positive regulators of ABA signaling, antagonize embryonic-to-vegetative and 
vegetative-to-reproductive phase transitions, and regulate lateral organ 
development in Arabidopsis thaliana (343, 344). SnRK1 was also shown to 
interact with the PETAL LOSS (PTL) TF that represses growth in inter-sepal 
zones of Arabidopsis (345), and with the plant-specific NAC TF family member 
ATAF1. ATAF subfamily members are positive regulators of plant development 
and accordingly, ATAF downregulation leads to dwarfism, sterility and reduced 
or absent flower initiation (346). Recently SnRK1!1 was shown to 
phosphorylate and repress the indeterminate domain 8 (IDD8) TF, with a 
consequent delay in flowering (347).  
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1.5 | Conserved Structures of SNF1/AMPK/SnRK1 complexes 
 
The common ancestral functions shared by SNF1/AMPK/SnRK1 kinases in 
the regulation of energy and carbon metabolism are accompanied by structural 
similarities (211, 348, 349). Purification and characterization of the AMPK 
complex revealed an heterotrimeric complex composition with an !-catalytic 
subunit, and a " and #-regulatory subunits (350). Multiple isoforms of the three 
subunits have been recognized in the genomes of almost all eukaryotes due to 
a remarkable structural conservation (220, 234, 239, 351). The !"# 
heterotrimeric complex is assembled through varied combinations of specific ! 
(Snf1 in yeast, !1/!2 in mammals, !1/!2 in plants), " (Sip1/Sip2/Gal83 in yeast; 
"1/"2 in mammals; "1/"2/"3 in plants) and # subunit isoforms (Snf4 in yeast; 
#1/#2/#3 in mammals; $/"#  in plants) (234, 239, 240, 276, 350).  Some 
experimental evidence also suggests the existence of atypical complexes, such 
as in the case of complexes devoid of AMPK#-regulatory subunits, that interact 
with the upstream hypothalamic calcium/calmodulin-dependent protein kinase 
kinase 2 (CaMKK2) independently of the adenine nucleotide ratios (352, 353). 
Even though dimeric complexes of SnRK1 have also been suggested (335, 
354), more recent studies do not support this (355, 356). Finally, alternative 
transcription initiation or splicing events can further increase the number of 
subunit variants and thereby the diversity of complexes assembled (276, 351, 
357). Some insights regarding complex-specific functions, distribution and 
regulation have emerged but further work is required in this respect (303, 358). 
The catalytic and regulatory subunits of SNF1/AMPK/SnRK1 complexes will be 























Figure 1.7 | Heterotrimeric structure of the SnRK1 complex. 
The !-subunit (in blue) is composed of a catalytic domain (in blue with the T-loop in cyan) and 
a regulatory domain (in purple-blue), which encompasses an ubiquitin-associated (UBA) domain, 
and a kinase-associated (KA1) domain for binding the "- and #-subunits. The #-subunit (in yellow) 
is composed of two “Bateman” domains, each of them containing two CBS (cystathionine-"-
synthase) domains and a "-interacting sequence ("IS). The plant-specific SnRK1"# possesses a 
carbohydrate-binding module (CBM). The "-subunit (in red) harbors an ASC (association to the 
Snf1 complex) domain, containing the sites of interaction with ! and #, a CBM and an N-terminal 
extension. The KIS (kinase interacting sequence) domain, traditionally used for designating the 
region comprising the CBM and the site for interaction with the !-subunit, is no longer used. The 
plant-specific SnRK1"3 is an atypical "-subunit, as it does not possess the CBM or the N-terminal 
extension. Adapted from (359). 
 
1.5.1 | !-catalytic subunit  
 
The catalytic subunit comprises an N-terminal kinase domain and a C-
terminal regulatory domain. It has the highest degree of cross-species 
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conservation amongst the three subunits, especially in the kinase domain of the 
protein (220, 360). The kinase domain displays a canonical fold (361) and 
contains the activation loop (T-loop), in which the phosphorylation of a 
conserved threonine (T) by upstream kinases is essential for activity 
(Snf1T210;AMPK!1T183/AMPK!2T172;SnRK1!1T175/SnRK1!2T176) (218, 359, 362-
365). The C-terminal regulatory domain in yeast and mammals harbors an auto-
inhibitory sequence (AIS) adjacent to the kinase domain (366, 367). This does 
not seem to be the case in SnRK1 (365), where instead an ubiquitin-associated 
domain (UBA) is present that may mediate the interaction with ubiquitylated 
proteins (368, 369). In addition, these kinases possess a kinase-associated 1 
(KA1) domain near the C-terminal end (also referred to as "-subunit interaction 
domain), responsible for the interaction with the regulatory subunits and the 
upstream phosphatases, as well as with other interacting proteins (241, 285, 
311, 368, 370-373) (Figure 1.7). A nuclear export sequence (NES) was 
identified in the C-terminal tail of AMPK! (374), whereas a nuclear localization 
signal (NLS) is present in the end of the kinase domain (375). Both signals 
seem to be conserved in the plant and yeast counterparts. It was shown that the 
yeast and mammalian !-catalytic subunits can form dimers, as observed in 
crystals and in in vivo co-immunoprecipitation assays (376-378), and the same 
might occur with the plant !-subunits (325, 379). However, the physiological 
relevance of such level of organization is still unclear. 
 
1.5.2 | "-regulatory subunit 
 
A primordial function of the "-regulatory subunit is to act as a scaffold 
between !- and #-subunits. It contains a carbohydrate-binding motif [CBM, also 
referred as glycogen-binding domain (GBD)] in the middle of the protein, shown 
to interact with glycogen in yeast and mammals (380-383). In plants, recent 




SnRK1 binding to starch or other carbohydrates, although an opposite 
conclusion was reached in a previous study (355, 384). Work in yeast supports 
that the CBM domain may exert regulatory functions independently of glycogen 
interaction (385, 386). The CBM domain largely overlaps, but not totally, with 
the previously assigned kinase interaction sequence (KIS) domain, which is 
required for the interaction with the regulatory domain of the !-catalytic subunit 
of yeast SNF1 and plant SnRK1 (234). A C-terminal domain, association with 
SNF1 complex (ASC), mediates the interaction with the #-subunit of yeast SNF1 
and plant SnRK1, and both !- and #-subunits of mammalian AMPK (351, 387). 
Besides the conserved domains, the "-subunits have variable N-terminal 
extensions that can determine subcellular localization, extent of activation and 
substrate specificity of the kinase complexes, through posttranslational 
modification switches (303, 348, 388-392). The plant-specific "3 subunit, 
contains only the ASC domain (lacking the N-terminal extension and CBM) and 
is still able to complement the gal83" sip1" sip2" yeast mutant devoid of all 
three "-subunits (240). In this atypical " subunit, the ASC domain interacts with 
both !- and #- plant subunits (Figure 1.7). 
 
1.5.3 | #-regulatory subunit  
 
#-subunits harbor two Bateman domains (393), comprising four 
cystathionine-beta-synthase (CBS) repeats that, in mammals, bind adenylates. 
Whereas CBS2 is free and CBS4 binds AMP non-exchangeably (394), CBS1 
and CBS3 bind adenylates (ATP/ADP/AMP) interchangeably (395, 396), and by 
this mean control the activity of the AMPK !-catalytic subunit (348, 349, 397). 
The CBS motifs are preceded by a pre-CBS domain in the N-terminus that is 
highly divergent (398). 
In plants there is an atypical #-subunit, apparently derived from a fusion of a 
CBM sequence present in the "-subunits, to the N-terminus of a #-subunit (276, 
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354) (Figure 1.7). The plant SnRK1"# protein is able to complement the yeast 
snf4" mutant, and it interacts with !- and "-subunits, forming plant-specific 
SnRK1 complexes (241, 276, 335, 355, 356, 399). On the contrary, the 
SnRK1#-subunit is unable to rescue snf4" and does not appear to interact with 
!- and "-subunits, suggesting that the SnRK1"# is the only canonical #-type 
subunit in plants (239, 355, 356).  
Crystal structures have revealed the dimerization of #-subunits in yeast and 
mammals. Yeast Snf4 and plant SnRK1"# were also shown to form dimers in 
vivo (399-401).  
 
1.6 | Regulation of SNF1/AMPK/SnRK1 kinases 
 
The activity of protein kinases can be regulated at the expression level and 
also through swift posttranslational modifications (PTMs), such as 
phosphorylation, acetylation and ubiquitylation, amongst many others. The 
binding of activating subunits, inhibitor proteins or metabolites can adjust the 
kinase response to specific cues. Additionally, kinase modulation is also 
achieved through oligomerization, intracellular translocation or protein cleavage. 
The possible interconnection between the different modes of regulation further 
expands the versatility and complexity of the system. Whereas most of the 
regulatory mechanisms are reversible (e.g. phosphorylation/ dephosphorylation 
or binding of protein regulators), an irreversible downregulation (e.g. by 
degradation through the ubiquitin-proteasome system) can dictate signal 
termination. The commitment to degradation is most often triggered by an active 
kinase, especially when the activity is sustained (402).  
The SNF1/AMPK/SnRK1 kinases are controlled by numerous mechanisms 
that have an impact on kinase activity, stability, and/or subcellular localization. 











Figure 1.8 | Regulatory mechanisms controlling the SnRK1 kinase. 
Multiple factors regulate SnRK1, some of which are conserved across eukaryotic orthologs. 
Broken lines and full lines designate links that are indirect or require further support, and direct 
connections, respectively. P, phosphorylation; Ub, ubiquitylation; Myr, myristoylation; SnAKs, 
SnRK1-activating kinases; GRIKs, Geminivirus Rep-interacting kinases; 5PTase13, myoinositol 
polyphosphate 5-phosphatase 13; PRL1, Pleiotropic Regulatory Locus 1; PP2C, Protein 
Phosphatase type 2C; ABA, abscisic acid; G1P, Glucose-1-phosphate; G6P, Glucose-6-
phosphate; T6P, Trehalose-6-phosphate. 
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1.6.1 | Complex composition 
 
Multiple combinations of the different catalytic and regulatory subunits of 
SNF1/AMPK/SnRK1 heterotrimers lead to a diversity of kinase complexes. 
Furthermore, the spatiotemporal regulation of individual subunits is determinant 
for complex composition, which can be a mean to attain specificity. Different 
upstream regulators and downstream effectors likely recognize different 
SNF1/AMPK/SnRK1 complexes, and strategies to determine complex 
composition should be undertaken in the study of the respective signaling 
pathways.  
As previously mentioned, hormones, metabolic and environmental cues, 
differentially regulate the expression of specific subunits of the SnRK1 complex 
(e.g. through transcriptional control and alternative splicing). Subunit 
composition may also be unique to particular subcellular compartments, tissues 
or developmental stages (312). For instance, Arabidopsis SnRK1" genes have 
specific patterns of expression throughout plant development, and the 
expression of SnRK1"1 is induced by ammonium (304) and dark, and 
repressed by sugar (303). SnRK1"1 containing complexes specifically interact 
with NR, promoting its phosphorylation and inhibition with a consequent 
downregulation of nitrogen assimilation (303).  
The total number of !-, "-, and #-subunits present in Arabidopsis prompts the 
possibility of 6 different heterotrimers, taking into account that the #-subunit 
does not interact with !- or "-subunits, and that "# is considered the only 
canonical #-type subunit (403, 404). Though, the number of possible 
heterotrimers increases if alternatively spliced variants are considered.  
In a study using bean seeds, SnRK1 complexes were separated by size 
exclusion chromatography and the distribution of SnRK1 activity was evaluated 
through detection of T-loop phosphorylated and non-phosphorylated catalytic 
subunits in each fraction. A differential distribution of SnRK1 activity per 




supports the idea that multiple types of SnRK1 complexes might be present. In 
the same study, the regulation of SnRK1 activity by metabolites, or in different 
developmental stages, revealed differences that were dependent on the 
substrate sequence used in the in vitro kinase assays, evidencing a possible 
substrate specificity conferred by different SnRK1 complexes (405). On the 
other hand, G1P, G6P, and T6P inhibit SnRK1 in young tissues via an 
intermediary factor that is separable from SnRK1. Since maximal inhibition by 
G1P and G6P metabolites was found on SnRK1 complexes of the same size as 
for T6P (~174kDa), it is likely that the SnRK1 complexes inhibited by these 
metabolites are very similar, requiring possibly the same intermediary factor.  
Moreover, plant-specific regulatory subunits "3 and "# have probably 
evolved to confer SnRK1 complexes plant-specific functions (211, 331, 359). It 
was suggested that SnRK1 could form heterodimers composed of ! and "#-
subunits, and devoid of a "-regulatory subunit (335, 354). However, the most 
recent studies do not support the existence of such SnRK1 dimers (355, 356).  
In the yeast system, three alternate SNF1 heterotrimeric complexes exist 
composed of distinct "-subunits, Sip1, Sip2 or Gal83, together with single !- 
(Snf1) and #- (Snf4) subunits. The "-subunits have divergent N-termini that 
confer unique subcellular localization patterns and direct the localization of the 
catalytic Snf1 subunit, upon glucose deprivation (348). The differential 
distribution of distinct SNF1 complexes within the cell can affect substrate 
access. Thus, despite of a considerable functional overlap, "-subunits are 
implicated in distinct processes. For instance, Sip2 is implicated in aging (406) 
whereas Gal83 mediates the interaction of Snf1 with the transcriptional activator 
Sip4 (407), and possibly with the transcriptional apparatus (408). The different 
"-subunits also confer stress-dependent preferences for activation by the 
upstream kinases Sak1, Tos3, and Elm1 (348, 409). 
Similarly, AMPK heterotrimers are composed of distinct !-, "-, and #-subunits 
that show differential tissue-specific expression and activation. AMPK!2 is 
highly abundant in skeletal muscle whereas AMPK!1 is more evenly distributed 
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across different tissues. AMPK"1 and "2 subunits show an expression profile 
comparable to AMPK!1 and !2, respectively. Regarding the regulatory #-
subunits, #1 and #2 have a more widespread distribution whereas #3 is mostly 
restricted to the skeletal muscle (357). For instance, it was shown that specific 
AMPK complexes containing the AMPK!2 catalytic subunit are required for the 
direct activation of fatty acid oxidation by leptin, in skeletal muscle cells (375, 
410). On the other hand, the small molecule activator A-769662 is selective for 
the AMPK"1 isoform (358), exemplifying how complex composition can 
determine the regulation of specific AMPK heterotrimers (357). Some 
experimental evidence suggests the existence of atypical AMPK complexes, 
devoid of AMPK#, that interact with the upstream hypothalamic 
calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) independently 
of the adenine nucleotide ratios (352, 353). 
 
1.6.2 | Scaffold proteins 
 
The binding of adaptor proteins can further increase the versatility of 
SNF1/AMPK/SnRK1 complexes by bridging their interaction with specific targets 
or upstream effectors, and also by turning the complex susceptible to regulation 
by different metabolites. For instance, SnRK1 complex inhibition by T6P 
requires a yet unknown intermediary factor. Recently, it has been proposed that 
proteins containing the domain of unknown function 581 (DUF581) may work as 
auxiliary adaptor modules of SnRK1, providing specificity towards distinct 
regulators or substrates under certain conditions (312). DUF581 proteins 
interact with Arabidopsis SnRK1!1 and !2 catalytic subunits and their co-
expression re-located SnRK1 to different subnuclear loci. The expression of 
DUF581 genes is differentially regulated by hormonal and environmental cues, 
indicating possible specialized functions for each of the nineteen DUF581 




regulated dormancy 1 (MARD1), appears to be a positive regulator of seed 
dormancy, as mard1 seeds are less dormant and their radicle protrusion during 
germination is resistant to external ABA (411). This resembles the ABA 
insensitive phenotypes of SnRK1 silencing in pea seeds (286). On the other 
hand, overexpression of DUF581-18 in Arabidopsis increases resistance to 
aphids (412), and overexpression of a drought-inducible DUF581 wheat protein 
in Arabidopsis conferred salt and drought tolerance and rendered seeds 
hypersensitive to ABA (413). Furthermore, SnRK1 catalytic subunits and 
DUF581-18 shared a common target, the storekeeper related 1 (STKR1) 
transcriptional regulator (312), implied in sucrose-regulated gene expression in 
potato (414).  
 
1.6.3 | Oligomerization 
 
The formation of higher order oligomeric complexes can provide an additional 
layer of kinase regulation (415). Yeast SNF1 catalytic (Snf1) and regulatory 
(Snf4) subunits were shown to form dimers in crystals and in vivo (376, 377, 
400). Dimerization was also observed with mammalian AMPK! or # subunits 
(378, 401) and with maize "#-subunits (399). The dimerization interface in Snf1 
and AMPK! seems to involve extensive hydrophobic interactions around the 
activation loop of the catalytic subunits (377, 378). Importantly, supramolecular 
assemblies of dimers of heterotrimers have been reported for SNF1 and AMPK 
(372, 416, 417). Furthermore, the expected molecular weights of AMPK and 
SnRK1 heterotrimers were largely exceeded in size exclusion chromatography 
analyses (325, 417), suggesting higher order oligomers and/or complex 
assembly with other proteins. It is proposed that the regulation by 
oligomerization may be particularly important in specific subcellular loci where 
the kinases are highly concentrated, since dimerization appears to be a 
reversible and concentration-dependent process (378, 417). Higher order 
CHAPTER 1 | 
! 68 
oligomers were associated with an inactive state of the AMPK complex (378) 
and it was also speculated that upon dimerization Snf1 becomes inaccessible 
for T-loop phosphorylation, rendering the oligomer inactive (377). A similar 
outcome could result from SnRK1 oligomerization since the distribution of T-
loop phosphorylation in size fractionation studies reveals a weaker phospho-
signal associated with higher order complexes, and a stronger phospho-signal 
in fractions with the average heterotrimer molecular weight (325). 
 
 
1.6.4 | Subcellular localization 
 
The emergence of subcellular compartments in eukaryotes allowed for new 
ways of storing nutrients beyond the extracellular and cytosolic boundaries, and 
required additional sensors to tightly balance and coordinate cellular and whole-
organism metabolism (418). The mechanisms that regulate SNF1/AMPK/SnRK1 
subcellular localization modulate their access to downstream targets or 
interacting proteins in vivo (374). Recently, it was suggested that under low 
nutrient conditions, AMPK activation by the upstream kinase tumor suppressor 
liver kinase B1 (LKB1) occurs on the surface of the lysosome, through the 
adaptor protein AXIN. On the other hand, AXIN associates with LAMTOR, a 
component of the Ragulator complex, shown to promote binding of target of 
rapamycin complex-1 (mTORC1) to the lysosome under nutrient rich conditions. 
It was suggested that the Ragulator complex could act as a switch between 
catabolism (through AMPK activation) and anabolism (through mTORC1 
activation) at the lysosomal membrane (419, 420).  
As previously mentioned, in yeast, the "-subunits direct the localization of the 
catalytic subunit Snf1 (348). All three "-subunits are cytoplasmic in conditions of 
abundant glucose. However, in response to glucose depletion, the Sip1 "-
subunit re-localizes to the vacuolar membrane (389), similarly to the lysosome 




nucleus, whereas Sip2 remains cytoplasmic (421). Whether SnRK1 can 
similarly localize to the vacuole surface or not is still an open question.  
The subcellular localization of SnRK1 can be differentially regulated in 
various tissues, developmental stages and under various conditions. In 
agreement with a cytoplasmic role, SnRK1! catalytic subunits associate with "- 
and "#-regulatory subunits in the cytoplasm (399), and directly target and 
phosphorylate key metabolic cytoplasmic enzymes. SnRK1 accumulated in 
Golgi bodies, and a dispersed signal was obtained upon incubation with the 
Golgi disruptor brefeldin A (335). On the other hand, the nuclear localization of 
some of the subunits of the SnRK1 complex (218, 276, 335, 345) is also in 
accordance with the central role of SnRK1 in transcriptional reprogramming. 
Both NLS and NES motifs were characterized in AMPK! (374, 375), and seem 
to be conserved in the catalytic subunits of plant (SnRK1!1 and SnRK1!2) and 
yeast (Snf1). It was hypothesized that the TFs FUS3 and PTL, at least, may 
retain SnRK1!1 in the nucleus through binding to its C-terminal part and thus 
masking of the conserved NES in this region (345).  
Furthermore, the described interaction of SnRK1!1 and SnRK1"# at the 
plasma membrane is consistent with the potential assembly of SnRK1 
heterotrimeric complexes with membrane-bound myristoylated SnRK1"1 and 
"2. The atypical subunit SnRK1"3 lacks the conserved N-terminal and CBM 
domains, is not myristoylated (240), and should be absent in membrane-
associated complexes (276, 337). However, it cannot be excluded the presence 
of SnRK1"2 and "1 in SnRK1 heterotrimeric nuclear complexes, since 
SnRK1"2 can co-localize with "# in the nucleus (276), and deletion of the N-
terminal myristoylation signal results in nuclear accumulation of SnRK1"1 
complexes (337). Tissue and subcellular distribution of SnRK1!1 and SnRK1"# 
were analyzed throughout development, using a BAC-recombineering strategy 
in Arabidopsis (335). SnRK1"# had a predominant nuclear localization that 
overlapped with similar localization of SnRK1!1 in young organs, such as leaf 
primordia, and meristematic zones of roots and shoots. However, and unlike 
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SnRK1"#, SnRK1!1 accumulation was observed in the cytoplasm and at the 
plasma membrane in most other tissues throughout development (335). 
SnRK1!1 was also reported to localize in chloroplasts and the "#-subunit has a 
chloroplast transit peptide (263). Finally, it has to be considered that different 
cues might trigger re-localization of the kinase to yet other subcellular 
compartments. 
 
1.6.5 | Adenylates, sugars and hormones 
 
The SNF1⁄AMPK⁄SnRK1 kinases are regulated by universal signals like 
adenylates and sugars, whereas more specific hormonal cues have likely 
evolved to regulate these kinases at the whole organism-level. Adenylates are 
interconverted from ATP to ADP in energy consuming processes, or from ADP 
to ATP during catabolism. The adenylate kinase brings AMP to this dynamic 
equation through the bidirectional reaction 2ADP*ATP + AMP, favored from left 
to right in metabolically stressed cells. In such case, the AMP:ATP ratio 
increases to a greater extent than ADP:ATP. Thus, adenylate ratios (AMP:ATP 
and ADP:ATP) act as fundamental signals of the energy charge of the cell 
(422). In mammals, increases in AMP⁄ATP ratio exert a tripartite regulation on 
AMPK kinase activation. AMP binding to CBS motifs in the #-regulatory subunit 
promotes 1) AMPK allosteric activation and 2) phosphorylation by the upstream 
kinase LKB1, whereas AMP or ADP binding 3) prevents dephosphorylation by 
upstream phosphatases (349, 373, 390, 391, 397, 423). In yeast, ADP is 
involved in a bipartite regulation of SNF1 activation that is independent of the 
regulatory subunits, promoting phosphorylation by upstream kinases, but mostly 
protecting from dephosphorylation by upstream phosphatases (424). In plants, 
SnRK1 regulation by AMP was only associated with protection from 




SnRK1 complex from spinach leaves (246). However, the mechanism 
underlying this regulation is still poorly understood in plants (359).  
The regulation of SnRK1 signaling by various sugars and hormones, have 
been addressed in previous sections. 
 
1.6.6 | Posttranslational modifications 
 
Posttranslational modifications (PTMs) allow rapid and dynamic changes on 
the proteome that do not rely on translation, which besides consuming amino 
acids, is one of the most energy-demanding processes in the cell (418, 425). 
PTMs regulate the activity, stability and subcellular localization of 
SNF1/AMPK/SnRK1 kinases, and likely play an important role in the response 
to environmental and metabolic cues. 
Whereas the essential role of T-loop phosphorylation on the catalytic subunit 
has been extensively characterized, several other PTMs including ubiquitylation, 
sumoylation, acetylation, myristoylation, and oxidation, have been implicated in 
the regulation of either catalytic and/or regulatory subunits within 
SNF1/AMPK/SnRK1 complexes (359).  
 
1.6.6.1 | Phosphorylation 
 
Phosphorylation of a conserved threonine (T) residue (Snf1T210; 
AMPK!1T183/AMPK!2T172; SnRK1!1T175/SnRK1!2T176) in the catalytic subunit is 
essential for SNF1/AMPK/SnRK1 activity. A size fractionation analysis from 
Arabidopsis seedlings, revealed a distribution of SnRK1!1T175/SnRK1!2T176 
phosphorylation with a stronger signal intensity coupled with the main peak of 
SnRK1 activity, at approximately 100 kDa, suggesting that the phosphorylated 
catalytic subunit is incorporated into a heterotrimeric complex (325). In this 
study, the majority of SnRK1 activity was attributed to the SnRK1!1 isoform, as 
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previously observed in preparations from Arabidopsis cell suspension cultures 
(284, 325). In yeast and mammalian systems, differential phosphorylation is 
observed in high energy (kinase repressing) versus low energy (kinase 
activating) conditions. Yeast cells subjected to glucose deprivation become 
strongly phosphorylated on Snf1T210 rendering the complex active, whereas 
Snf1T210 phosphorylation is undetected in cells grown in abundant glucose (363). 
AMPK allosteric activation by AMP in energy deficit conditions is coupled with 
reversible phosphorylation of AMPK!T172 (426). However, unlike the yeast and 
mammalian counterparts, equal phosphorylation levels of 
SnRK1!1T175/SnRK1!2T176 are detected in control and stress activating 
conditions in plants (218, 263, 285, 290). A finer level of regulation, with tissue 
or subcellular-specificity, might have been missed with analyses of total plant 
cell extracts, but additional phospho-residues as well as other mechanisms for 
controlling activity may also be involved in SnRK1 regulation.  
Several of the upstream kinases of SNF1/AMPK/SnRK1 complexes show 
great homology, highlighting the conservation of these systems. The upstream 
kinases of SNF1 in yeast, Sak1, Elm1 and Tos3 have partially redundant 
functions, since growth on alternative carbon sources is only impaired in the 
triple elm1" sak1" tos3" mutant (427), but show stress-dependent preferences 
for particular "-subunit containing SNF1 complexes (409).  The AMPK upstream 
kinase tumor suppressor liver kinase B1 (LKB1) was identified based on its 
sequence similarity with the yeast SNF1 activating kinases, and a CaMKK, 
CaMKK", was shown to phosphorylate AMPK!T172, allowing the input of Ca2+ 
signals into the AMPK pathway (428, 429), independently of the adenine 
nucleotide ratios (352, 353). The transforming growth factor "-activated kinase 1 
(TAK1) might also be an AMPK upstream kinase, particularly under conditions 
where reactive oxygen species and redox imbalance are generated (430, 431). 
All AMPK upstream kinases were shown to complement the yeast elm1" sak1" 
tos3" triple mutant (432). Sequence comparison, complementation and 




2 (SnAK1/2; also called Geminivirus Rep-interacting kinase 2/1, GRIK2/1), as 
the upstream kinases of SnRK1 in plants (248, 268, 364, 365). Similarly to 
LKB1, SnAKs appear to be constitutively active, and are insensitive to Ca2+, 
AMP and to the CaMKK-specific inhibitor STO-609, when assayed in vitro (365). 
SnAKs autophosphorylate on SnAK1T153/SnAK2T154, and this phosphorylation is 
required for their activity (364, 433). SnRK1 cross-phosphorylates and 
inactivates SnAK1S260/SnAK2S261 in vitro, probably as part of a negative 
feedback loop to tightly control SnRK1 activation (364). This kinase cross-
regulation may be conserved in the yeast system (434). However, along with the 
lack of in planta evidence for SnAKs functional relevance on SnRK1 signaling, 
SnAKs/GRIKs are only detected in geminivirus-infected mature leaves and in 
actively proliferating tissues that do not cover the range of detection of SnRK1 
phosphorylation (365). Proteasomal degradation of SnAKs may justify the 
undetectably low levels of these proteins in several tissues, but the possible 
existence of other upstream kinases awaits further exploration (268, 365). 
Mammalian CaMKK can phosphorylate SnRK1 purified from spinach in vitro 
(246), and the CIPK15-SnRK1A-MYBS1 circuitry, required for rice seedlings to 
tolerate flooding (309), suggests that endogenous Ca2+-dependent kinases like 
CIPKs or others may also serve as SnRK1 upstream kinases (359).  
In the SNF1/AMPK/SnRK1 systems, reversal of T-loop phosphorylation by 
upstream phosphatases occurs in response to nutrient supply and in energy 
homeostasis conditions. When glucose is available, the yeast protein 
phosphatase 1  (PP1) Glc7-Reg1 is able to access and dephosphorylate 
Snf1T210 (435), and the PP2A-like phosphatase, Sit4, is also able to 
dephosphorylate Snf1T210 in vivo (436). PP2A and PP2C phosphatases were 
reported to dephosphorylate and inactivate mammalian AMPK and plant SnRK1 
in vitro (242, 246, 437). Recently, clade A PP2Cs, ABI1 and PP2CA, were 
reported to interact and dephosphorylate Arabidopsis SnRK1!1 (285). ABI1 and 
PP2CA are negative regulators of the ABA pathway via their interaction with 
SnRK2 kinases, and are blocked by the ABA receptors upon ABA binding (438).  
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PP2Cs inactivate SnRK1 in response to sugars and conversely, repression of 
PP2Cs by the ABA receptors allows the activation of SnRK1 by this 
phytohormone (285). Other PPs were reported to interact with SnRK1!2 in vitro 
and in yeast two-hybrid assays, namely PP2C74 (439) and the dual-specificity 
protein tyrosine phosphatase PTPKIS1 (440), although the functional relevance 
of these interactions is still unknown. PTPKIS1 binds starch through a CBM 
domain (441) and was identified as the component responsible for starch 
overaccumulation in the sex4 mutant (442), suggesting it may regulate the initial 
steps of starch degradation at the granule surface (442, 443). 
In addition to phosphorylation of the conserved T-loop threonine residue, 
other phosphorylation events have been described in the regulation of 
SNF1/AMPK/SnRK1 kinases. AMPK phosphorylates and activates the 
autophagy-initiating kinase Ulk1 (444). The cross-phosphorylation of AMPK 
catalytic and regulatory subunits by Ulk1 and subsequent inactivation, can be 
part of a negative feedback loop to reset AMPK (445). Phosphorylation of 
AMPK! S485 (446, 447) and S173 (448) residues inhibits AMPK activity in 
response to insulin (mediated by Akt/PKB kinase) and to PKA-mediated cAMP 
signaling, respectively. These phosphorylation events seem to interfere with the 
phosphorylation of AMPK!T172. Other phosphorylated residues were found in 
AMPK!- and "-subunits, but the relevance of those modifications is still unclear 
(357, 449-451). Interestingly, the cell death suppressor Adi3, triggered by 
pathogens in tomato, interacts with SnRK1!1 and phosphorylates the Gal83 "-
subunit inhibiting the activity of the SnRK1 complex (275). The functional 
relevance of this mechanism should be determined in response to other types of 
environmental, metabolic and hormonal cues. 
 
1.6.6.2 | Ubiquitylation 
 
Signal termination in kinase-mediated pathways can be achieved through the 




impairment may lead to sustained kinase activity with deleterious outcomes. As 
previously mentioned, the activation of protein kinases can initiate their 
downregulation, and several mechanisms may signal the kinase activation 
status to the ubiquitylation machinery. Phosphorylation of active kinases, either 
through a cis or trans modification can create a binding site for E3 ligases or a 
phosphodegron recognized by phospho-dependent Skp1-cullin-F-box (SCF) 
ligases. Kinase activation may lead to conformational changes that allow the 
binding of E3 ligases, or expose degrons that were otherwise masked in the 
inactive state. Importantly, multiple E3 ligases often cooperate to terminate 
kinase signaling, depending on spatiotemporal and stimuli specificities (402). In 
agreement with this view, the inactive kinases SnRK1!1K48M and T-loop 
phosphorylation mutant SnRK1!1T175A accumulate to much higher levels than 
the WT SnRK1!1 protein in Arabidopsis (218), suggesting that stability of the 
SnRK1 protein kinase is connected with its activity and phosphorylation status.  
Large proteomic studies to identify ubiquitylated proteins in planta detected 
ubiquitylation of SnRK1!1 (on K20 and K43 of the SnRK1!1.1 and SnRK1!1.2 
splice variants, respectively) (452), SnRK1!2 and SnRK1"#  (453). The extent 
of ubiquitylation increased substantially upon MG132 treatment, indicating it 
may be an important signal for proteasomal breakdown of SnRK1 subunits 
(453). Accordingly, SnRK1!1 is targeted for proteasomal degradation in a 
myoinositol polyphosphate 5-phosphatase (5PTase13)-dependent manner 
under low nutrient conditions (326). SnRK1!1 degradation may also be 
mediated by the DDB1-CUL4-ROC1-PRL1 E3 ubiquitin ligase, in which PRL1 is 
the putative substrate receptor of the complex (454). SnRK1!1 interacts with 
PRL1 (311, 368) and its proteasomal degradation is slower in prl1 and cul4cs 
extracts than in the WT, accumulating to a higher extent in these mutants (454). 
On the other hand, PRL1 was reported to compete with SKP1/ASK1 for binding 
SnRK1!1 and SnRK1!2. SKP1/ASK1 is a component of SCF E3 ubiquitin 
ligases and although SnRK1 participates in the assembly of a proteasomal 
complex with this E3 ligase, there is also the possibility that SnRK1 degradation 
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is mediated either by the SCF complex or the CUL4-DDB1 machinery upon 
varied conditions (368, 454).  
During growth on alternative carbon sources, ubiquitylation of yeast Snf1 
negatively modulates its stability through proteasome-mediated degradation, as 
well as phosphorylation and catalytic activity (455). The deubiquitylase Ubp8 is 
part of the histone modifier SAGA complex and was shown to counteract Snf1 
ubiquitylation (455), whereas the SUMO-targeted ubiquitin ligase (STUbL) Slx5–
Slx8 promoted UPS mediated degradation of sumoylated Snf1 (171). 
The first detection of AMPK ubiquitylation allowed the identification of 
unusual ubiquitin-chain topologies (like the K29/K33-linked polyubiquitin chains) 
that might be associated with non-proteolytic outcomes (456). Ubiquitylation of 
AMPK" with K63-linked chains promoted AMPK" stability, possibly through its 
allocation into inclusion bodies and protection from proteolytic turnover. 
However the latter modification did not affect global AMPK activity (457). On the 
other hand, the cell death-inducing DFF45-like effector (Cidea) forms a complex 
in vivo with AMPK and modulates AMPK stability and activity promoting its 
ubiquitylation and proteasome-mediated degradation in brown adipose tissue 
(458). Cidea-null mice accumulate higher levels of AMPK!, ", and # subunits 
with a consequent increment of AMPK!T172 phosphorylation and catalytic activity 
(458).  
 
1.6.6.3 | Sumoylation 
 
Regulation of AMPK and SNF1 by sumoylation was recently described and 
associated with various outcomes. In AMPK, both catalytic and "2 subunits 
were identified as SUMO targets (37, 459). MS analyses within a large 
proteomic study detected sumoylated AMPK!1 and AMPK!2 in response to 
proteasome inhibition, suggesting sumoylation may be implicated in 
proteasomal degradation of AMPK! subunits. A single lysine residue was 




were also retrieved after SUMO protease inhibition and heat shock treatments, 
and to a lesser extent in control conditions (37). In contrast, in another study, 
sumoylation of AMPK"2 enhanced AMPK activity by increasing T-loop 
phosphorylation. It was suggested that sumoylation and ubiquitylation might be 
antagonistic processes in AMPK"2 (459). On the other hand, Snf1 sumoylation 
downregulates SNF1, independently of T-loop phosphorylation. In response to 
glucose, Snf1 is sumoylated at a single lysine residue, and a conformational 
switch induced by the interaction between the sumoylated residue and a SUMO-
interacting motif (SIM), leads to a rapid inhibition of the kinase. In a long-term 
response, sumoylated Snf1 is ubiquitylated via the SUMO-targeted ubiquitin 
ligase Slx5–Slx8, and targeted for degradation, with the consequent decrease in 
Snf1 levels in response to glucose sensing (171). 
Arabidopsis SnRK1!1 interacted with the E2 SUMO conjugating enzyme 
(SCE1) and with the SUMO protease ESD4 in a yeast two-hybrid screen (67). 
Furthermore, in the same study, SnRK1!1 was found to be sumoylated with 
both SUMO1 and SUMO3 isoforms in a high-throughput assay in Escherichia 
coli. The fact that SnRK1!1 has high probability SUMO attachment sites (67) 
and that sumoylation has been implicated in the plant abiotic stress response 
(460) suggests that sumoylation may be a conserved mechanism for controlling 
SNF1/AMPK/SnRK1 activity and stability (359). 
 
1.6.6.4 | Acetylation 
 
Modification by acetylation has been described for SNF1 and AMPK. The "-
regulatory subunit of SNF1, Sip2, is a substrate of the nucleosome 
acetyltransferase of H4 complex (NuA4) and was found acetylated in vitro and 
in vivo (461). Sip2 acetylation stabilizes an inhibitory interaction with the Snf1 
catalytic subunit and seems to promote longevity, since Sip2 acetylation 
mimetics live longer (462). AMPK!1 is acetylated in vitro by the p300 
acetyltransferase (463, 464) and AMPK#1 was also found acetylated in its N-
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terminus (449). However, the functional relevance of these modifications awaits 
further clarification. Even though none of SnRK1 subunits was found acetylated 
until now, the studies in mammals and yeast suggest all three subunits could be 
subjected to this modification (359). 
 
1.6.6.5 | Myristoylation 
 
Myristoylation is the irreversible co-translational conjugation of myristate to 
proteins, and depends on an N-terminal consensus motif MGxxxS/T, where 
myristate becomes attached to Glycine2 via an amide bond (337, 465). 
Myristoylation of AMPK, SNF1, and SnRK1 modulates their activity and 
subcellular localization. Both AMPK"1 and "2 regulatory subunits are 
myristoylated in vivo (391, 449).  It was proposed that when ATP levels are 
high, the myristoyl-group binds a hydrophobic region within the AMPK complex, 
keeping it in an inactive state. In AMPK activating conditions, AMP binding 
triggers a conformational change and exposes the myristoyl group to the solvent 
allowing kinase activation and membrane association if required. This model 
evidences the requirement of myristoylation for the allosteric activation of AMPK 
by AMP (390-392).  
Sip1 and Sip2 "-regulatory subunits of SNF1 are also myristoylated. 
Myristoylation of Sip2 is fundamental for the normal cellular life span of S. 
cerevisae (466) and for the proliferative potential during stationary phase (467). 
In young cells, myristoylated Sip2 is located at the plasma membrane and 
sequesters Snf4, the activating #-subunit of the SNF1 complex. With aging, Sip2 
re-localizes from the plasma membrane to the cytoplasm allowing Snf4/Snf1 
entry into the nucleus where the Snf1 catalytic subunit modifies chromatin 
structure (466). Myristoylation of Sip1 regulates its subcellular localization in 
response to the carbon status of the cell. In glucose grown cells, Sip1 localizes 
to the cytosol and in response to carbon stress re-localizes to the vacuolar 




Myristoylation of SnRK1 was found to be a critical event for shoot apical 
meristem differentiation and plant development. In an nmt1-1 mutant SnRK1 
kinase activity and SnRK1"1 transcript levels were five-fold and two-fold higher, 
respectively, than in wild type plants. In the same study, GFP fusions of either 
SnRK1"1 or SnRK1"2 localized to the plasma membrane, whereas a G2A 
substitution preventing myristoylation of the "-subunits re-localized SnRK1"1 to 
the nucleus and SnRK1"2 to the cytoplasm, mimicking what happens in the 
nmt1-1 line. It was hence suggested that myristoylation of "1 or "2 subunits 
sequesters the complex to the plasma membrane, acting as a negative 
regulator of the SnRK1 pathway, in accordance with the glucose hypersensitivity 
of the nmt1-1 mutant (337, 468). 
 
1.6.6.6 | Oxidation 
 
AMPK is regulated by the intracellular redox status through two key cysteine 
residues in the catalytic subunit. Oxidation leads to the formation of AMPK 
aggregates through intermolecular disulfide bonds and compromises the 
interaction with the upstream kinase LKB1, blocking AMPK phosphorylation and 
activation. On the other hand, thioredoxin 1 reduces these cysteine residues 
and promotes AMPK activation during energy starvation (469). Sequence 
alignment reveals that these two residues are the only cysteines completely 
conserved in the respective kinases in yeast, mammals and plants, opening the 
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1.7 | Aims and thesis scope 
 
The aim of the work described in this thesis was to gain further insight on 
SnRK1 signaling in plants, namely through dissection of its regulatory 
mechanisms. We focused on novel posttranslational modifications of the SnRK1 
kinase that could explain its activation in response to energy deprivation 
conditions. Considering 1) the presence of high probability SUMO attachment 
site (hpSAS) motifs on SnRK1!1 catalytic subunit, 2) the detection of high 
molecular weight (hMW) SnRK1!1 forms potentially corresponding to SnRK1!1-
SUMO conjugates, and 3) the important roles ascribed to the SUMO pathway 
and SnRK1 signaling in the plant response to various biotic and abiotic stresses 
(22, 29, 103, 221, 259, 447, 459), we hypothesized that SUMO and SnRK1 
could be entwined in the plant stress response, namely through sumoylation of 
the SnRK1 kinase, and possibly through SnRK1-dependent phosphorylation of 
SUMO pathway components, due to several SnRK1 phosphorylation consensus 
motifs in these proteins. 
Detailed evidence of posttranslational modification of the SnRK1 complex by 
sumoylation and ubiquitylation, and their functional implications in SnRK1-
dependent energy signaling in plants, will be provided. Furthermore, a 
mechanism of signal termination through sumoylation of activated SnRK1 is 
proposed based on the obtained results, and suggested to be conserved in the 
SNF1 and AMPK orthologs as well. The next sections will be organized as 
follows: 
 
Chapter 2 | Sumoylation of the SnRK1 complex 
In this chapter we present evidence that SnRK1 is sumoylated at the whole 
complex level, possibly in multiple residues and/or with (poly)SUMO chains. 
Using yeast two-hybrid assays, a heterologous system that reconstitutes the 
Arabidopsis SUMO pathway in E. coli, and through immunoprecipitation of 
SnRK1!1 from plants followed by immunodetection with anti-SUMO1 antibody, 
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we unravel sumoylation as a new layer of regulation of this central kinase in 
plant energy signaling. We also show that in planta SnRK1 sumoylation by 
SUMO1 is mediated by the E3 SUMO ligase SIZ1. Finally, considering the data 
presented, together with the reported sumoylation of Snf1 and AMPK in vivo, we 
suggest sumoylation is a conserved posttranslational regulatory mechanism of 
the central family of SNF1/AMPK/SnRK1 kinases. 
 
Chapter 3 | Biochemical and functional outcomes of SnRK1 sumoylation  
In this chapter we present evidence that SnRK1 sumoylation is a novel 
regulatory mechanism that impacts SnRK1 protein stability and thereby 
impinges on its activity and SnRK1 signaling in planta. We suggest that there is 
a cooperative interplay between SnRK1 sumoylation and its subsequent 
ubiquitylation, in targeting the protein kinase towards proteasomal degradation. 
We also present preliminary evidence supporting sumoylation may affect 
SnRK1 complex composition and a putative oligomerization state. 
 
Chapter 4 | SnRK1 pathway activation and signal termination 
In this chapter we present evidence suggesting that the SUMO-dependent 
degradation of SnRK1 is triggered by its activation, as part of a negative 
feedback loop to prevent deleterious effects derived from overly high SnRK1 
signaling. Furthermore, we show that SnRK1 phosphorylates the E3 SUMO 
ligase SIZ1 in vitro, and hypothesize that such mechanism may couple stress 
and SnRK1 activation to its sumoylation/ubiquitylation, and subsequent 
degradation in planta. 
 
Chapter 5 | Concluding remarks and future perspectives 
In this chapter we discuss and integrate the main findings resulting from the 
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Plants sense and adapt to environmental stresses to promote survival under 
ever-changing conditions. The plant SnRK1 (Snf1-Related protein Kinase 1) is a 
central component of the stress response conserved in all eukaryotes. It 
functions as a heterotrimer composed of !-catalytic and " and #-regulatory 
subunits. In contrast to its mammalian and yeast homologues, SnRK1! T-loop 
phosphorylation/dephosphorylation is required but insufficient to determine its 
activation under stress and subsequent inactivation once homeostasis is 
restored. Thus, based on several lines of evidence, we hypothesized that other 
posttranslational modifications, like SnRK1 sumoylation, may be involved. Here, 
we show that SnRK1 interacts with the E2 SUMO conjugating enzyme in yeast 
two-hybrid assays and undergoes sumoylation in a heterologous E. coli system. 
Immunoprecipitation experiments further demonstrate that sumoylation of 
SnRK1 occurs in planta, seemingly as a coordinated event at the whole-
complex level, as both catalytic and regulatory subunits undergo this 
modification. Moreover, poly- and/or multisumoylation events seem to occur on 
these subunits. We identify SIZ1 as the E3 SUMO ligase responsible for SnRK1 
sumoylation by SUMO1 in Arabidopsis, and suggest SnRK1 sumoylation adds a 
new layer of regulation of this central kinase in plant energy signaling. 
 
 
2.1 | Introduction 
 
The plant Snf1-related Protein Kinase 1 (SnRK1) is a central component of a 
sophisticated signaling network, at the interface of several stress, hormonal, and 
metabolic signaling pathways, that translates plant carbon status into defense, 
growth and developmental decisions (1). SnRK1 is the plant ortholog of the 
budding yeast SNF1 (Sucrose-non-fermenting 1) and mammalian AMPK (AMP-
activated protein kinase). All three enzymes function as heterotrimeric 
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complexes composed of an !-catalytic and two "- and #-regulatory subunits, 
and in all cases kinase activity requires phosphorylation of a conserved T-loop 
threonine in the !-subunit (2-6). However, the clear connection between T-loop 
phosphorylation and kinase activation in response to declining energy levels 
observed in SNF1 and AMPK is not established in plants (2, 7-9). Moreover, 
SnRK1 intrinsic kinase activity appears unchanged under conditions that induce 
SnRK1 signaling as well as in pp2c mutants that display deficient repression of 
the SnRK1 pathway (2, 7, 9). Additional regulatory mechanisms may operate in 
such conditions to modulate SnRK1 signaling accordingly. Finally, the plant 
enzyme has incorporated unique regulatory subunits and other distinct features, 
presumably to respond to plant-specific signals and/or to perform plant-specific 
functions (4, 5, 10, 11). These studies reveal the atypical nature of the plant 
kinase and underscore our lack of knowledge on the factors that determine the 
signaling lifetime of such a central component. 
SUMO (Small Ubiquitin-like Modifier) is a small protein (about 12kDa) that is 
conjugated posttranslationally to target proteins in a reversible manner to 
regulate crucial biological processes. Sumoylation is required for normal growth 
and development, and consequently, mutants defective in the SUMO pathway 
are either lethal or display strong phenotypes (12, 13). In addition, exposure to 
environmental or metabolic stresses induces a dramatic accumulation of SUMO 
conjugates, constituting what is considered to be a cellular protective response 
in all eukaryotes (14). Accordingly, many SUMO targets identified in Arabidopsis 
are stress-related components (15-17) and sumoylation is important for a wide 
range of plant stress responses (18). Diverse biochemical functions have been 
ascribed to sumoylation, including changes in stability, activity, and subcellular 
localization, primarily through the modulation of intra- and intermolecular protein 
interactions (19, 20).  
Sumoylation requires the maturation of the SUMO moiety by a SUMO 
protease, exposing a characteristic C-terminal di-glycine motif. Mature SUMO is 
then activated by the SUMO activating enzyme (E1 enzyme, SAE1/2 in 
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Arabidopsis), with the formation of a thioester bond, and transferred to the 
SUMO conjugating enzyme (E2 enzyme, SCE1 in Arabidopsis) through a 
transthiolation reaction. Finally, SCE conjugates SUMO to a target lysine, either 
alone or with the help of an E3 SUMO ligase (SIZ1 and HPY2, in Arabidopsis) 
(21). Substrates can carry single SUMO moieties or SUMO polymers, and in 
Arabidopsis, two E4 SUMO ligases were recently implicated in the assembly of 
such SUMO chains (22). SUMO chains have various roles and can trigger 
ubiquitylation via SUMO-targeted ubiquitin ligases (STUbLs), hence targeting 
the protein for proteasomal degradation (23, 24). 
The work here described aimed at deciphering additional posttranslational 
regulatory mechanisms of the SnRK1 kinase. We focused on the modification of 
SnRK1 by SUMO due to the presence of high probability SUMO attachment site 
(hpSAS) motifs on the SnRK1!1 catalytic subunit, and to the detection of high 
molecular weight (hMW) SnRK1!1 forms, potentially corresponding to 
SnRK1!1-SUMO conjugates. Recently, SnRK1!1 was identified as an interactor 
of two SUMO machinery components, the E2 SUMO conjugating enzyme 1 
(SCE1), and the SUMO protease Early in Short Days 4 (ESD4) (16). SUMO 
substrates can be directly recognized and bound on their target lysines in vitro 
by the E2 conjugation enzyme, and thus the SnRK1!1-SCE1 interaction also 
suggests that SnRK1!1 may be a target of sumoylation. Furthermore, SUMO 
pathway and SnRK1 signaling share important roles in the plant response to 
various biotic and abiotic stresses (2, 15, 17, 18, 25-27). In this chapter, we 
present evidence that SnRK1 is sumoylated at the whole complex level in 




2.2 | Results 
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2.2.1 | SnRK1!1 bears two high probability SUMO attachment sites  
 
Analysis of the primary structure of Arabidopsis SnRK1!1 with the 
bioinformatic tool SUMOplot™ (www.abgent.com) retrieved two high probability 
SUMO attachment sites (hpSAS), latter defined with an arbitrary cutoff value of 
hpSAS (91% (16). Both hpSAS, involving lysine(s) (K) 471 and 144, matched 
the canonical 'KxE motif (Introduction- SCE1). Other putative sumoylation 
sites, but with a lower probability score, were retrieved at K465, K230, K292 and 
K421. The predicted target K(s) on SnRK1!1 are listed in descending order of 
probability of SUMO attachment (Figure 2.1). In accordance with the high level 
of conservation within the kinase domain (28), the hpSAS motif encompassing 
K144 was fully conserved amongst SnRK1 orthologs in yeast, moss, Drosophila 
and mammals. None of the other predicted SUMO attachment sites were 












Figure 2.1 | Potential SUMO attachment sites on SnRK1!1 predicted using SUMOplotTM. 
Predicted SUMO target lysines (K) are identified on SnRK1!1 domains. Numbers below 
SUMO attachment site (SAS) motifs depict their probability scores. In red, hpSAS ((91%), and in 
blue, SAS with a probability score lower than 91%. UBA, ubiquitin associated domain; KA1, kinase 
associated domain 1. 
 




2.2.2 | SnRK1!1 catalytic subunit interacts with SCE1 in Yeast two-
hybrid assays  
 
The E2 SUMO conjugating enzyme 1 (SCE1) is crucial in SUMO conjugation 
and binds directly the target through a patch surrounding the active site (29, 30). 
As a first approach to test whether SnRK1 is modified by sumoylation, we 
assayed the interaction between the Arabidopsis E2 SCE1 and SnRK1!1 by 
yeast two-hybrid assays (Y2H). We observed that SnRK1!1 interacts with SCE1 
and that this interaction occurs through the regulatory domain (RD) of SnRK1!1. 
Yeast cells transformed with SCE1 and SnRK1!1-RD%KA1, or with SnRK1!1 
kinase domain (KD) were also able to grow but in less stringent selection media. 
Collectively, these data indicate that several regions of SnRK1!1 interact with 
SCE1 in Y2H assays (Figure 2.2A), and that SnRK1!1 is potentially sumoylated 
on the kinase and regulatory domains. 
We also tested if SCE1 could interact with the ortholog of SnRK1!1 in 
Drosophila, SNF1A. Interestingly, the full-length (FL) catalytic subunit SNF1A 
interacted with SCE1 in the Y2H assay, suggesting that SNF1A may also be 
regulated by sumoylation (Figure 2.2B).  
A proteome-wide Y2H screen for SUMO substrates in Arabidopsis, using the 
E2 SCE1 or ESD4 SUMO protease as baits, retrieved subsequently the 
interaction between FL SnRK1!1 with both referred SUMO machinery 
components (16). The results obtained by Elrouby et al. strengthened our own 
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Figure 2.2 | Arabidopsis SnRK1!1 and Drosophila SNF1A interact with the E2 SUMO 
Conjugating Enzyme 1 (SCE1) in Y2H assays.  
The full-length coding sequence (FL), C-terminal Regulatory Domain (RD) encompassing the 
KA1 domain, C-terminal RD without the KA1 domain (RD%KA1) or the N-terminal Kinase Domain 
(KD) of SnRK1!1 (A), as well as FL SNF1A (B), were cloned into pGADT7 in fusion with the 
GAL4 activation domain (AD) and co-transfected with pGBKT7 harboring either the GAL4 binding 
domain (BD) alone (empty) or in fusion with the full-length SCE1. The growth of transformed 
AH109 yeast cells was assessed in permissive [-Leucine (L), -Tryptophan (W)], selective [-L-W-
Histidine (H)], or more stringent [-L-W-H,-Adenine (A)] media. A representative experiment of a 
minimum of two independent assays is shown. 
 
 
2.2.3 | Multiple SnRK1 subunits are sumoylated in a heterologous 
system in E. coli  
 
To investigate whether the interaction between SnRK1!1 and SCE1 results 
into SnRK1 sumoylation, we first employed a heterologous system in which the 
Arabidopsis sumoylation machinery is reconstituted and co-expressed with 
individual potential substrates in E. coli (31). In the presence of mature SUMO1 
(SUMO1-GG) or mature SUMO3 (SUMO3-GG), SnRK1!1 displayed a clear 
sumoylation signal characterized by the presence of high molecular weight 
(hMW) SnRK1!1 forms (marked by red arrowheads) in Western-blot (WB) 
analyses. This signal was absent when the corresponding non-conjugatable 
isoforms (SUMO-AA) were used as negative controls (Figure 2.3A).  
Sumoylation often targets groups of functionally engaged proteins that may 
pre-assemble upon given stimuli, regulating entire signaling networks (19). 
Thus, we next decided to explore if the regulatory subunits of the SnRK1 
heterotrimeric complex could also be sumoylated. Using the E. coli heterologous 
system, we could observe sumoylation of both SnRK1"1 and SnRK1"2 
regulatory subunits, but not of the #-type regulatory subunit, SnRK1"# (Figure 
2.3A). SnRK1# was also clearly sumoylated (Figure 2.3A). However, the 
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functional connection of this potential #-subunit to SnRK1 remains uncertain, as 
it does not interact with the other established subunits [Figure 2.6C, (10, 11)]. In 
all sumoylated substrates, multiple bands with slower migration could be 
detected, indicating multi- and/or polysumoylation events. SUMO1 and SUMO3 
isoforms generated similar sumoylation patterns within the same substrate (for 
SnRK1# only SUMO3 was tested), but in most cases the intensity of the signal 
was stronger with SUMO3. Altogether, these results indicate that in the E. coli 
heterologous system, SUMO is conjugated to several and specific components 
of the SnRK1 complex in Arabidopsis.  
To obtain further insight regarding a conserved regulation by sumoylation 
amongst SnRK1 orthologs, we also tested if the Drosophila catalytic subunit 
SNF1A could be a target of sumoylation using the same system. Indeed, we 
could detect sumoylation of the SNF1A C-terminal domain in the presence of 
the SUMO3 conjugatable isoform (Figure 2.3B). Since human AMPK (32) (33) 
and yeast SNF1 (34) were recently identified as sumoylation targets as well, it is 
possible that all members of the eukaryotic SNF1/AMPK/SnRK1 family of 


















Figure 2.3 | Multiple SnRK1 subunits, as well as the Drosophila SNF1A catalytic subunit, are 
sumoylated in a heterologous E. coli system. 
 A-B. SnRK1 or SNF1A subunits harboring 6*Histidine (His) and T7 tags were co-expressed in 
E. coli with the indicated SUMO isoform together with the SUMO-activating (AtSAE1a/AtSAE2) 
and SUMO-conjugating (AtSCE1) enzymes. SnRK1 subunits were purified via the His-tag by 
immobilized metal ion affinity chromatography (IMAC) and immunoblotted against their T7 tag. GG 
and AA refer to conjugatable and non-conjugatable SUMO variants, respectively. Unmodified 
SnRK1 subunits have an approximate molecular weight (MW) of 58kDa (!1), 30kDa ("1), 32kDa 
("2), 53kDa ("#) and 48kDa (#), whereas unmodified SNF1A N- and C-terminal regions have a 
MW of 33kDa (N) and 31kDa (C), respectively. His- and T7 tags give a small increment of 2kDa to 
the respective protein MW, and a single SUMO moiety can contribute with an average increment 
of 20kDa (20). Black and red arrowheads designate non-sumoylated and sumoylated proteins, 
respectively.  
 
In order to better understand the molecular mechanism of SnRK1 
sumoylation, we decided to identify the target lysine (K) residue(s) in SnRK1!1 
catalytic subunit using the E. coli sumoylation assay. Several sumoylation 
events were observed with constructs expressing only the kinase domain (KD; 
1-293) or the regulatory domain (RD; 294-512) (Figure 2.4A), suggesting that 
SnRK1!1 is sumoylated on several residues of both domains (Figure 2.4B), in 
agreement with the results obtained from the Y2H assay (Figure 2.2A). 
Mutation of both hpSAS residues K471 and K144 to arginine (R) did not prevent 
SnRK1!1 sumoylation in the E. coli assay (Figure 2.4C), suggesting that other 
residues might be involved. Therefore, to identify the target K residues, we 
performed Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) of 
sumoylated SnRK1!1 KD and RD (Figure 2.4D). To this end, we employed 
regular mature SUMO3 (SUMO3-GG) and a variant (SUMO3S91R-GG) that yields 
a small tryptic footprint and thereby facilitates LC-MS/MS analyses (31). We 
focused these analyses on SUMO3 due to the stronger signal intensity but 
similar sumoylation pattern compared with SUMO1, allowing a better yield. We 
uncovered nine sumoylated residues (including K144 but not K471), of which 
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two are located in the KA1 domain and seven in the KD (Figure 2.4A and 2.4E). 
The structural model of the SnRK1 complex predicts that all of these residues 
are accessible (Figure 2.4E, residues indicated). A single K390R mutation and 
a double K34R/K63R mutation were sufficient to abrogate sumoylation of the 
RD and KD, respectively (Figure 2.4F). Furthermore, sumoylation could no 
longer be detected in the full-length SnRK1!1K34/63/390R triple mutant (Figure 
2.4G), suggesting that these three K residues could be the genuine targets of 
sumoylation in vivo. 
LC-MS/MS analysis was also performed on sumoylated C-terminal SNF1A  
(Figure 2.3B), and retrieved four sumoylated residues (SNF1A K447, K456, 
K469 and K505). However, none of these sumoylated K(s) are conserved 
amongst SnRK1!1 and SNF1A kinases (Appendix - Figure 1). 
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Figure 2.4 | SnRK1$1 residues sumoylated in the E. coli assay. 
A. Schematic representation of SnRK1$1. K48 (catalytic phospho-transfer) and T175 
(activating T-loop phosphorylation) are two residues crucial for SnRK1 enzymatic activity. 
Predicted hpSAS residues [Figure 2.1, (16); results in C], residues found by LC-MS/MS analysis 
(from sample shown in D), and residues confirmed to be crucial for sumoylation in E. coli (results 
in F and G) are indicated. Numbering corresponds to gene model At3g01090.1 according to TAIR. 
B-D, F-G. Sumoylation assay using the Arabidopsis SUMO machinery reconstituted in E. coli. The 
indicated SnRK1$1 variants harboring 6*His and T7 tags were co-expressed in E. coli with the 
indicated SUMO isoform together with the SUMO-activating (AtSAE1a/AtSAE2) and SUMO-
conjugating (AtSCE1) enzymes. GG and AA refer to conjugatable and non-conjugatable SUMO 
variants, respectively. Sumoylation was assessed by Western-blot (WB) using antibodies against 
the T7-tag. B. Several residues are sumoylated in SnRK1$1, as shown by the positive 
sumoylation signal with truncated SnRK1$1 variants harboring only the KD or RD. Black and red 
arrowheads designate non-sumoylated and sumoylated proteins, respectively. C. Mutation of 
predicted hpSAS residues (A, “hpSAS”) does not abolish SnRK1$1 sumoylation. D. WT SnRK1$1 
samples used to identify the sumoylated residues. SnRK1$1KD and SnRK1$1RD were purified 
via the His tag by IMAC and immunoblotted against the T7 tag. Bands corresponding to 
sumoylated SnRK1$1 (red arrowhead) were excised and analyzed by LC-MS/MS. "RGG", mature 
SUMO3 mutated at the C-terminus to generate smaller tryptic peptides more amenable for MS 
analyses. E. The structure of the SnRK1 complex in cartoon representation was modeled with the 
Swiss model portal using the AMPK structure as a template (2Y94). SnRK1$1 is in blue [with the 
KA1 domain in dark blue; residues 14 to 395 coupled to a model of the KA1 (9) from 396 to 512], 
SnRK1"1 is in yellow (209-281), and SnRK1"# is in wheat (152-486). SnRK1$1 K residues found 
to be sumoylated by LC-MS/MS (A, “LC-MS/MS”) are shown with their side chains in stick 
representation in red. The three K numbered in red correspond to the three lysines confirmed to 
be crucial for the sumoylation signal using a site-directed mutagenesis approach (A, “Confirmed”; 
see panel F-G). F. Same analysis as in B, on total soluble protein extract from bacteria expressing 
the indicated SnRK1$1 domains mutated or not for the K(s) shown. An area pointed out with a 
blue arrowhead indicates where the sumoylated protein should be in the mutated variant 
(compare to red arrowhead in the WT control of the same panel). G. Validation of the mutational 
analysis in F using affinity-purified protein from bacteria expressing a full length SnRK1$1 mutated 
or not for the three confirmed K(s) (K34/63/390). KD, Kinase domain; RD, Regulatory Domain; 
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2.2.4 | SnRK1 is sumoylated in planta  
 
To determine if SnRK1 sumoylation also occurs in planta, we first generated 
transgenic Arabidopsis lines expressing SnRK1!1-GFP to pull down SnRK1!1 
via its GFP-tag, and to assess the presence of SUMO-conjugates by 
immunodetection with anti-SUMO1 antibody. These lines express SnRK1!1 to a 
similar level than wild-type (WT) plants and were produced by complementing a 
snrk1!1 knockout mutant with SnRK1!1 fused to GFP and controlled by its own 
upstream and downstream regulatory regions (pSnRK1!1::SnRK1!1-
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Figure 2.5 | Generation of SnRK1!1-GFP transgenic plant lines. 
A. Structure of the SnRK1!1 gene (At3g01090.2 gene model). All indicated positions have the 
start codon (noted +1) as a reference. The promoter (2kb upstream of the start codon) and 
terminator (1kb downstream of the stop codon) regions used, as well as the kinase and KA1 
domains, are indicated. The location of the T-DNA insertion defining the snrk1!1-3 mutant line 
(GABI-KAT: 579E09) is indicated as well as the position of the three genotyping primers (LP, Left 
Primer; RP, Right Primer; LB, Left Border; Appendix Table 1). The sequence providing the exact 
location of the insertion (2583) is indicated inside the red box (”lost” denotes the 11 bases lost due 
to the insertion). White boxes correspond to exons and the straight lines between them to introns. 
Black boxes correspond to UTR regions and the straight lines outside are regulatory regions. B. 
Genotyping PCR using primers LP, RP, and LB, shown in A. The expected sizes of the two 
products are indicated on the left (LP: LP-RP reaction, 386bp indicates WT allele; LB: LB-RP 
reaction, 190bp indicating a mutant allele). C. Total proteins from adult Arabidopsis leaves of Col-
0 or the snrk1!1-3 mutant were analyzed by Western-blot (WB) using antibodies against 
SnRK1!1 or P-AMPK (recognizing the phosphorylated T175/176 of SnRK1!1/!2, respectively). 
The black and grey arrowheads indicate phospho-SnRK1!1 and phospho-SnRK1!2, respectively. 
Equal loading is shown by Coomassie staining of the membrane (“loading”). D. SnRK1!1-GFP 
transgenic lines were generated by transformation of the snrk1!1-3 mutant with the pBm43GW,0 
MultiSite Gateway Binary vector, containing the promoter, the genomic coding region (exons-
introns) fused to GFP, and the terminator of the SnRK1!1 gene (At3g01090.2; indicated in A). 
Several transformants were tested for the presence of SnRK1!1-GFP by WB using antibodies 
against SnRK1!1 and GFP. The selected lines (presenting a SnRK1!1 signal close to Col-0) are 
indicated with arrows. E. SnRK1!1"KA1-GFP transgenic lines analyzed as in D. Several 
transformants were tested for the presence of SnRK1!1%KA1-GFP by WB using antibodies 
against SnRK1!1 and GFP. MW, Molecular Weight. 
 
Expression of SnRK1!1-GFP in these lines allowed the rapid 
immunoprecipitation of SnRK1!1 under mild denaturing conditions, which is a 
prerequisite for detecting the scarce and otherwise extremely labile SUMO 
conjugates (35). As shown in Figure 2.6A, SUMO1 conjugates were detected in 
immunoprecipitates from SnRK1!1-GFP (FL) plants but not from control 35S-
GFP plants (Ctrl). Interestingly, SUMO1 conjugates associated with SnRK1!1-
GFP were not resolved as distinct bands, but rather as a high molecular weight 
(hMW) ladder, suggesting the formation of (poly)SUMO chains and/or the 
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sumoylation of multiple residues. The same SUMO1 pattern was obtained with 
two other independent SnRK1!1-GFP lines (Figure 2.6B). The presence of 
hMW SnRK1!1 forms in the SnRK1!1 immunoblot further supported a possible 
sumoylation of SnRK1!1 (Figure 2.6A, middle panel). Immunodetection with 
SnRK1"1, SnRK1"2 and SnRK1"# antibodies confirmed the association of 
these subunits with SnRK1!1-GFP (Figure 2.6C). We could detect hMW forms 
of SnRK1"1 and SnRK1"2 but not of SnRK1"#, suggesting that the only SnRK1 
regulatory subunits sumoylated in planta are the "(s), in accordance with the 
results obtained in the E. coli assay (Figure 2.3A). To assess the contribution of 
",subunits to the overall SnRK1 sumoylation, we generated a transgenic line 
expressing a truncated SnRK1!1 variant lacking the KA1 domain (9), required 
for the interaction with " and # regulatory subunits (36, 37) 
(pSnRK1!1::SnRK1!1"KA1-GFP::tSnRK1!1/snrk1!1-3; hereafter referred as 
SnRK1!1"KA1-GFP, Figure 2.5A and E). As expected, we could not detect 
SnRK1"1, SnRK1"2 or SnRK1"# associated with SnRK1!1%KA1-GFP (%) 
(Figure 2.6C). Interestingly, the lack of regulatory subunits was accompanied by 
a dramatic reduction in SUMO1 conjugates and hMW SnRK1!1 forms (Figure 
2.6A and C), indicating that the regulatory subunits contribute significantly to the 
overall sumoylation of the SnRK1 complex. Nevertheless, even if reduced, the 
presence of SnRK1!1 hMW forms and SUMO1 conjugates in SnRK1!1%KA1-
GFP immunoprecipitates suggests that the interaction with the regulatory 
subunits is not strictly necessary for SnRK1!1 sumoylation.  
In accordance with previous observations (10, 11), SnRK1# did not co-purify 
with SnRK1!1-GFP catalytic subunit, immunoprecipitated through its GFP tag 
(Figure 2.6D). Therefore, the putative sumoylation of SnRK1# does not 
contribute to the overall sumoylation signal observed for SnRK1.  
Collectively, these results suggest that several subunits of the SnRK1 
complex are sumoylated in planta and that this may involve the formation of 
SUMO chains and/or the modification of multiple residues.  
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Figure 2.6 | The SnRK1 complex is sumoylated in planta.  
A-D. Leaf crude extracts of plants expressing 35S-GFP (Ctrl), SnRK1!1%KA1-GFP (%) and full 
length SnRK1!1-GFP (FL), or WT Col-0 (B), were used for GFP immunoprecipitation (IP). 
Immunoprecipitates were analyzed by Western-Blot (WB) using antibodies against GFP, 
SnRK1!1 and SUMO1 in A, against SUMO1 in B, against SnRK1!1, SnRK1"1, SnRK1"2, 
SnRK1"#, and SUMO1 in C, or against SnRK1"1 and SnRK1# in D. In B, two distinct SnRK1!1-
GFP lines (A8.2 and A4.5, described in Figure 2.5D) show the same SUMO1 profile as the one 
observed after GFP IP of the SnRK1!1-GFP line used in A (B4.2) and throughout the following 
work. D. SnRK1# does not co-purify with SnRK1!1-GFP by anti-GFP IP. Co-immunoprecipitation 
of SnRK1"1 was used as a positive control. In B and D, the input corresponds to the soluble 
protein extracts used for IP. Black arrowheads indicate the respective SnRK1 subunits non-
sumoylated. Grey brackets designate high molecular weight (hMW) forms of the indicated protein 
that may correspond to SUMO conjugates. MW, Molecular Weight.  
 
 
2.2.5 | SnRK1 sumoylation is mediated by the E3 ligase SIZ1 in planta 
 
We next decided to identify the E3 ligase(s) responsible for SnRK1 
sumoylation in planta. Even though SCE1 is sufficient for conjugating the SUMO 
peptide to a substrate in vitro, E3 SUMO ligases are important for substrate 
specificity and sumoylation efficiency in vivo (38). In Arabidopsis, only two E3 
SUMO ligases have been identified, SIZ1 and HPY2/MMS21 (39-41). Given the 
strong association of SIZ1 with plant stress responses and the involvement of 
HPY2 mostly in developmental processes (18), we first tested if SnRK1 
sumoylation could be mediated by SIZ1. To test this, we introduced the 
pSnRK1!1::SnRK1!1-GFP::tSnRK1!1 construct previously described (Figure 
2.5D) in siz1-2, a null mutant of SIZ1 (39) [hereafter referred as SnRK1!1-
GFPsiz1-2 (Figure 2.7A)], and performed GFP pull-downs and immunoblot 
analyses as previously (Figure 2.6). As shown in Figure 2.7B, SnRK1!1-GFP 
could be pulled-down from both SnRK1!1-GFP ("WT") and SnRK1!1-GFPsiz1-2 
("siz1-2") plants. However, immunodetection with anti-SUMO1 antibody revealed 
the complete absence of SUMO1 conjugates in SnRK1!1-GFPsiz1-2 
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immunoprecipitates, demonstrating that SIZ1 is responsible for SnRK1 
sumoylation by SUMO1 in planta. Importantly, the relative abundance of hMW 
SnRK1!1 forms in SnRK1!1-GFPsiz1-2 was strongly reduced (more than 50%) 
when compared to SnRK1!1-GFP plants, indicating that a significant proportion 
of these forms correspond to sumoylated SnRK1!1 (Figure 2.7B). Collectively, 
these results show that SnRK1 is sumoylated in planta and that this modification 




Figure 2.7 | SIZ1 is required for SnRK1 sumoylation. 
A. SnRK1!1-GFPsiz1-2 transgenic lines were generated by transformation of the siz1-2 mutant 
with the pBm43GW,0 MultiSite Gateway Binary construct described in Figure 2.5D. Several 
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transformants were tested for the presence of SnRK1!1-GFP by Western-blot (WB) using 
antibodies against SnRK1!1 and GFP. The selected lines are indicated with arrows. B. SnRK1$1-
GFP was immunoprecipitated (IP) from leaf crude extracts of SnRK1%1-GFP (“WT”) and 
SnRK1%1-GFPsiz1-2 (“siz1-2”) and analyzed by Western-Blot (WB) using antibodies against 
SnRK1$1 and SUMO1. The quantification of hMW SnRK1!1 forms in both genotypes is 
presented on the right and corresponds to the ratio of hMW forms (indicated with a bracket in the 
“!1-long” longer exposure) per unmodified SnRK1!1 (“SnRK1!1” shorter exposure). The values 
are normalized to the ratio in control plants (“WT”). Stars denote statistical significance, as 




2.2.6 | Alternative strategies employed for determining SnRK1 
sumoylation in Arabidopsis 
 
The detection of SUMO substrates in vivo is particularly challenging, 
explaining why sumoylation was discovered relatively late (42, 43). One main 
reason for this is that usually, only a minor fraction of the total pool of a protein 
is sumoylated at a given time point. Furthermore, the already scarce SUMO 
conjugates are compromised with an increased lability due to high SUMO 
protease activity associated with cell lysis (35). In addition, sumoylation may 
occur only in response to particular stimuli (25, 44).  
We could determine SnRK1 sumoylation in planta using a rapid 
immunoprecipitation of SnRK1!1 from Arabidopsis rosette extracts, under mild 
denaturing conditions (Section 2.2.4). However, alternative strategies had 
previously been undertaken that suffered technical limitations and were hence 
unable to detect, or provided a low-level confidence regarding the in vivo 
sumoylation of SnRK1. Some of these approaches will be described in this 
section. 
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We could observe SnRK1!1 high molecular weight (hMW) bands in crude 
plant extracts from wild type (WT) (Figure 2.8A) or SnRK1!1-HA 
overexpressing (OE) (Figure 2.8B) plants grown under control conditions, using 
anti-SnRK1!1 and anti-HA antibodies, respectively. The extensive SUMO1 
conjugation detected in the same plant extracts spanned a broad range of MWs 
(Figure 2.8A-B), thereby precluding any correlation between a particular 
SnRK1!1 hMW form and a particular SUMO1 signal. To indirectly test whether 
SnRK1!1 hMW forms could correspond, at least partially, to SUMO conjugates, 
we decided to monitor variations in the abundance and profile of these bands 1) 
through nuclear enrichment and through manipulation of protein subcellular 
localization strategies, and 2) using a genetic approach, with several SUMO 
machinery mutant plants. 
SUMO, sumoylation machinery components, and SUMO conjugates are 
particularly enriched in the nuclear compartment and have been implicated in 
diverse nuclear processes (17, 45). On the other hand, SnRK1!1 localizes in 
the nucleus and cytoplasm, and its distribution varies with tissue and 
developmental stage, and possibly upon different stimuli (46). SnRK1!1 hMW 
bands could be detected in "soluble" and nuclear enriched fractions obtained 
after differential centrifugation  (Figure 2.8C, gray arrowheads). Interestingly, 
the amount of hMW forms relative to unmodified SnRK1!1 was higher in the 
nuclear fraction, supporting the notion they could correspond to nuclear 
enriched, putatively sumoylated SnRK1!1. 
Transient co-expression of a protein of interest with SUMO in cell cultures is 
frequently used to induce sumoylation and to demonstrate that the protein is a 
sumoylation target (47-49). Following the same rationale we tested the 
Arabidopsis protoplast (leaf mesophyll cells with digested cell walls) expression 
system (50) as a tool to study SnRK1 sumoylation. However, we could not 
detect SnRK1!1 hMW bands in a clear and consistent manner, from protoplasts 
transiently expressing epitope tagged SnRK1!1 and mature SUMO isoforms, 
alone (Figure 2.8D-E) or in combination with SCE1 and/or SUMO ligases to 
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enhance sumoylation (Figure 2.8F). SnRK1!1 constructs were co-transfected 
with mature SUMO1, a mature SUMO1 variant mutated in a conserved 
glutamine (Q) residue (SUMO1Q90A) that exhibits a slower deconjugation rate 
compared to WT SUMO1 (51) (Figure 2.8E-F and 2.9B-C), or with a mature 
SUMO3 [with a methionine (M) in the respective Q position of SUMO1], to 
further enrich for in vivo SUMO substrates (see Introduction - SUMO isoforms).  
Several SnRK1!1 constructs were tested, including variants mutated in potential 
nuclear localization signal (NLS) (52) and nuclear export signal (NES) (53)!
motifs. Manipulation of SnRK1!1 localization in these variants was expected to 
potentially influence its sumoylation status, with the underlying hypothesis that 
nuclear localization could promote or enrich SnRK1!1 sumoylation (17, 45). A 
parallel strategy included the use of SnRK1!1 variants mutated in the regulatory 
threonine residue of the T-loop. Phospho-mimetic (active) and phospho-mutant 
(inactive) versions of this residue were expressed with the expectation that 
kinase activity could influence its putative sumoylation (54, 55). Finally, N-
terminal and C-terminal tagged constructs of SnRK1!1 variants were tested, to 
minimize effects due to the position of the tag. We also incubated transfected 
cells with the nuclear export inhibitor leptomycin or with the proteasome inhibitor 
MG132, in the latter case, with the underlying hypothesis that SUMO 
conjugation to SnRK1 could trigger its proteasomal degradation (23, 24). 
However, while taking advantage of the versatility of the protoplast system by 
testing several constructs and incubation conditions, SnRK1!1 hMW bands 





































Figure 2.8 | Detection of SnRK1!1 high molecular weight bands in plant crude extracts (A-B), 
after nuclear enrichment (C) and in protoplast samples (D-F). 
 A-B. Plant crude extracts from Arabidopsis leaves of 5-week old WT (A) or SnRK1!1-HA OE 
(B) plants, were analyzed by Western-Blot (WB) using antibodies against SnRK1!1, SUMO1 or 
Sumoylation of the SnRK1 complex 
! !
! 127 
HA (the latter, in B). Grey arrowheads or bracket indicate SnRK1!1 high molecular weight (hMW) 
bands. Black arrowheads indicate SnRK1!1 main band, with the expected size of SnRK1!1 
protein. C. A full rosette (~30 leaves) of 6-week-old Col-0 subjected to 1 hour of night extension 
(SnRK1!1 activation condition) was used to separate soluble (S) and nuclei-enriched (N) 
fractions. These fractions were subsequently analyzed by SDS-PAGE and by immunodetection 
with antibodies against SnRK1!1 and CYP37, a protein localized in the chloroplast that should be 
absent in the nuclear fraction. Green arrowhead indicates CYP37 protein, only present in 
"Soluble", black arrowhead indicates SnRK1!1 main band, and grey arrowhead indicates 
SnRK1!1 hMW bands. In C, the panel on the right evidences nuclear enrichment in "N" with the 
immunodetection with anti-Histone3 (His3) and anti-Rubisco antibodies, using the same protocol 
but in a parallel nuclear enrichment experiment. D-F. Protoplast samples were transfected with 
constructs expressing HA-tagged SnRK1!1, SCE1 and/or SIZ1 (in F), together with FLAG 
constructs of mature forms of SUMO1, SUMO1Q90A (in E-F), or SUMO3. Immunodetection was 




We next decided to investigate the presence of hMW SnRK1!1 forms in plant 
extracts from mutants of the two Arabidopsis E3 SUMO ligases (siz1-2 and 
hpy2-1), and from the esd4 SUMO protease [shown to interact with SnRK1!1 in 
a Y2H screen (16)] mutant, where putative SnRK1!1 SUMO conjugates could 
be potentially diminished (39, 40) or enriched (56), respectively. These samples 
were compared to SnRK1!1 RNAi, WT, and SnRK1!1-HA OE plants that 
accumulate different SnRK1!1 amounts. For this purpose, we used a buffer with 
a strong denaturing agent (8M urea) to minimize breakdown of SUMO 
conjugates during cell lysis and to discard SUMO non-covalent interactions (57). 
However, we could not observe clear differences in the accumulation of 
SnRK1!1 hMW forms relative to SnRK1!1 main band, amongst the genotypes 
analyzed (Figure 2.9A). Besides possible technical limitations, further 
characterization is required regarding other stimuli that could be more suitable 
to trigger differences in putative SnRK1!1-SUMO conjugates, amongst the 
different genotypes. 
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In a totally different approach, we made use of the Ubc9 fusion-directed 
sumoylation (UFDS) methodology (58-60) to identify if SnRK1!1 could be a 
target of this modification. The UFDS system consists in the direct fusion of the 
E2 SUMO conjugating enzyme to the target protein being analyzed, bypassing 
the requirement for E3 SUMO ligases. This strategy dramatically enhances 
sumoylation and facilitates the study of weakly and/or transiently modified 
SUMO substrates. UFDS has been successfully used to demonstrate both 
constitutive and stimulus-dependent sumoylation. Half of the proteins 
sumoylated through UFDS were shown to be sumoylated in an UFDS-
independent manner, and in specific SUMO attachment sites (58-60). Hence, 
we generated protein fusions of SCE1 with SnRK1!1 or SnRK1!1%KA1 in both 
N- and C-terminal orientations, and expressed them transiently in Arabidopsis 
protoplasts. We could detect SnRK1!1 hMW bands in the presence of both 
mature SUMO1Q90A ("1") and SUMO3 ("3") isoforms, and for both orientations 
of the UFDS constructs (Figure 2.9B, lower panel, red marks).  The improved 
detection with the SUMO1 variant is at least partly due to a higher expression 
level of this construct (not shown). We could also detect these hMW bands in 
UFDS constructs in which the SCE1 was mutated in two subsequently identified 
SUMO attachment sites (K15 and K154) (17, 22) (Figure 2.9C, red asterisks). 
However, due to the translational fusion between SCE1 and SnRK1!1, and 
since mutated SCE1 (SCE1**) alone still exhibits hMW bands, we cannot 
exclude that the observed SCE1**-SnRK1!1 hMW bands are due to 
modification of some additional residues on SCE1** (Figure 2.9C). On the other 
hand, SCE1 does not seem to be sumoylated by SUMO3 (Figure 2.9B, upper 
panel), whilst for the SCE1-SnRK1!1%KA1 fusion protein a shift in size can be 
observed with both SUMO1 and SUMO3 (Figure 2.9B, lower panel). This 
suggests that the observed sumoylation with SUMO3 using the UFDS 
constructs is strictly SnRK1 dependent. 
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Figure 2.9 | Detection of SnRK1!1 high molecular weight forms in SUMO pathway mutants 
(A) and using the Ubc9 fusion-directed sumoylation (UFDS) methodology in protoplasts (B-C). 
A. Detached leaves from SnRK1!1 RNAi (RNAi), Col-0 (WT), SnRK1!1-HA (OE), hpy2-1 
(hpy2), siz1-2 (siz1), or esd4 plants were processed in 8M urea extraction buffer. 
Immunodetection was done with anti-SnRK1!1 antibody and short and long exposures are 
shown. Black arrowhead indicates SnRK1!1 main bands, and grey arrowhead, SnRK1!1 hMW 
bands. B-C. Protoplast samples were transfected with HA tagged constructs of SnRK1!1, SCE1, 
SnRK1!1-SCE1, SCE1-SnRK1!1 or SCE1-SnRK1!1%KA1, together with FLAG constructs of 
mature SUMO1Q90A ("1", B-C), mature SUMO3 ("3", in B), or with control DNA (in C). In C, the 
SCE1 used in the respective constructs is mutated in two SUMO attachment sites, SCE1K15/K154R 
("SCE**"). Immunodetection was done with anti-SnRK1!1 and anti-HA antibodies. Black 
arrowheads indicate each construct's main band; red asterisks and red line indicate its respective 
hMW bands (putative SUMO conjugates). Brown arrowheads indicate endogenous SnRK1!1 
main band. MW, Molecular Weight; WB, Western-blot. 
 
 
The requirement to address the specificity and identity of SnRK1!1 hMW 
bands, urged us to use an immunoprecipitation (IP) step in the analysis of crude 
plant extracts. Similarly, protoplasts transfected with differentially tagged SUMO 
and SnRK1!1 constructs, alone or with other SUMO machinery components, 
were purified through immunoprecipitation of one of the tagged proteins 
(SnRK1!1 or SUMO). The subsequent detection with an antibody against the 
other tagged construct  (SUMO or SnRK1!1), could be a mean to assign 
identity to hMW bands with the same size (SnRK1!1-SUMO conjugates). 
However, as previously mentioned, it was always very hard to detect SnRK1!1 
hMW bands and an associated SUMO signal from protoplast samples. Our 
efforts focused then in the IP analyses from crude extracts of Arabidopsis 
rosettes (Figure 2.6).  
The buffer composition used in cell lysis, proved to be determinant for 
detecting SnRK1 sumoylation in vivo. The alkylating agent and inhibitor of 
SUMO proteases N-Ethylmaleimide (NEM) (61) and the proteasome inhibitor 
MG132 (through a direct inhibition of proteasomal dependent degradation of 
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SUMO conjugates (23, 24), or via an indirect mechanism) proved to be crucial. 
We employed a lysis buffer with some denaturing properties conferred by the 
ionic detergents sodium dodecyl sulfate (SDS) and sodium deoxycholate, since 
the usage of strong denaturants would compromise the subsequent IP step. The 
ionic and nonionic (IGEPAL CA-630) detergents present in the buffer allowed 
the extraction of cytoplasmic, membranar and nuclear proteins.  However, in 
this case, both covalent and non-covalent (SUMO and others) interactions can 
be retrieved in the immunoprecipitates.  As already shown, SnRK1" regulatory 
subunits co-purify with SnRK1!1, contributing to the overall SUMO1 signal 
(Figure 2.6A-B). 
In order to confirm the identity of SnRK1!1 hMW bands as SnRK1!1-SUMO 
conjugates, we incubated SnRK1!1-GFP immunoprecipitates with the 
commercially available SUMO protease Ulp1 (recombinant fragment), from 
Saccharomyces cerevisiae. SUMO conjugates (and SnRK1!1 hMW bands) 
should decrease upon SUMO protease treatment, which was the case when 
SnRK1!1 sumoylated in E. coli was used as a positive control (Figure 2.10A). 
However, when SnRK1!1-GFP immunoprecipitates were used as substrates, 
no clear differences were observed in SUMO1 and SnRK1!1 immunoprofiles 
between Ulp1-treated and non-treated samples (Figure 2.10B). Ulp1 has a 
predominant role in SUMO precursor maturation whereas the SUMO protease 
Ulp2 is mainly associated with SUMO chain processing in vivo (62-64). Thus, it 
is possible that despite Ulp1 is able to cleave the SUMO moiety from 
sumoylated SnRK1!1 purified from E. coli, Ulp1 becomes inefficient to remove 
SUMO moieties from the endogenous SnRK1!1, possibly because it harbors 
multiple sumoylated residues or SUMO chains. Furthermore, the in vitro 
processing of SnRK1!1-GFP SUMO conjugates by Ulp1 may be additionally 
hindered by co-purified components or extra modifications that can occur in the 
N-terminus of sumo moieties (e.g. ubiquitylation). In such scenario, prior 
processing through distinct machinery would be required, as recently described 
for Ulp2 proteolytic activity (65). 















Figure 2.10 | Processing of SnRK1!1-SUMO conjugates by recombinant Ulp1 SUMO 
protease. 
A-B. Purified recombinant SnRK1!1 eluates and plant immunoprecipitates of SnRK1!1 were 
incubated with (+) or without (-) a recombinant fragment of Ulp1 SUMO protease in 1x SUMO 
protease buffer for 1h at 25ºC.  Samples were analyzed by immunoblot with anti-SUMO1 and anti-
SnRK1!1 antibodies. A. His-T7-SnRK1!1 catalytic subunit was sumoylated in the E. coli system 
as shown in Figure 2.3 and purified via the His-tag by immobilized metal ion affinity 
chromatography (IMAC) prior to SUMO protease assay. In A, after immunodetection with anti-
SUMO1 antibody, the same membrane was re-probed with anti-SnRK1!1 antibody.  B. 
Immunoprecipitates from SnRK1!1-GFP plants were obtained as shown in Figure 2.6 and 




2.3 | Discussion 
 
Sumoylation of the SnRK1 complex 
! !
! 133 
Protein kinases are swiftly regulated by posttranslational modifications 
(PTMs) that adjust the kinase activity and/or its stability and subcellular 
localization, in line with the cellular and whole organism demands. Unlike yeast 
Snf1 and mammalian AMPK, the phosphorylation of a conserved residue in the 
T-loop of SnRK1!1 is unchanged in control and stress conditions that activate 
SnRK1 signaling (2, 7-9). Here, we discovered that the SnRK1 complex  
(catalytic and multiple regulatory subunits) is sumoylated and hypothesize that 
this PTM may be important for the regulation of SnRK1 activity.  
We have shown that SnRK1!1 interacts through several domains with SCE1 
in Y2H assays (Figure 2.2), and that SnRK1!1, SnRK1"1 and SnRK1"2 are 
sumoylated in a heterologous system that reconstitutes the Arabidopsis 
sumoylation machinery in E. coli. SnRK1# is also sumoylated, although this 
subunit is not an established component of the SnRK1 complex (31) (Figure 
2.3). The SnRK1"# regulatory subunit was not sumoylated, and SnRK1!2 and 
SnRK1"3 subunits remain to be tested regarding a putative sumoylation using 
the E. coli system. LC-MS/MS analyses revealed that nine lysines are 
sumoylated both in the kinase and regulatory domains of SnRK1!1. We could 
determine that three lysines (K34, K63 and K390) were the major targets of 
sumoylation in E. coli, since this modification could no longer be detected in the 
SnRK1!1K34/K63/K390R triple mutant (Figure 2.4), and hypothesize that these 
residues are the genuine targets of sumoylation in vivo. SnRK1!1 has two high 
probability SUMO attachment sites (Figure 2.1) but, despite their apparently 
favorable 3D context, none of these residues seems to be crucial for SnRK1!1 
sumoylation (K144, Figure 2.4D; K471, not shown). Potential SUMO substrates 
are enriched in high probability SUMO attachment sites (hpSAS) [70% 
compared to 40% of the Arabidopsis proteome (16)], but an increasing number 
of studies report sumoylation at noncanonical motifs (32). Other factors, besides 
the sequence of the SUMO attachment motif, may be required to fulfill 
sumoylation.  
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In order to study a possible conservation of sumoylation as a 
posttranslational regulatory mechanism amongst SNF1/AMPK/SnRK1 family of 
protein kinases, we analyzed if SNF1A, the ortholog of SnRK1!1 in Drosophila, 
could be a target of this modification. Recent reports have shown the 
sumoylation of mammalian AMPK catalytic and regulatory subunits (32, 33), and 
yeast Snf1 catalytic subunit (34). Similarly to SnRK1!1, SNF1A interacted with 
SCE1 in Y2H assays (Figure 2.2B) and was sumoylated in the E. coli system 
(Figure 2.3B). Since both systems use the Arabidopsis SUMO machinery, the 
fact that sumoylation of Drosophila SNF1A still occurs probably reflects the high 
level of conservation of the SUMO pathway, as well of SnRK1 orthologs. 
However, none of the four sumoylated residues identified through MS in the 
regulatory domain of SNF1A (K447, K456, K469 and K505) are conserved in 
SnRK1!1.  
In protein group sumoylation events, several proteins of a particular complex 
are targeted synchronously and often at multiple sites by the sumoylation 
machinery. The sumoylation of SnRK1 catalytic and regulatory subunits 
suggests this might be the case in the SnRK1 complex, and possibly also in its 
orthologs (32, 33). In the cases of protein group sumoylation, SUMO attachment 
occurs on multiple sites on a protein and these sites tend to not be conserved in 
orthologs of other species (44). Furthermore, structural studies suggest that the 
SUMO consensus motif needs to adopt an extended conformation in order to 
facilitate the interaction with SCE, and function as a bona fide sumoylation site. 
Consequently, sumoylation often occurs outside of folded, functional domains, 
and thus is less likely to interfere with the intrinsic activities of the modified 
proteins (44). These pieces of evidence might help to explain the lack of 
conservation between SNF1A and SnRK1!1 sumoylation sites. Similarly, in 
yeast, Snf1 sumoylation occurs in a single residue in its regulatory domain (RD) 
(Snf1 K549) (34), and this sumoylation site is not conserved in SnRK1!1 or 
SNF1A. However, we cannot exclude that other sumoylated residues would 
have been found in SNF1A if targeted by the Drosophila SUMO machinery. On 
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the other hand, AMPK!1 and !2 were found sumoylated in a single residue (32) 
conserved in SnRK1!1, and crucial for its sumoylation (SnRK1!1 K390) (Figure 
2.3E and F). In the latter case, sumoylation of a conserved site may be required 
to achieve a specific molecular or functional outcome. For instance, sumoylation 
of yeast proliferation cellular nuclear antigen (PCNA) targets a conserved K164 
residue that is also a conserved acceptor site for PCNA ubiquitylation in 
eukaryotes, leading to different repair pathways upon DNA damage (19, 66). 
After employing several strategies, we were able to show SnRK1 
sumoylation in vivo, using a rapid GFP immunoprecipitation step from 
Arabidopsis rosettes of SnRK1!1-GFP plants. In this approach, the buffer 
optimization was crucial to enrich for the extremely labile SUMO conjugates. We 
were able to observe the sumoylation of SnRK1!1 catalytic subunit and 
probably of SnRK1"1 and SnRK1"2 regulatory subunits in vivo. 
Immunodetection with subunit-specific antibodies revealed that the three SnRK1 
subunits display high molecular weight bands that partially overlap with the 
signal obtained with SUMO1 immunodetection from the same sample. 
Importantly, SnRK1!1 high molecular weight bands were strongly diminished in 
the siz1-2 background, impaired in SIZ1-dependent sumoylation (Figure 2.7B). 
The detected ladder of SUMO1 conjugates suggests that several subunits are 
sumoylated in vivo, possibly either on multiple sites, involving the formation of 
(poly)SUMO1 chains, or both. SnRK1"# co-purified with SnRK1!1 but was not 
sumoylated, whereas SnRK1# did not associate with the SnRK1!1 catalytic 
subunit (Figure 2.6C-D). SnRK1"# has two putative SUMO interacting motifs 
(SIM; 1 SIMa, LLGL, 484-487; 1SIMr, SSSLPIL, 324-330) (Introduction - 
SUMO interacting motifs). Despite not being covalently modified by SUMO, 
SnRK1"# may have increased affinity for sumoylated proteins through non-
covalent SUMO-SIM interactions, and can thus be an important signal 
transducer downstream of SnRK1! and SnRK1" sumoylation. On the other 
hand, SnRK1# has a hydrophobic motif followed by acidic residues (VVDVD, 
95-99) that may be a SIM (67). However, this motif does not appear to be 
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sufficient to promote SnRK1# interaction with sumoylated SnRK1! and "-
subunits (Figure 2.6C). Overall, the results obtained in planta validate the 
previously determined SnRK1 sumoylation in E. coli.  
Interestingly, a significant fraction of the SUMO signal seems to associate 
with SnRK1 regulatory subunits, since removal of the KA1 domain, through 
which regulatory proteins interact, leads to a strong decrease (but not 
disappearance) of the SUMO signal. It is also possible that proteins other than 
the regulatory subunits bind SnRK1!1 through its KA1 domain (9, 36, 68, 69), 
also contributing to the SUMO1 signal associated with SnRK1!1-GFP IPs. 
Moreover, SnRK1!1%KA1 (1-389) loses the residue K390 shown to be crucial 
for SnRK1!1 sumoylation in E. coli, and K421, also sumoylated in this system, 
as well as other downstream K(s) that might contribute to SUMO signal intensity 
in planta. However, to conclusively demonstrate sumoylation of a particular 
SnRK1 subunit, future analyses should employ plants expressing His-tagged 
SUMO1 or SUMO3 (17, 51) to perform SUMO pulldowns under denaturing 
conditions followed by immunoblots for the protein of interest. This would 
retrieve only components covalently bound to SUMO (as opposed to 
components interacting through non-covalent protein-protein interactions).  
Despite SnRK1 sumoylation occurs in the absence of SUMO ligase(s) and 
with several SUMO isoforms in the E. coli heterologous system (Figure 2.3 and 
2.4), SUMO ligases, SUMO proteases, additional PTMs on the substrate, and 
others, may confer specificity to SnRK1 sumoylation in vivo. Importantly, we 
were able to identify SIZ1 as the E3 SUMO ligase responsible for SnRK1 
sumoylation by SUMO1 in planta. When SnRK1!1-GFP was 
immunoprecipitated from the SnRK1!1-GFPsiz1-2 plants that lack SIZ1, the 
SUMO signal was completely abolished and a clear reduction in SnRK1!1 hMW 
bands was observed, confirming that many of these bands correspond indeed to 
SUMO1 conjugates of SnRK1!1 (Figure 2.7). On the other hand, a good 
antibody tool is required to better dissect a possible sumoylation of SnRK1 by 
SUMO3, or even SUMO5 in planta, and a putative role for the E3 SUMO ligase 
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HPY2 in such scenario. Nevertheless, in accordance with our results of SnRK1 
sumoylation, an increase in SUMO1 and SUMO2 conjugates,! associated with 
several types of stresses, is mainly driven by the E3 SUMO ligase SIZ1 (12). 
Also, given the high similarity and probably functional equivalence between 
SUMO1 and SUMO2 isoforms (12, 25, 70, 71), we could not uncouple the 
modification of SnRK1 by either SUMO1 or SUMO2 in planta.  
Overall, we were able to show the SIZ1-dependent sumoylation of SnRK1 by 
SUMO1, through its catalytic and regulatory subunits, in Arabidopsis. Therefore, 
considering the data presented here, together with the reported sumoylation of 
Snf1 and AMPK in vivo, sumoylation emerges as a posttranslational regulatory 




2.4 | Materials and Methods 
 
A list of all primers, cloning steps, and constructs used in this study, is 
provided in Appendix Table 1. 
 
 
2.4.1 | Plant Material, Growth Conditions and Transformation 
 
Unless otherwise specified, plants were grown in soil under a 12h light 
(100µE), 22°C/12h dark, 18°C regime. Arabidopsis thaliana plants used in this 
study are in the Columbia (Col-0) background, except for the 35S-SnRK1!1-HA 
(SnRK1-OE) and SnRK1!1 RNAi lines that are in the Landsberg erecta (Ler) 
background. The siz1-2 (SALK_065397) (72, 73), hpy2-1 (40), 35S-SnRK1!1 
(2) and SnRK1!1 RNAi (2) plants have been previously described. esd4 
(GABI_216D08) homozygous plants were selected after kanamycin selection 
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and subsequent genotyping for the presence of the insertion in both alleles of 
the ESD4 gene (AT4G15880; not shown). A homozygous insertion line for the 
SnRK1!1 gene (At3g01090), was identified in the GABI-KAT collection 
(GABI_579E09; Figure 2.5A-C) and was designated as snrk1!1-3 [previously 
described snrk1!1-1 and snrk1!1-2 mutants are not null (74)]. Genotyping was 
performed using primers snrk1!1-GABIa and snrk1!1-GABIb in combination 
with a left border T-DNA primer (GABI-08409-LB). To determine the T-DNA 
exact insertion site a genomic DNA fragment was amplified by PCR with a 
forward primer binding to the SnRK1!1 locus (SnRK1!1-seqF Fw) and a 
reverse primer binding to the T-DNA right border (GABI1-RB-seq Rv). 
Sequencing reactions were subsequently performed on the gel-purified PCR 
product using the same primers. The T-DNA insertion was mapped to position 
2583-2593, immediately before the last exon. The last 11 bases of the intron at 
the insertion site are missing. The potential presence of a second insertion in 
the IMS2 gene (AT5G23020), as annotated in the GABI-Kat site, was ruled out 
by genotyping with primers IMS2-Fw and IMS2-Rv in combination with the 
GABI-08409-LB primer. The absence of SnRK1!1 protein in snrk1!1-3 plants 
was confirmed by immunoblotting with antibodies recognizing epitopes well 
before the T-DNA insertion, an SnRK1!1-specific antibody and an AMPK!-
pT172 antibody recognizing the phosphorylated T-loop of SnRK1!1 and 
SnRK1!2 [T175 and T176, respectively; (75)].  
The pSnRK1!1::SnRK1!1-GFP::tSnRK1!1 and pSnRK1!1::SnRK1!1"KA1-
GFP::tSnRK1!1 constructs are in the pBm43GW,0 MultiSite Gateway Binary 
vector (76) and the corresponding areas of the gene are indicated in Figure 2.5. 
Both constructs were generated using a pDONR-P4P1R harboring the 
SnRK1!1 upstream regulatory region (pSnRK1!1, 2000bp upstream of the 
SnRK1!1 start codon in the At3g01090.2 gene model; amplified using primers 
PROM-5'UTR_gSnRK1!1 attB4 Fw and PROM-5'UTR_gSnRK1!1 attB1r Rv) 
and a pDONR-P2RP3 harboring the SnRK1!1 downstream regulatory region 
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(tSnRK1!1, 1000bp downstream of the SnRK1!1 stop codon in the 
At3g01090.2 gene model; amplified using primers TERM-3'UTR_gSnRK1!1 
attB2r Fw and TERM-3'UTR_gSnRK1!1 attB3 Rv). In pSnRK1!1::SnRK1!1-
GFP::tSnRK1!1 the middle pDONR221-P1P2 contained the full genomic 
sequence of SnRK1!1 fused to GFP (primers gSnRK1!1-GFP attB1 Fw and 
gSnRK1!1-GFP attB2 Rv), whereas in pSnRK1!1::SnRK1!1"KA1-
GFP::tSnRK1!1, it contained the coding sequence of SnRK1!1 truncated at the 
KA1 domain and fused to GFP (primers gSnRK1!1-GFP attB1 Fw and 
gSnRK1!1-GFP attB2 Rv). The pSnRK1!1::SnRK1!1-GFP::tSnRK1!1 and 
pSnRK1!1::SnRK1!1"KA1-GFP:tSnRK1!1 constructs were introduced into 
Agrobacterium tumefaciens (GV3101) and snrk1!1-3 or siz1-2 plants were  
transformed by the floral dip method (77) to generate  pSnRK1!1::SnRK1!1-
GFP::tSnRK1!1/snrk1!1-3 (referred as SnRK1!1-GFP) and 
pSnRK1!1::SnRK1!1"KA1-GFP::tSnRK1!1/snrk1!1-3 (referred as 
SnRK1!1"KA1-GFP). BASTA-resistant transformants were selected based on 
their segregation ratio (T2) and homozygosity (T3). Homozygous T3 or T4 
generation transgenic lines were used.  
 
 
2.4.2 | Cloning and site-directed mutagenesis 
 
All cloning steps and primers are detailed in Appendix Table1. To generate 
point mutations, PCR was performed using primers carrying the intended 
mutation and annealing to the same sequence on opposite strands of the 
original plasmid template. A 25µl reaction mix [primers (25ng each), template 
plasmid (50ng), 250µM of dNTPs, Pfu polymerase (1.25U, Promega M7745) 
and 1XPfu buffer] was split in two tubes (12.5µl each); one was incubated in a 
thermocycler [95°C - 3min; (95°C -30s, 55°C-40s, 68°C-2min/kb) x 14] while the 
other was kept at 4°C. Ten units of DpnI (NEB) were thereafter added to both 
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and incubated at 37°C for 12h prior to bacteria transformation (4µL typically 
used). Positive clones were always confirmed by sequencing. 
 
2.4.3 | Antibodies and Protein Expression Analyses 
 
The SnRK1!1 (1/500, anti-AKIN10, AS10919), SnRK1"1 (1/500, anti-
AKINB1, AS09460), SnRK1"2 (1/500, anti-AKINB2, AS09 462), SnRK1"# 
(1/1000, anti-AKINBG, AS09463), SnRK1# (1/2000, anti-AKING1, AS09613), 
Rubisco (1/5000, anti-RbcL, AS03037), Histone 3 (1/1000, anti-H3, AS10710) 
and CYP37 (1/2000, anti-PPIase CYP37, AS101589) antibodies were 
purchased from Agrisera. Phospho-SnRK1!1/2 (T175/176) was detected with 
an anti–phosphoT172-AMPK! antibody (1/1000 in 5% BSA-TBS-Tween, 
referred to as P-AMPK; #2535, Cell Signaling). SUMO1 (1/5000, ab5316, 
Abcam) antibody was used to detect the respective protein modification. Anti-
HA (1/1000, Roche, #11867423001), and anti-T7 (1/10000, #69522-3, 
Novagen) antibodies were used to detect the corresponding tagged proteins. 
For immunoblotting all primary antibodies were diluted in 1% non-fat Milk in 
TBS (unless otherwise stated) and incubated with the membrane under gentle 
shaking for 12h at 4°C. Secondary antibodies (Jackson ImmunoResearch Lab, 
inc) were used at 1/10000 in 1% non-fat Milk in TBS for 1h at room temperature 
(RT). In the case of immunoprecipitated samples, secondary antibodies 
subsequently used in the immunodetection were against the light chain of IgG. 
 
2.4.4 | Protoplast Transient Expression Assays 
 
Protoplasts from Col-0 plants were isolated and transfected as already 
described (78). All effector constructs (Appendix Table 1) were generated by 
cloning the corresponding coding sequences into a pHBT95 vector harboring a 
N-terminal FLAG (for SUMO constructs) or C-terminal HA (78), for the remaining 
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constructs. The indicated mutations were introduced by site-directed 
mutagenesis and verified by sequencing. For protein expression analyses, 
protoplasts were directly resuspended in 4X Laemmli solubilization buffer (79) 
and boiled for 5min at 95°C. Leptomycin (Sigma, L2913, methanol: water (7:3) 
stock) and MG132 (Sigma, C2211; DMSO stock) solutions were used at a final 
concentration of 2-M and 50-M, respectively.  
 
 
2.4.5 | GFP, SnRK1!1-GFP and SnRK1!1$KA1-GFP 
Immunoprecipitation  
 
Proteins from 5-week-old SnRK1!1-GFP, SnRK1!1"KA1-GFP, or 35S-GFP 
plant leaves were extracted with immunoprecipitation (IP) buffer [50mM Tris-HCl 
pH8.0, 50mM NaCl, 1% (V/V) Igepal CA-630, 0.5% (w/V) Sodium deoxycholate, 
0.1% (w/V) SDS, 1mM EDTA pH8.0, 50µM MG132, 50mM N-Ethylmaleimide 
and cOmplete protease inhibitor cocktail (one tablet/10mL)]. After clearing 
samples by centrifugation (6,785g, 2°C, 10min), 800µL of supernatant were 
supplemented with fresh MG132 (50µM) and incubated at 4°C for 1h with 40µL 
of -MACS Anti-GFP MicroBeads (-MACS GFP Isolation Kit, Miltenyi, 130-091-
125). Samples were thereafter loaded in -Columns (Miltenyi, 130-042-701) pre-
equilibrated with 1ml of IP buffer, and allowed to flow through. Columns were 
washed four times with 200-L of IP buffer and proteins eluted with 80-L of 
Elution Buffer (Miltenyi, 130-091-125) at 95°C. For SUMO protease assays, 
columns were washed further with 1ml of 20mM Tris-HCl pH8.0 and eluted with 
50-L of 20mM Tris-HCl pH8.0 at RT prior to incubation with SUMO protease 
(2.4.8. SUMO protease assays). "-Mercapto-Ethanol (2%) was added to the 
eluates prior to boiling for 5 min at 95°C. Proteins were resolved by SDS-PAGE, 
wet-transferred to a PVDF membrane (30V, 16h at 4°C), and analyzed by 
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immunoblotting with SnRK1!1, SnRK1"1, SnRK1"2, SnRK1"#, SnRK1#, 
SUMO1, and GFP antibodies. For each GFP immunoprecipitation experiment, 
immunodetection with different antibodies was done using equal loading on 
independent membranes. 
2.4.6 | Nuclear enrichment  
 
Full rosettes from 6-week-old Col-0 plants were ground in liquid nitrogen and 
extracted with 15ml/rosette of Nuclear Enrichment Extraction buffer (EB) [20mM 
Tris-HCl pH6.8, 25% Glycerol (V/V), 1% Triton-X (V/V), 2.5mM MgCl2, 20mM 
KCl, 2mM EDTA, 8.8% Sucrose (w/V), 0.5mM Spermidine, 30mM "-Mercapto-
Ethanol, cOmplete protease inhibitor cocktail (one tablet/25mL), 1/500 (v/v) 
phosphatase inhibitor 2 (Sigma P5726) and 3 (Sigma P0044), 10mM NEM]. 
Liquid and homogenous plant extracts were filtered through four layers of 
Miracloth and kept on ice for 15-20min. Samples were thereafter cleared by 
centrifugation using a swing-out rotor (1000g, 4ºC, 10min). The supernatant, 
containing the "soluble fraction" was frozen (15-20µl of supernatant loaded per 
gel), and the pellet containing the nuclei was gently washed three times with 3ml 
of Nuclei Resuspension buffer (RB) [20mM Tris-HCl pH6.8, 25% Glycerol (V/V), 
2.5mM MgCl2, 0.5mM Spermidine, 30mM "-Mercapto-Ethanol, cOmplete 
protease inhibitor cocktail (one tablet/25mL), 1/500 (v/v) phosphatase inhibitor 2 
(Sigma P5726) and 3 (Sigma P0044), 10mM NEM], and resuspended in 60ul of 
RB (20µl of nuclei enriched fraction loaded per gel). Prior to SDS-PAGE 




2.4.7 | Protein extraction under denaturing conditions 
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Leaves from WT Col-0, SnRK1!1-OE, SnRK1!1 RNAi, siz1-2, hpy2-1 and 
esd4 plants were collected and flash-frozen. Leaves were ground in liquid 
nitrogen and extracted with approximately the same volume of Urea Lysis Buffer 
[8M Urea, 100mM NaH2PO4.2H2O, 10mM Tris-HCl pH8.0, 0.1% (V/V) Triton X-
100, 0.1%SDS, 1mM "-Mercapto-Ethanol, cOmplete protease inhibitor cocktail 
(one tablet/100mL), 10mM NEM]. Plant extracts were transferred to a fresh 
tube, resuspended by vortexing, incubated 10min at room temperature and 
2min at 95ºC. Extracts were then centrifuged  (20,000g, 25°C, 15 min) and the 
supernatants collected. Proteins were quantified prior to SDS-PAGE analysis 
with the 2D Quant Kit (GE Healthcare, #80-6483-56), according to the 
manufacturer's instructions, and equal protein amounts were loaded. 
 
 
2.4.8 | E. coli heterologous sumoylation assay 
 
Constructs for reconstituting the Arabidopsis thaliana SUMO machinery in E. 
coli were kindly provided by Katsunori Tanaka (80). pET28a was used to 
express potential SUMO targets (SnRK1!1 and its truncated and mutant 
variants, SnRK1"1, SnRK1"2, SnRK1"#, and SnRK1#). BL21(DE3) cells were 
transformed with pACYCDuet-AtSAE1a-AtSAE2 and selected on 34-g/ml 
chloramphenicol (Cm) LB Agar plates. 100-l of pACYCDuet-AtSAE1a-AtSAE2 
transformed BL21(DE3) competent cells were co-transformed with 30-50ng of 
pCDFDuet-AtSUMO1/3(AA or GG)-AtSCE1a and pET28a-SnRK1!1 (and its 
truncation and mutation variants)/SnRK1"1/SnRK1"2/SnRK1#/SnRK1"# and 
then selected on 17-g/mL Cm, 15-g/mL Kanamycin (Kan) and 25-g/mL 
Spectinomycin (Spec) LB Agar plates. Transformed cells were incubated in 
34-g/mL Cm, 30-g/mL Kan and 50-g/mL Spec LB liquid media at 25°C, 
200rpm, until Abs600nm reached 0.5-0.8. The expression of recombinant proteins 
was induced with 0.15mM IPTG (PROMV3955, Promega) at 25°C for 12h.  
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For analyzing total soluble proteins, cells were harvested from 3mL cultures 
and lysed with 100-L of BugBuster Protein Extraction Reagent (Novagen) 
supplemented with 2-L of ProteoBlock  (#R1321, Fermentas), 2-L of Lysozyme 
(L1667, Sigma) and 2-L of DNAse (PROMM6101, Promega). Samples were 
incubated 20min at RT and cleared by centrifugation (20,000g, 4°C, 25min). 
About 100-g of soluble protein (estimated by Abs280nm) were subjected to SDS-
PAGE and immunoblotting with an anti-T7 antibody. For analyses from purified 
proteins, bacteria were pelleted at 4000g for 30min at 4°C, resuspended in Lysis 
buffer [50mM Hepes-NaOH pH7.25, 0.1M NaCl, antiprotease cOmplete without 
EDTA (1 tablet/50mL)], and sonicated. After centrifugation (20,000g for 30min at 
4°C) the soluble fraction was subjected to IMAC purification (Ni-NTA agarose, 
Qiagen, 30210). Beads were pre-equilibrated in Lysis buffer and incubated with 
the soluble protein extract under gentle shaking for 1h at RT. Beads were 
thereafter washed under gravity flow with Lysis buffer (5 BV, bed volume) and 
then with 50mM Hepes-NaOH pH7.25 until Abs230nm reached 0 or stabilized at 
less than 0.1. A final wash was applied with 50mM Hepes-NaOH pH7.25, 20mM 
imidazole. Three consecutive elutions with 50mM Hepes-NaOH pH7.25 
supplemented with 100, 200 or 500mM of imidazole were performed during at 
least 20min at RT under gentle shaking. Eluates were dialyzed to reach a 20mM 
imidazole concentration, concentrated on 30kDa Amicon columns (Millipore), 
and analyzed (20-g) by SDS-PAGE and immunoblotting with anti-T7. 
 
2.4.9 | Mass spectrometry analyses 
 
For Mass spectrometry analyses, 15-30-g of concentrated eluates were 
resolved on SDS-PAGE (8%) and stained with Coomassie Brilliant Blue R250 
(VWR: 443283M, 0.2% w/V in 14% Acetic Acid, 14% ethanol) and destained 
(10% Acetic Acid, 25% ethanol) until the bands were clearly visible. Bands were 
excised, alkylated with iodoacetamide (carbamidomethylation of cysteines), and 
Sumoylation of the SnRK1 complex 
! !
! 145 
digested with trypsin. Eluted peptides were separated by liquid chromatography 
and detected with an Orbitrap Velos Pro Hybrid Ion Trap Mass Spectrometer 
(Thermo Scientific). An initial hit search was done in the NCBI non-redundant 
database with "Arabidopsis thaliana" as a query organism. Approximately 3400 
queries were made for each sample, with peptide mass tolerance ± 3ppm and 
fragment mass tolerance ± 0.8Da. For a more refined validation, a micro-
database was created containing in silico predicted masses of the branched 




2.4.10 | SUMO protease assay 
 
SnRK1!1-GFP immunoprecipitates (in 21.25-l of 20mM Tris-HCl pH8.0), or 
2-g of purified and concentrated eluates of recombinant SnRK1!1 (in 21.25-l of 
20mM Tris-HCl pH8.0) sumoylated with SUMO1GG in the E. coli assay, were 
incubated with 1X SUMO protease buffer + Salt (2.5 -l, final salt concentration 
of 150mM NaCl) and with or without 1.25-l of SUMO protease (1.25U, 
recombinant fragment of Ulp1, Life Technologies, #12588-018), for 1hour at RT. 
Prior to SDS-PAGE analysis, samples were boiled for 5min at 95°C with 4X 
Laemmli solubilization buffer (79). Immunodetection was done with anti- 
SnRK1!1 and anti-SUMO1 antibodies. 
 
 
2.4.11 | Y2H Assays 
 
Y2H assays were performed as described (81). The full-length coding 
sequence of SnRK1!1 and the various deletions were cloned into pGADT7 in 
fusion with the GAL4 activation domain. pGADT7 constructs were faced with 
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pGBKT7 harboring full-length SCE1 fused to the DNA binding domain of GAL4. 
The empty vectors were used as negative controls. The growth of transformed 
AH109 yeast cells was assessed in permissive (-Leucine, -Tryptophan), 
selective (-Leucine, -Tryptophan, -Histidine), or more stringent (-Leucine, -
Tryptophan, -Histidine, -Adenine) media.  
 
2.4.12 | Statistical Analyses 
 
Statistical analyses were performed with the GraphPad Prism 6 software 
(GraphPad softwares). 
 
2.4.13 | Accession Numbers 
 
Sequence data can be found in the Arabidopsis Genome Initiative database 
under the following accession numbers: SnRK1!1, At3g01090; SnRK1#1, 
At5g21170; SnRK1#2, At4g16360; SnRK1#$, At1g09020; SnRK1$, At3g48530; 
SIZ1, At5g60410; HPY2, At3g15150; ESD4, At4g15880; SUMO1, At4g26840; 
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Many protein kinases are regulated by sumoylation, often with interplay 
between SUMO and other posttranslational modifications. Sumoylation 
functions mainly through modulation of intra- and intermolecular protein 
interactions, thereby affecting a protein activity, stability and/or subcellular 
localization. We show that absence of the SUMO E3-ligase SIZ1 leads to 
enhanced SnRK1 activity in the siz1-2 mutant, that can be reverted to wild-type 
(WT) levels by transient complementation with SIZ1, but not with the 
catalytically inactive SIZ1C379A variant. Furthermore, a translational fusion of 
SUMO1 to SnRK1!1 mimics sumoylation and restores SnRK1 signaling in siz1-
2, supporting that the overactivation of the SnRK1 pathway in this mutant is 
caused by lack of SnRK1 sumoylation. We observed increased stability and 
accumulation of several SnRK1 subunits in siz1-2, suggesting SnRK1 
sumoylation promotes its degradation, thereby restraining SnRK1 signaling. We 
further show that SnRK1 is ubiquitylated in planta and targeted for proteasomal 
degradation. SUMO and ubiquitin conjugates co-purify in SnRK1 
immunoprecipitates. However, in the siz1-2 background, SnRK1-ubiquitin 
conjugates are greatly reduced, suggesting interplay between sumoylation and 
ubiquitylation in targeting SnRK1 for degradation. Additionally, preliminary 
results suggest sumoylation may affect also SnRK1 complex composition, and 
possibly SnRK1 complex assembly and its putative oligomerization. 
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3.1 | Introduction 
 
 
The attachment of small ubiquitin-like modifier (SUMO) to substrate proteins 
is involved in a wide range of biological functions, and allows modulation of 
various pathways and processes in all eukaryotes, including plants (1). 
Downstream effects of sumoylation occur primarily through modulation of 
interactions of the modified substrate with other proteins, since SUMO 
attachment alters the properties and binding surface of the target. The most 
common outcome of sumoylation is to promote protein-protein non-covalent 
interactions, but the SUMO moiety in a substrate can also act as a "repellent", 
blocking the access of binding partners to the same residue or to a close 
binding site. On the other hand, substrate sumoylation can lead to a change in 
its conformation due to the establishment of intramolecular SUMO-SIM 
interactions with relevant functional consequences. By any of these means, 
sumoylation can have an impact on substrate stability, activity, and/or 
subcellular localization.  
Many protein kinases are regulated by sumoylation, often through interplay 
between SUMO and other posttranslational modifications (PTMs), allowing a 
robust and versatile response to specific physiological contexts or signaling 
cues (2-4). Increasing reports evidence a crosstalk between sumoylation and 
ubiquitylation at the substrate level. In many cases, multi- or poly-sumoylation 
and poly-ubiquitylation occur sequentially and in a cooperative manner to bring 
protein targets for proteasomal degradation (5-7). Novel classes of modulators 
such as E4 SUMO ligases that promote SUMO chain extension (8), SUMO 
targeted Ubiquitin ligases (STUbLs) that bind and ubiquitylate multi- or poly-
sumoylated targets (9, 10), and specific deubiquitylases that revert STUbLs' 
action by deubiquitylating hybrid SUMO-ubiquitin chains (11), are being 
unraveled at a fast pace, helping to clarify the mechanisms of SUMO and 
ubiquitin interplay. Here, we show sumoylation impacts SnRK1 protein stability 
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and consequently SnRK1 signaling in planta. Sumoylation-dependent 
ubiquitylation of SnrK1 is shown to target the protein kinase towards proteolytic 
degradation. Furthermore, we analyze a possible impact of sumoylation in 




3.2 | Results 
 
3.2.1 | Sumoylation inhibits SnRK1 signaling  
 
To investigate whether sumoylation has an impact on SnRK1 signaling, we 
focused on the major catalytic subunit SnRK1!1, as it accounts for nearly 90% 
of SnRK1 activity in planta (12). To this end, we used a cell-based (protoplast) 
assay in which SnRK1 activity is measured as an induction of the pDIN6::LUC 
reporter and transient SnRK1!1 overexpression is sufficient to trigger strong 
activation of the SnRK1 pathway (13, 14). We assessed whether co-expression 
of SUMO machinery components (E2 SCE1, E3 SIZ1, or E3 HPY2) and mature 
SUMO variants (mSUMO1 or mSUMO3) in this assay could promote SnRK1!1 
sumoylation and thereby alter SnRK1 signaling. A similar approach was 
successfully used to demonstrate sumoylation of the plant transcription factors 
ICE1, ABI5 and MYB30 in vivo (15-17), where the overexpression with SUMO 
isoforms was sufficient to stimulate sumoylation. SnRK1!1 overexpression 
resulted, as expected, in strong activation of the SnRK1 pathway. However, no 
increase or reduction of SnRK1 signaling could be observed upon co-
expression of SnRK1!1 with E2 SCE1 (SCE) alone or with mature SUMO 
variants (mS1, mS3) (Figure 3.1A).  
Since SnRK1 sumoylation is totally abolished in the siz1-2 mutant (Figure 
2.7), we next decided to co-express SnRK1!1 and SUMO1 or SUMO3 with the 
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E3 ligase SIZ1. Interestingly, SnRK1 pathway activation was reduced to half in 
the presence of SIZ1 and mature SUMO1, but not when SnRK1!1 was co-
expressed with SIZ1 and mature SUMO3 (Figure 3.1B). Furthermore, by co-
expressing SnRK1!1 with the E3 ligase HPY2 using the same settings, we 
could no longer observe an impact on SnRK1 pathway activation (Figure 3.1C). 
Altogether, these results suggest that SnRK1!1 sumoylation represses SnRK1 
signaling in Arabidopsis. In agreement with our previous findings (Figure 2.7), 
SIZ1 is responsible for this sumoylation and requires specifically the SUMO1 
isoform. 
The SnRK1 pathway can also be activated downstream of the SnRK1 kinase, 
through overexpression of the GBF5 transcription factor (13, 14). To assess 
whether SIZ1-mediated repression of SnRK1 signaling occurs at the kinase 
level or downstream of it, we monitored pDIN6::LUC reporter activation by 
GBF5 in the presence or absence of SIZ1 and mature SUMO1. A similar 
response was observed when overexpressing GBF5 alone or in combination 
with SIZ1 and mature SUMO1 (Figure 3.1D), indicating that SIZ1 acts upstream 
of GBF5 on SnRK1 signaling, presumably on SnRK1 itself.  
We next decided to test if a SnRK1!1K34/63/390R triple mutant (SnRK1!13K), 
which is not sumoylated in the E.coli system, could escape the repression by 
SIZ1 and SUMO1 (Figure 2.4F). However, the SnRK1!13K variants were 
comparable to the WT kinase in their susceptibility to SIZ1-dependent 
repression of SnRK1 signaling (Figure 3.1E). Furthermore, a SnRK1!1 variant 
mutated in all sumoylated lysines detected in the E. coli system (SnRK1!18K), 
except K144 as this mutation abolishes kinase activity [(18) and data not 
shown], induced the reporter normally (Figure 3.1F). The same was observed 
for the SnRK1!13K variant, whereas an inactive SnRK1!1T175A kinase (13) had 
no effect. These results suggest that SnRK1!1 can be sumoylated on other 
residues in planta, and/or that sumoylation of other components of the complex 
(e.g. the "-regulatory subunits) is sufficient to exert SUMO function.  
 






Figure 3.1 | SIZ1-mediated sumoylation of SnRK1$1 represses SnRK1 signaling.  
A. Normal induction of SnRK1 signaling by SnRK1$1 in the presence of the E2 SUMO 
conjugating enzyme SCE1 (SCE) and mature SUMO isoforms. Co-expression of SCE and mature 
SUMO1 (mS1) or SUMO3 (mS3) does not alter the ability of SnRK1$1 to induce the pDIN6::LUC 
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reporter. B. Repression of SnRK1 signaling by SIZ1 and SUMO1. Co-expression of E3 SUMO 
ligase SIZ1 and mature SUMO1 (mS1) but not SUMO3 (mS3) represses the ability of SnRK1$1 to 
induce the pDIN6::LUC reporter. C. Normal induction of SnRK1 signaling by SnRK1$1 in the 
presence of HPY2 and mature SUMO isoforms. Co-expression of E3 SUMO ligase HPY2 and 
mature SUMO1 (mS1) or SUMO3 (mS3) does not alter the ability of SnRK1$1 to induce the 
pDIN6::LUC reporter. D. The ability of GBF5 to induce SnRK1 signaling is not altered by the 
presence of SIZ1 and mature SUMO1. Co-expression of E3 SUMO ligase SIZ1 and mature 
SUMO1 (mS1) represses the ability of SnRK1$1, but not of GBF5, to induce the pDIN6::LUC 
reporter. E. Normal repression of SnRK1 signaling by SIZ1 and mature SUMO1 in SnRK1$1 
lysine mutants. Co-expression of E3 SUMO ligase SIZ1 and mature SUMO1 (mS1) represses the 
ability of WT SnRK1$1 and of a SnRK1$13K variant to induce the pDIN6::LUC reporter (#1 and #2 
denote two independent clones). 3K, K34R/K63R/K390R. F. Normal induction of SnRK1 signaling 
by SnRK1$1 multiple-lysine mutants. Expression of SnRK1$1 in Arabidopsis mesophyll 
protoplasts triggers SnRK1 signaling, as measured by induction of the pDIN6::LUC reporter. 
Mutation of K residues found to be sumoylated in the E. coli system does not alter the ability of 
SnRK1$1 to induce the pDIN6::LUC reporter. 3K, K34R/K63R/K390R; 8K, 
K20R/K34R/K44R/K56R/K63R/K69R/K390R/K421R. An inactive T-loop phosphomutant (T175A) 
is used as a negative control. A-F n(3, in E one representative biological experiment is shown. 
Error bars=SEM. Stars denote statistical significance, as determined by ratio paired t-test (ns 
p>0.05, *p<0.05, **p<0.005). 
 
 
As an alternative strategy to globally block sumoylation of the SnRK1 
complex and to assess its functional relevance, we decided to compare SnRK1 
signaling in Col-0 (WT) and siz1-2 plants, impaired in SnRK1 sumoylation 
(Figure 2.7). To this end, we treated plants with control (3h light) or SnRK1 
activating conditions (3h darkness) and measured the expression of SnRK1 
target genes by quantitative RT-PCR (qRT-PCR), as readout of SnRK1 pathway 
activation (13, 14). As expected, exposure to darkness triggered a strong 
induction of SnRK1 target genes (AXP, DIN6 and TPS8) in Col-0 plants (Figure 
3.2A). This induction was two-fold higher in the siz1-2 mutant, showing that, in 
accordance with the SIZ1-mediated repression of SnRK1 signaling observed in 
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Col-0 protoplasts (Figure 3.1C), SIZ1 is a negative regulator of SnRK1 signaling 
in Arabidopsis. 
Given the compromised growth and pleiotropic phenotypes of the siz1-2 
plants (19), we next employed the cell-based system to rule out potential 
secondary effects of the long-term depletion of SIZ1 on SnRK1 activity in the 
mutant. To this end, we isolated protoplasts from Col-0 and siz1-2 plants and 
monitored activation of the pDIN6::LUC reporter by SnRK1!1. As expected, 
SnRK1!1 overexpression in Col-0 protoplasts triggered a strong activation of 
the reporter. However, reporter activation was roughly 3-fold higher in the siz1-2 
mutant (Figure 3.2B), consistent with the analyses of endogenous gene 
expression. We next complemented the siz1-2 mutant by transiently co-
expressing SIZ1, or a catalytically inactive SIZ1 variant (SIZ1C379A) that lacks 
SUMO E3 ligase activity (20), with SnRK1!1. Whilst co-expression of SIZ1 or 
SIZ1C379A did not alter reporter activity in Col-0 cells, the overactivation of the 
reporter in siz1-2 could be reverted to Col-0 levels by SIZ1 but not by SIZ1C379A 
expression (Figure 3.2B). This result further supports that the E3 ligase activity 
of SIZ1 restrains SnRK1 signaling in vivo.  
On the other hand, pDIN6::LUC reporter activation by GBF5 in siz1-2 was 
normal, and a similar response was observed by co-expressing SIZ1 or 
SIZ1C379A, as in Col-0 cells (Figure 3.2C). These results evidence that SIZ1-
mediated repression of SnRK1 signaling occurs upstream of GBF5, namely on 
SnRK1, as previously suggested (Figure 3.1D).  
As a complementary strategy to restore normal SnRK1 pathway activation in 
siz1-2, we generated a SnRK1!1 ”SUMO mimetic”, through a translational 
fusion of SnRK1!1 to a non-conjugatable mature SUMO1-AA isoform 
(SnRK1!1-SUMO1) (21), and tested its ability to induce the pDIN6::LUC 
reporter. Fusion of SUMO1 to SnRK1!1 restored SnRK1 signaling in siz1-2 to 
the levels observed in Col-0 cells (Figure 3.2D), further supporting that the 
overactivation of SnRK1 signaling in the siz1-2 mutant is caused by lack of 
SnRK1!1 sumoylation.  
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Figure 3.2 | SnRK1 signaling overactivation in siz1-2 is due to lack of SnRK1 sumoylation. 
A. Overinduction of SnRK1 signaling in the siz1-2 mutant. Relative gene expression of SnRK1 
marker genes (AXP, DIN6, TPS8) in Col-0 or siz1-2 mutant plants treated under control (Light) or 
energy stress (Dark) conditions. Stars denote statistical significance, as determined by paired t-
test (n=4; error bars=SEM; **p<0.01; ***p<0.001). B. Overinduction of SnRK1 signaling in siz1-2 is 
rescued to WT levels by the E3 ligase activity of SIZ1. Expression of SnRK1$1 triggers a three-
fold higher induction of the pDIN6::LUC reporter in siz1-2 than in Col-0 protoplasts. Normal 
pDIN6::LUC expression is recovered by co-expression of SIZ1, but not of a catalytically inactive 
SIZ1C379A variant. C. Induction of SnRK1 signaling downstream of SnRK1 is normal in siz1-2. 
Expression of the GBF5 transcription factor triggers similar induction of the pDIN6::LUC reporter in 
Col-0 and siz1-2 protoplasts. Stars (B,C) denote statistical significance, as determined by two-way 
ANOVA (n=3; error bars=SEM; ns., p>0.05; **p<0.01; ****p<0.0001). D. A SnRK1!1 SUMO-
mimetic restores normal SnRK1 signaling in siz1-2 protoplasts. Expression of SnRK1$1 triggers a 
three-fold higher induction of the pDIN6::LUC reporter in siz1-2 than in Col-0 protoplasts. 
Expression of SnRK1$1-mSUMO1 fusion protein mimics SnRK1$1 sumoylation in siz1-2 cells and 
rescues pDIN6::LUC induction to the levels of the WT protein in Col-0 protoplasts. Statistical 
significance was determined by paired t-test (n=3; error bars=SEM; ns. p>0.05). 
 
Several phenotypes of siz1-2, such as diminished plant size, heightened 
innate immunity, and drought- or basal thermo-tolerance, amongst others, are 
largely due to the elevated salicylic acid (SA) levels of the mutant (19, 22-27). 
Thus, we next asked if the effect of the siz1-2 mutation on SnRK1 signaling was 
indirect, and more specifically induced by SA. To test this, we treated Col-0 
protoplasts transfected with the pDIN6::LUC reporter and SnRK1!1 with SA or 
mock control. As shown in Figure 3.3A, SA had no effect on SnRK1 signaling 
during a short (2h) or extended (overnight, 15h) incubation. Furthermore, 
examination of public microarray datasets with the Genevestigator tool (28) 
revealed that various SA treatments that induce systemic acquired resistance 
(SAR) marker genes, do not affect SnRK1 marker genes (DIN6, AXP and TPS8) 
(Figure 3.3B), ruling out an indirect effect of the siz1-2 mutation on SnRK1 
signaling mediated by SA. 
Overall, the results presented show that SIZ1 inhibits SnRK1 signaling in 
vivo, most probably through sumoylation of the SnRK1 complex. 





















Figure 3.3 | Salicylic acid (SA) has no effect on SnRK1 signaling.  
A. SA does not alter SnRK1 reporter gene induction in protoplasts. The pDIN6::LUC reporter 
for SnRK1 signaling is induced by SnRK1$1 expression, but this induction is similar in mock- and 
SA-treated cells. Protoplasts were transfected with a plasmid expressing SnRK1$1 or control 
DNA, incubated for 4h and thereafter treated with SA (5-M) or ethanol (mock control) and the t0 
was collected. After 2h or 15h, the cells were collected for luciferase/ glucuronidase activity 
assays. Expression was confirmed by Western blot (WB) with anti-SnRK1$1 antibody. Data 
presented are means and error bars are SEM (n=3). B. Various SA treatments induce the 
expression of two marker genes of Systemic Acquired Resistance (SAR), PR1 (At2g14610) and 
PR5 (At1g75040), but not of SnRK1 marker genes DIN6 (At3g47340), AXP (At2g33830), and 
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3.2.2 | Sumoylation triggers SnRK1 degradation 
 
Proteins modified by SUMO acquire novel molecular features that can affect 
their stability, activity, and/or subcellular localization, primarily through altered 
interactions with other proteins (29). To determine whether the SIZ1-dependent 
inhibition of SnRK1 signaling involved changes on SnRK1 specific activity, we 
performed in vitro kinase assays using ABF2 as a peptide substrate (14). To 
minimize potential cross-contamination with other related kinases (e.g. SnRK2 
kinases) we used SnRK1!1 immunoprecipitated from Col-0 or siz1-2 plants 
instead of total protein extracts. As shown in Figure 3.4A, ABF2 
phosphorylation was two-fold higher with SnRK1 immunoprecipitated from the 
siz1-2 mutant than from the Col-0 control. However, despite starting from 
identical amounts of total protein in both Col-0 and siz1-2 extracts, the higher 
activity was fully explained by the two-fold higher amount of SnRK1!1 
immunoprecipitated from siz1-2 plants (Figure 3.4A, lower panel). This shows 
that the overactivation of SnRK1 signaling in siz1-2 plants is not caused by 
changes in SnRK1 specific activity, but rather by an enhanced accumulation of 
the kinase in the siz1-2 background. Furthermore, the reduced induction of 
SnRK1 signaling by SnRK1!1-mSUMO1 (see also Figure 3.2D) correlated with 
a decreased accumulation of the "sumo mimetic" protein in comparison to WT 
SnRK1!1, in Col-0 cells (Figure 3.4B).  
To determine more precisely SnRK1 protein levels in Col-0 and siz1-2 
genotypes, we performed immunoblot analyses using total protein extracts. 
These analyses confirmed that SnRK1!1 is about 2.5-fold more abundant in 
siz1-2 than in Col-0 plants (Figure 3.4C). As a result of increased accumulation, 
SnRK1!1 T-loop phosphorylation is also 2.5-fold higher in the siz1-2 mutant, 
consistent with a similar SnRK1 specific activity in Col-0 and siz1-2 plants. T-
loop phosphorylation was detected with an antibody (P-AMPK) that recognizes 
both SnRK1!1 and SnRK1!2 phosphorylated on their regulatory T-loop 
threonine (T175 and T176, respectively) (13). The levels of phosphorylated 
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SnRK1!2 were also higher in siz1-2 (Figure 3.4C), suggesting that regulation of 
kinase stability through sumoylation may also apply to the SnRK1!2 isoform.  
In accordance with our previous indications that sumoylation could target 
several SnRK1 subunits (Figure 2.3A and 2.6B), we also detected an increase 
in SnRK1"1 protein amounts in siz1-2, whereas SnRK1"2 accumulation was 
unchanged in both genotypes (Figure 3.4D). Similar comparisons were not 
possible for SnRK1"# since the available antibodies recognize multiple bands in 
total protein extracts (not shown), despite being adequate for analyzing SnRK1 
immunoprecipitates (Figure 2.6B). Interestingly, and although SnRK1# is not 
fully established as a SnRK1 subunit, it displayed a 3.5-fold accumulation in the 
siz1-2 mutant (Figure 3.4E).  
To investigate the cause of enhanced SnRK1!1 accumulation in siz1-2, we 
next performed protein half-life measurements, using protoplasts isolated from 
siz1-2 or Col-0 plants and transfected with a plasmid expressing SnRK1!1. 
Following 6h of incubation to allow protein expression, translation was blocked 
by the addition of cycloheximide and SnRK1!1 protein levels were quantified 
after 2 and 4 hours. As shown in Figure 3.4F, SnRK1!1 degradation was 
significantly reduced in siz1-2 compared to Col-0 cells. Importantly, the 
SnRK1!1-mSUMO1 fusion protein that mimics SnRK1!1 sumoylation and 
restores SnRK1 signaling in siz1-2 protoplasts (Figure 3.2D), recovered 
SnRK1!1 degradation in siz1-2 to a similar extent as in Col-0 cells.  
Collectively, the data presented suggests that SIZ1-dependent sumoylation 
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Figure 3.4 | SnRK1 stability is increased in siz1-2.  
A. SnRK1 specific activity is not altered in the siz1-2 mutant. SnRK1!1 was 
immunoprecipitated from Col-0 and siz1-2 leaf extracts and incubated in the presence of #-32P-
ATP and an ABF2 substrate. SnRK1!1 levels and ABF2 phosphorylation were quantified by 
Western-blot (WB) and by autoradiography (P-ABF2), respectively. n=3; error bars=SEM. B. 
SnRK1!1 "SUMO mimetic" accumulates less than WT SnRK1!1. Col-0 protoplasts were 
transfected with SnRK1!1 or with a SnRK1!1 variant fused to mature SUMO1 (SnRK1!1-
mSUMO1). Luciferase/ glucuronidase activity assays were performed using the pDIN6::LUC 
reporter as in Figure 3.2D, and protein accumulation was analyzed by Western-blot (WB) with 
anti-SnRK1!1 antibody, considering the loading control. Quantified signals were normalized to 
SnRK1!1 (n(2; error bars=SEM). C-E. SnRK1 accumulation in the siz1-2 mutant. Total leaf 
protein extracts of Col-0 and siz1-2 plants were analyzed by Western-blot (WB) using antibodies 
against SnRK1!1 and the phosphorylated T-loop of SnRK1!1 and SnRK1!2 (P-!1/P-!2, P-
AMPK) (C), or against the SnRK1"1 and SnRK1"2 (D), or SnRK1# subunits (E). The signals were 
quantified and normalized to loading. The average quantification in siz1-2 normalized to Col-0 is 
presented. F. Reduced SnRK1!1 degradation in siz1-2 is restored in a SUMO-mimetic SnRK1!1 
variant. SnRK1!1 fused to mature SUMO1 (-mS1, empty marks) or not (WT, filled marks) was 
expressed in Col-0 (squares) or siz1-2 (circles) protoplasts. Protoplasts were thereafter treated 
with cycloheximide (CHX), samples were harvested at the indicated time points, and analyzed by 
Western-blot (WB) using anti-SnRK1!1 antibody. The signal was quantified and normalized to the 
t=0 for each kinetics. Stars denote statistical significance, as determined by ratio paired t-test prior 
to normalization (C-E; n=3; error bars=SEM), or by one-way ANOVA (F) (n=5; error bars=SEM); 








Given the increasing association between sumoylation, ubiquitylation and 
proteasomal degradation (5-7), we next asked whether SnRK1!1 degradation, 
observed in Col-0 and diminished in siz1-2 protoplasts (Figure 3.4F), occurred 
via the ubiquitin proteasome system. To this end, we determined SnRK1!1 
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turnover in the presence of the proteasome inhibitor MG132 or DMSO (mock 
control). In accordance with previous results [Figure 3.4F and degradation 
assays in cell extracts (30, 31)], we could observe a strong reduction in 
SnRK1!1 levels, 3h after the addition of cycloheximide (Figure 3.5A). However, 
this degradation was significantly blocked in cells treated with MG132, showing 
that SnRK1!1 protein turnover is largely dependent on the proteasome (Figure 
3.5A). 
To address whether SnRK1 is ubiquitylated in planta, we employed the same 
system as for assessing SnRK1 sumoylation (Figure 2.6A-C) and performed 
GFP immunoprecipitation from SnRK1!1-GFP, SnRK1!1"KA1-GFP, and 35S-
GFP control plants, to check for the presence of ubiquitin conjugates. These 
analyses revealed a higher accumulation of ubiquitin conjugates in 
immunoprecipitates from SnRK1!1-GFP plants than in those from 
SnRK1!1"KA1-GFP plants, while none were detected in the 35S-GFP control 
(Figure 3.5B). This pattern is clearly similar to that of SUMO conjugates (Figure 
2.6A), suggesting that SnRK1 ubiquitylation and sumoylation might be 
interconnected. To test whether SnRK1 sumoylation is a prerequisite for its 
ubiquitylation, we next immunoprecipitated SnRK1!1-GFP from SnRK1!1-
GFPsiz1-2 plants and checked for the presence of ubiquitin conjugates. As shown 
in Figure 3.5C, ubiquitin conjugates were markedly reduced in SnRK1!1-GFP 
immunoprecipitates from SnRK1!1-GFPsiz1-2 plants, indicating that SnRK1 
















Figure 3.5 | Sumoylation-dependent ubiquitylation of SnRK1 and its degradation by the 
proteasome. 
A. SnRK1$1 is degraded through the proteasome. SnRK1$1 was expressed in Col-0 
protoplasts and its levels were assessed by Western-blot (WB), following a 3h treatment with 
cycloheximide (CHX) in the presence or absence of the proteasome inhibitor MG132. Quantified 
levels were normalized to t=0. Stars denote statistical significance, as determined by ratio pair t-
test prior to data normalization (**p<0.01; *p<0.05). n=3; error bars=SEM. B. The SnRK1 complex 
is ubiquitylated in planta. Leaf crude extracts of plants expressing 35S-GFP (Ctrl), 
SnRK1!1%KA1-GFP (%) and full length SnRK1!1-GFP (FL) were used for GFP 
immunoprecipitation (IP). Immunoprecipitates were analyzed by Western-Blot (WB) using 
antibodies against SnRK1!1 and Ubiquitin11. C. SnRK1 ubiquitylation is largely dependent on 
SIZ1. SnRK1$1-GFP was immunoprecipitated (IP) from leaf crude extracts of SnRK1%1-GFP 
(WT) and SnRK1%1-GFPsiz1-2 (siz1-2) plants and analyzed by Western-Blot (WB) using antibodies 
against SnRK1$1 and Ubiquitin11. MW, Molecular Weight. 
 
 
3.2.4 | Sumoylation affects SnRK1 complex composition and possibly 
its oligomerization 
 
We have shown that SnRK1 sumoylation triggers its degradation through the 
ubiquitin proteasome system. However, the siz1-2 mutation affects differentially 
SnRK1"1 and SnRK1"2 protein accumulation (Figure 3.4D), despite both 
regulatory subunits are likely sumoylated in planta. In order to determine if 
sumoylation could promote selective degradation or stabilization of specific 
SnRK1 complexes, we analyzed SnRK1!1-GFP immunoprecipitates from 
SnRK1!1-GFP and SnRK1!1-GFPsiz1-2 plants. Surprisingly, the abundance of 
both SnRK1"1 and SnRK1"2 subunits co-purifying with SnRK1!1-GFP was 
markedly reduced in SnRK1!1-GFPsiz1-2 when compared to SnRK1!1-GFP 
plants (Figure 3.6A). On the other hand, the abundance of SnRK1"#, relative to 
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the immunoprecipitated SnRK1!1-GFP catalytic subunit, was the same in both 
genotypes (Figure 3.6A). A similar pattern was obtained while analyzing 
SnRK1!1 immunoprecipitates from Col-0 or siz1-2 plants (Figure 3.6B), ruling 
out artifacts potentially derived from the GFP-tagged protein. Due to the 
unavailability of an anti-SnRK1"3 antibody, we could not determine how the 
absence of SIZ1-dependent sumoylation in the siz1-2 background influences 
SnRK1"3-subunit containing complexes.  
Several studies have suggested that oligomerization of SNF1/AMPK/SnRK1 
complexes may play a role in the control of kinase activity (see Introduction), 
and, in plants, the "#-regulatory subunit was shown to homodimerize (32). 
Consistent with this view, we were able to detect the interaction between two 
SnRK1!1 subunits in Y2H assays (Figure 3.6C). Furthermore, SnRK1!2 was 
co-immunoprecipitated with SnRK1!1-GFP from SnRK1!1-GFP plants, but this 
interaction was strongly diminished in SnRK1!1-GFPsiz1-2 immunoprecipitates 
(Figure 3.6A). These results suggest that, likewise the yeast Snf1 and 
mammalian AMPK! kinases, SnRK1 !-catalytic subunits have the ability to 
dimerize (33, 34). On the other hand, it remains to be assessed if the 
dimerization can be determined by the composition of the constituent trimers.  
Hence, based on these preliminary results, and besides overall accumulation of 
individual SnRK1 subunits, sumoylation appears to also affect their assembly 
into SnRK1 heterotrimeric complexes, as well as a putative complex 
oligomerization. 
 




Figure 3.6 | Sumoylation affects SnRK1 complex composition and oligomerization.  
A. SnRK1$1-GFP was immunoprecipitated through its GFP tag (IP:GFP) from leaf crude 
extracts of SnRK1%1-GFP (WT) and SnRK1%1-GFPsiz1-2 (siz1-2) plants and analyzed by Western-
Blot (WB) using antibodies against SnRK1$1, SUMO1, Ubiquitin11, SnRK1"#, SnRK1"2, 
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SnRK1"1 and SnRK1$2. B. SnRK1$1 was immunoprecipitated using SnRK1$1 antibody (IP: 
SnRK1$1) from leaf crude extracts of Col-0 (WT) and siz1-2, and analyzed by Western-Blot (WB) 
using antibodies against SnRK1$1, SnRK1"#, SnRK1"2, and SnRK1"1. MW, Molecular Weight. 
C. SnRK1!1 homodimerizes in a Y2H assay. Full length (FL) SnRK1!1 was cloned in pGBKT7 
and co-transfected with FL SnRK1!1 in pGADT7. The growth of transformed AH109 yeast cells 
was assessed in permissive (-L, -W) or stringent (-L-W-H-A) media. A representative experiment 
of a minimum of two independent assays is shown. 
 
 
3.2.5 | Preliminary studies on the genetic interaction between SIZ1 and 
SnRK1!1 in Arabidopsis thaliana, and other approaches to address the 
relevance of SnRK1 sumoylation at the whole plant level 
 
In order to better understand the physiological implications of SnRK1 
sumoylation at the whole plant level, we first undertook a "loss-of-function" 
approach and analyzed phenotypically the siz1-2 plants (35, 36). A more 
specific approach, through mutation of several target lysines on SnRK1 !-
catalytic subunit, thus blocking directly sumoylation at the substrate level, 
proved to be unsuccessful in the protoplast system (Figure 3.1F). The 
abrogation of SIZ1-dependent sumoylation leads to an accumulation of SnRK1 
in the siz1-2 mutant, and consequent overactivation of SnRK1 signaling in this 
background (Figure 3.4 and Figure 3.2, respectively). siz1-2 plants were 
compared with Col-0 (WT), SnRK1!1 overexpressor [SnRK1!1-OE, (13)], and 
SnRK1!1 knockout [snrk1!1-3 (Figure 2.5A-B)] plants, in an attempt to 
correlate the various levels of SnRK1!1 expression with phenotypic traits in the 
different backgrounds. Furthermore, we generated double mutant siz1-2 
snrk1!1-3 plants, by crossing siz1-2 with snrk1!1-3 (Figure 3.7A). siz1-2 
snrk1!1-3 double mutant plants were also analyzed.  
 
 





Figure 3.7 | Generation of siz1-2 snrk1!1-3 double mutant plant lines. 
 A. Representation of SIZ1 and SnRK1!1 genes with a T-DNA insertion defining the siz1-2 
(SALK_065397) and snrk1!1-3 mutant parent lines (GABI-KAT: 579E09) (Figure 2.5A-B). 
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Genotyping reactions were done using snrk1!1-3, siz1-2, siz1-2 snrk1!1-3 and Col-0 (WT) plant 
extracts, and are represented as A to D. Reaction A allows the detection of the T-DNA insertion in 
SIZ1, and in B, of the WT SIZ1 gene. C and D reactions can amplify respectively SnRK1!1 with a 
T-DNA insertion or the WT SnRK1!1 gene. Genotyping primers are indicated in Appendix Table 
1. For SIZ1, a 710bp band indicates a mutant allele (A reaction) and a 1042bp band indicates a 
WT allele (B reaction). Unspecific bands were amplified in reaction A and are annotated with an 
asterisk (*). For SnRK1!1, a 190bp band indicates a mutant allele and a 386bp band indicates 
WT allele (C+D reaction). B. Total proteins from adult Arabidopsis leaves of snrk1!1-3, siz1-2 
snrk1!1-3, siz1-2 or Col-0 were analyzed by Western-blot (WB) using antibodies against 
SnRK1!1, SnRK1!2 or P-AMPK (recognizing the phosphorylated T175/176 of SnRK1!1/!2, 
respectively, and annotated as "P- !1"/"P- !2"/). "L", loading is shown by Coomassie staining of 
the membrane; bp, base-pairs.  
 
 
Regarding overall plant growth, siz1-/+ snrk1!1-/- sesquimutants exhibited a 
"WT" phenotype, like the one observed for snrk1!1-3 plants. On the other hand, 
siz1-/- snrk1!1-/- double homozygous (siz1-2 snrk1!1-3) plants displayed a 
"siz1" phenotype, with dwarfism and reduced leaf size (37) (not shown). We 
decided to analyze if the differential accumulation of SnRK1!1 in the different 
backgrounds would impact sugar-responsive phenotypes during early seedling 
development, due to the relevance of SnRK1 in sugar sensing and signaling in 
plants (38).  We could observe the glucose hypersensitivity previously described 
for the SnRK1!1-OE seedlings (14) and the same sugar hypersensitivity was 
also observed for siz1-2 seedlings in the presence of 6% glucose (Figure 3.8A).!
However, siz1-2 snrk1!1 double mutants retained the glucose hypersensitivity 
displayed by siz1-2. Moreover, a mild enhancement of the siz1-2 glucose 
hypersensitivity occurred upon introduction of snrk1!1-3 into this genetic 
background (Figure 3.8A). We also tested if the ABA hypersensitivity described 
for siz1-2 in early seedling development (16, 20) could be ameliorated in the 
siz1-2 snrk1!1-3 genetic background, since SnRK1!1-OE seedlings also 
display to some extent ABA hypersensitivity (Figure 3.8B, left panel). However, 
as for the sugar sensitivity, siz1-2 snrk1!1-3 double mutants retained, even with 
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mild enhancement (not shown), the ABA hypersensitivity displayed by siz1-2 
((Figure 3.8B, right panel). We also tested starch accumulation in the different 
backgrounds, since it has been previously suggested SnRK1 might have a role 
in starch mobilization at night (13). However, no consistent differences were 
observed amongst the different plants analyzed (not shown). For other 
conditions such as flowering time (13, 26, 39, 40), or dark induced senescence, 
SnRK1!1-OE and siz1-2 plants have opposite phenotypes. SnRK1!1-OE and 
siz1-2 plants have delayed or accelerated dark induced senescence, 
respectively (not shown), and an opposite behavior is also expected regarding 
flowering time. For that reason, we did not pursuit the analysis of siz1-2 
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Figure 3.8 | Sugar- and ABA- response phenotypes during early seedling development of 
snrk1!1-3, siz1-2 snrk1!1-3, siz1-2, SnRK1!1-OE, or Col-0 plants. 
A. Altered glucose response of siz1-2 snrk1!1-3 and siz1-2 knockout mutants, and of 
SnRK1!1-OE plants, showing hypersensitivity to 6% glucose during early seedling development, 
compared to Col-0 or snrk1!1-3 plants. The sorbitol osmotic control (6%) and control plates with 
0.2% of glucose are also shown. All plates have 0.5xMS media. B. ABA response of snrk1!1-3, 
siz1-2 snrk1!1-3, and siz1-2 knockout mutants, and of SnRK1!1-OE and Col-0 plants during early 
seedling development. siz1-2 and siz1-2 snrk1!1-3 show high hypersensitivity to 1µM ABA.  All 
plates have 0.5xMS media with 0.2% of glucose. Control plates are devoid of ABA. 
 
 
SIZ1 is a key component of the SUMO machinery that has a determinant 
impact in the Arabidopsis sumoylome. The siz1-2 mutant abrogates sumoylation 
of many protein targets, explaining its pleiotropic phenotype, and thus fails to be 
an exclusive readout of impaired SnRK1 sumoylation. SIZ1 regulates SnRK1 
protein turnover and consequently SnRK1 pathway activation, but there are 
additional players in the SIZ1 sugar- or ABA- response during early seedling 
development. This is evidenced by the lack of dependence on SnRK1!1 
regarding the abovementioned phenotypes, as demonstrated by their 
persistence in the siz1-2 snrk1!1-3 double mutant. On the other hand, the siz1-
2 snrk1!1-3 double mutant still retains SnRK1 kinase activity through the 
SnRK1!2 catalytic subunit (Figure 3.7B), which may partially compensate for 
the loss of SnRK1!1. 
Using a different approach, we introduced 35S-SnRK1!1 into the siz1-2 
mutant background, by crossing SnRK1!1-OE and siz1-2 plants. However, the 
selection of double homozygous plants from this cross is still ongoing.  Our 
expectation is that SnRK1!1-OEsiz1-2 will have enhanced sugar hypersensitivity 
compared to SnRK1!1-OE plants, due to an even higher accumulation of 
SnRK1!1 and higher SnRK1 pathway activation. Whereas in SnRK1!1-OE, 
sumoylation-dependent degradation of SnRK1 should restrain to some extent 
SnRK1 signaling, such molecular mechanism should be absent in SnRK1!1-
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OEsiz1-2 plants, allowing even higher SnRK1 pathway activation. This would also 
explain the weakness of most phenotypes displayed by the SnRK1-OE plants, 
which are not in accordance with a strong constitutive activation of such a 
central stress response pathway. 
In order to address the functional relevance of SnRK1 sumoylation at the 
whole plant level we have also undertaken a "gain-of-function" approach and 
generated SnRK1!1-SUMO mimetic overexpressor plants (35S-SnRK1!1-
SUMO in the snrk1!1-3 genetic background; referred as SnRK1!1-SUMO-OE 
plants). Several lines were generated with fusions of SUMO1 and SUMO3, 
mature and non-conjugatable isoforms, and in the N- and C-terminal position of 
SnRK1!1 (Figure 1.3A). In parallel, we also generated several GFP-SUMO 
overexpressing plants (with fusions of SUMO1 or SUMO3, mature and non-
conjugatable isoforms, and in the N- or C-terminal position of GFP) (not shown), 
to control for possible effects derived from the constitutive overexpression of 
non-conjugatable SUMO isoforms at the plant level. In the future, SnRK1!1 
protein turnover and accumulation, SnRK1 pathway activation, and SnRK1!1-
OE associated phenotypes, such as glucose hypersensitivity amongst others, 
will be compared in SnRK1!1-OE and SnRK1!1-SUMO-OE plants. The 
expectation is that SnRK1!1-SUMO-OE will behave as a weak overexpressor of 
SnRK1!1 due to the repressive effect associated with SnRK1!1 sumoylation. 
These plants may also prove useful for assessing potential alterations in SnRK1 































Figure 3.9 | Generation of SnRK1!1-SUMO-OE  transgenic plants. 
A. SnRK1!1-SUMO-OE transgenic lines were generated by transformation of the snrk1!1-3 
mutant with the pCB302-derived minibinary expression vector, containing the coding sequence of 
SnRK1!1 (At3g01090.1) fused with the coding sequence of mature SUMO1 (At4g26840) or 
mature SUMO3 (At5g55170) non-conjugatable isoforms. SUMO fusion constructs were generated 
in both orientations (Appendix Table 1). Several transformants were tested for the presence of 
SnRK1!1-SUMO variants. Total proteins from adult Arabidopsis leaves of SnRK1!1-OE, different 
insertion lines (#1-#3) of SUMO1-SnRK1!1-OE, SUMO3-SnRK1!1-OE, SnRK1!1-SUMO1-OE 
and SnRK1!1-SUMO3-OE transgenic plants, or from the snrk1!1-3 mutant, were analyzed by 
Western-blot (WB) using antibodies against SnRK1!1 or P-AMPK (recognizing the 
phosphorylated T175/176 of SnRK1!1/!2, respectively). In the first panel, several plants that 
express SnRK1!1-SUMO variants are identified as well as SnRK1!1-HA (in SnRK1!1-OE line), 
through WB with anti-SnRK1!1 antibody. In the second panel, the same membrane used in the 
previous panel was incubated with anti-P-AMPK, allowing the detection of endogenous phospho-
SnRK1!2 [(phospho)-SnRK1!1 is absent in the snrk1!1-3 background] in the different lines. 
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Possible phospho-SnRK1!1-HA (in the SnRK1!1-OE line) and phospho-SnRK1!1-SUMO fusions 
are identified, despite we cannot discard the contribution from the preceding anti-SnRK1!1 




3.3 | Discussion 
 
In the previous chapter we showed that several SnRK1 subunits are 
sumoylated, supporting the view that sumoylation occurs at the level of the 
whole SnRK1 complex. This is in agreement with an increasing number of 
studies showing that SUMO ligases often act on preassembled protein 
complexes, hence modifying groups of physically interacting components rather 
than individual proteins (29, 41). 
In order to address the functional outcome of SnRK1 sumoylation we co-
expressed SUMO isoforms and SUMO machinery components with the 
SnRK1!1 catalytic subunit, using the protoplast system to monitor SnRK1 
pathway activation. Co-expression of the E3 SUMO ligase SIZ1 and mature 
SUMO1 specifically repressed the ability of SnRK1$1 to induce SnRK1 
signaling (Figure 3.1C). However, we could not observe any effect with the 
SUMO3 isoform or with the co-expression of the E3 SUMO ligase HPY2 with 
either of the two SUMO isoforms (Figure 3.1A-C), altogether suggesting that 
SnRK1$1 sumoylation leads to a downregulation of the kinase and that this 
requires both SIZ1 activity and SUMO1. This is also in accordance with the 
absence of SnRK1-SUMO1 conjugates in siz1-2 plants (Figure 2.7B). On the 
other hand, the induction of SnRK1 signaling by the downstream GBF5 
transcription factor was unaltered in the presence of SIZ1 and SUMO1, further 
supporting that sumoylation occurs at the kinase level (Figure 3.1D). 
We next aimed to address the relevance of this posttranslational modification 
by attempting to abolish SnRK1 sumoylation through mutation of specific SUMO 
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attachment residues on SnRK1!1. However, similarly to the WT kinase, SIZ1-
dependent repression of SnRK1 signaling was still observed with SnRK1!13K 
(Figure 3.1E), and SnRK1!13K and SnRK1!18K induced normally SnRK1 
signaling in Col-0 cells (Figure 3.1F). It has been noted the paradoxical 
discrepancy between strong phenotypes of SUMO pathway mutants and the 
lack of phenotypes obtained while mutating specific SUMO acceptor K(s) on 
substrates. In several instances this can be explained by the fact that 
sumoylation of other functionally engaged interacting proteins (29, 41) 
compensates for the lack of sumoylation in these K mutants. This appears to be 
the case in the SnRK1 complex, since mutation of the target K residues in a 
single subunit (SnRK1!1) is presumably compensated by sumoylation of the 
remaining subunits [SnRK1"(s)]. The K residues identified in E. coli may also be 
different from the ones sumoylated in planta, as the absence of an E3 ligase in 
the E. coli assay may compromise the specificity of the SUMO machinery (42). 
To add further complexity, non-lysine attachment has been observed for 
ubiquitin, where the free N-terminal amino group or internal cysteine, serine and 
threonine residues can function as acceptors (43-45). However, it remains 
unknown if the same happens with other ubiquitin-like modifiers. 
Using a different approach to block SnRK1 sumoylation, we analyzed siz1-2 
plants that lack the E3 SUMO ligase required for SnRK1 sumoylation in vivo. 
SnRK1 signaling pathway was overactivated in siz1-2 in comparison to Col-0 
plants, and the E3 SUMO ligase activity of SIZ1 inhibited specifically SnRK1 in 
vivo. First, endogenous SnRK1 target genes were overinduced in siz1-2 plants 
in response to dark stress conditions (Figure 3.2A). Second, a pDIN6::LUC 
reporter gene was overinduced by SnRK1!1 in siz1-2 cells (Figure 3.2B), whilst 
pDIN6::LUC induction by the downstream GBF5 transcription factor was normal 
(Figure 3.2C). Third, SnRK1 pathway overactivation in siz1-2 cells could be 
rescued to Col-0 levels by transient expression of SIZ1 but not of a catalytically 
inactive SIZ1C379A variant (20) (Figure 3.2C), ruling out long-term pleiotropic 
effects of the siz1-2 mutation on SnRK1 function. Similarly, mimicking SnRK1!1 
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sumoylation by using a SnRK1!1 "SUMO mimetic" in siz1-2 cells rescued 
SnRK1 signaling to WT levels (Figure 3.2D). Furthermore, SnRK1 pathway 
overactivation in siz1-2 seems to be independent of the SA accumulation in this 
mutant (22, 46) (Figure 3.3A-B). 
Using a combination of immunoprecipitation, in vitro kinase assays and 
immunodetection, we could show that the cause of SnRK1 pathway 
overactivation in the siz1-2 mutant is enhanced SnRK1 accumulation (Figures 
3.4A, C-E). The siz1-2 mutant accumulates two-fold higher amounts of 
SnRK1!1 and displays a proportional increase in T-loop phosphorylation in both 
SnRK1!1 and SnRK1!2 subunits. This confirms that SnRK1 complexes are in 
an active state in the siz1-2 mutant and suggests that both SnRK1! isoforms 
are similarly regulated by SIZ1 (Figure 3.4C). The siz1-2 mutant also 
accumulated higher levels of SnRK1"1, although in this case the accumulation 
exceeded nearly six-fold that of the SnRK1!1 subunit (Figure 3.4D). This is 
probably because, in addition to the effect of SIZ1 on SnRK1"1 protein 
accumulation, SnRK1 activation induces SnRK1"1 gene expression (13). 
Interestingly, we observed a 3.5-fold accumulation of SnRK1# in the siz1-2 
mutant (Figure 3.4E) even though, in agreement with previous reports (47, 48), 
we could not detect SnRK1# in SnRK1!1 immunoprecipitates (Figure 2.6C). 
Whether this accumulation reflects a functional interaction with the SnRK1 
complex and whether this is related to the potential sumoylation of the SnRK1# 
subunit (Figure 2.3A) remains an open question. Surprisingly, SnRK1"2 subunit 
accumulated to the same extent in Col-0 and siz1-2 plants (Figure 3.4D), 
despite being sumoylated in the E. coli system and most probably in planta 
(Figure 2.3A and 2.6B). Whereas sumoylation seems to negatively affect 
SnRK1"1 accumulation, a distinct biochemical outcome of SnRK1"2 
sumoylation remains to be clarified. This observation suggests that sumoylation 
may differentially impact SnRK1"1 and SnRK1"2 subunit-containing complexes. 
In such scenario, an interplay between complex composition and 
posttranslational modification would dictate the physiological outcome of 
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sumoylation, in which a putative destabilized SnRK1"1 subunit would a priori 
selectively enrich for SnRK1"2 and/or SnRK1"3 subunit-containing complexes. 
Surprisingly, the siz1-2 mutant is strongly depleted of both SnRK1"1- and 
SnRK1"2-subunit containing complexes, as well as of putative higher-order 
complexes containing !1 and !2 catalytic subunits (Figure 3.6A-B). One 
possible scenario is that SnRK1"3 is the preferential "-regulatory subunit 
present in SnRK1!1 complexes in siz1-2 (to be determined upon antibody 
availability). However, we can neither exclude that the !1-catalytic subunit is 
associated with a #-type regulatory subunit alone ("#), or even devoid of any 
regulatory subunit, upon sumoylation abrogation in the siz1-2 mutant. On the 
other hand, heterotrimer composition of SnRK1!2 containing complexes 
remains to be addressed in both genotypes, for instance through SnRK1!2 
immunoprecipitation followed by immunodetection of the different regulatory 
subunits. Since SnRK1"1 accumulation in siz1-2 is not accompanied by an 
increased association with SnRK1!1, a possible scenario is that it rather 
assembles into SnRK1!2-containing complexes, or that is not incorporated in 
heterotrimers and accumulates as a single subunit. Future efforts should aim to 
unravel the differential distribution of each SnRK1 complex constituent, ranging 
from the single subunit to heterotrimeric or even higher order oligomeric states, 
in WT and siz1-2 plants. Size-exclusion chromatography, blue native gels and 
other separation techniques followed by Western-blot and mass spectrometry 
analyses may provide insights in this regard and disclose an unexpected 
additional role for sumoylation in heterotrimer and oligomer assembly. 
Moreover, forthcoming advances in our understanding of the interplay between 
sumoylation and SnRK1 complex composition should be integrated with the 
observed SnRK1 signaling overactivation in the siz1-2 background. 
Protein half-life measurements of SnRK1!1 revealed that the reason for 
enhanced SnRK1!1 accumulation in siz1-2 cells was deficient protein 
degradation (Figure 3.4F). Furthermore, mimicking SnRK1!1 sumoylation was 
sufficient to rescue its degradation in the siz1-2 mutant (Figure 3.4F), indicating 
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that the cause of impaired SnRK1!1 degradation is the lack of sumoylation. 
SnRK1 seems to be degraded by the 26S proteasome, as it is strongly 
ubiquitylated (Figure 3.5B) and its degradation is largely blocked by the 
proteasome inhibitor MG132 (Figure 3.5A). This is consistent with the 
identification of SnRK1!1 as a target of ubiquitylation in high-throughput 
analyses as well as its stabilization by MG132 (30, 31, 49, 50). On the other 
hand, we were able to show that SnRK1 ubiquitylation is largely dependent on 
sumoylation, as the presence of ubiquitin conjugates in SnRK1!1 
immunoprecipitates was greatly reduced in the siz1-2 background (Figure 
3.5C). How sumoylated SnRK1 is ubiquitylated and targeted to proteasomal 
degradation is currently unknown but the process is likely to involve the action of 
SUMO-targeted Ubiquitin Ligases (STUbLs), responsible for the ubiquitylation of 
multi- or poly-sumoylated substrates (9). The recently uncovered E4 SUMO 
ligases, responsible SUMO chain extension (8), may also be implicated, as 
suggested from the presence of extremely high molecular weight SUMO1 
conjugates in SnRK1!1 immunoprecipitates (Figure 2.6A-B). Alternative 
mechanisms for targeting sumoylated SnRK1 for degradation could depend, for 
instance, on a conformational modification on SnRK1 upon sumoylation, that 
would expose a degron or create a binding site for E3 ligases (51).  
Besides sumoylation-dependent ubiquitylation of SnRK1, we cannot exclude 
other biological functions of the conjugated SUMO(s) prior to targeted 
ubiquitylation and degradation (or even prior to an eventual SUMO chain 
extension). Further studies employing SUMO protease, E4 SUMO ligase, and 
STUbL mutants will help to clarify such scenario. 
The fact that in the siz1-2 mutant there was a reduction but we still could 
detect hMW SnRK1!1 forms (Figure 2.7B), as well as SnRK1!1-associated 
ubiquitin conjugates (Figure 3.5C), supports the existence of SUMO-
independent ubiquitylation events. Indeed, protein kinases are often targeted by 
more than one E3 ubiquitin ligase (51). SnRK1!1 interacts with Pleiotropic 
Regulatory Locus 1 (PRL1) (52) and SnRK1!1 degradation is mediated by the 
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DDB1-CUL4-ROC1-PRL1 E3 ubiquitin ligase, in which PRL1 is the putative 
substrate receptor of the complex (30). On the other hand, PRL1 was reported 
to compete with SKP1/ASK1 for binding SnRK1!1 and SnRK1!2. SKP1/ASK1 
is a component of the SCF E3 ubiquitin ligase and participates with SnRK1 in 
the assembly of a proteasomal complex (52, 53). Proteasomal degradation of 
SnRK1!1 was also shown to occur in a Myoinositol Polyphosphate 5-
Phosphatase 13 (5PTase13)-dependent manner (31). Different E3 ubiquitin 
ligases and other components may act in an interdependent manner to trigger 
substrate degradation, but they may also be part of independent pathways that 
operate specifically under distinct cellular and environmental conditions. 
However, whether SCF or CUL4-DDB1 E3 ubiquitin ligases, 5PTase13, and 
SIZ1 act in the same pathway or in parallel ones towards SnRK1 degradation is 
currently unknown.  
Sumoylation has been recently described for SnRK1 orthologs in mammals 
(AMPK) and yeast (SNF1), affecting these kinases in various ways. In AMPK, 
both catalytic (!1/!2) subunits were found sumoylated using high-resolution MS 
(54). Sumoylation of AMPK!2 was detected only in the presence of MG132, 
whereas AMPK!1 sumoylation was significantly increased by proteasome 
inhibition, suggesting sumoylation may tag both catalytic subunits for 
degradation. On the other hand, as reported in a different study, AMPK"2 
sumoylation did not affect its degradation rate but instead enhanced AMPK 
activity. Furthermore, AMPK"2 sumoylation and ubiquitylation appeared to be 
antagonistic (55). Interestingly, a similar mechanism may be operating in the 
plant system, where sumoylation of SnRK1!1 catalytic subunit triggers its 
degradation (Figure 3.4F) but a putative SnRK1"2 sumoylation does not seem 
to affect its stability (Figure 3.4D). In the case of the yeast SNF1, sumoylation of 
Snf1 catalytic subunit was reported to downregulate the kinase in two 
independent ways. Firstly, a conformational switch induced by interaction of the 
sumoylated residue with a SUMO-interacting motif (SIM) on Snf1 causes a rapid 
inhibition of the kinase specific activity. It is unlikely that such a mechanism is 
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conserved as the two SIMs and the target lysine (Snf1 K549) implicated in this 
regulation are poorly conserved (Appendix- Figure 1). Secondly, Snf1 
sumoylation induces its degradation through the ubiquitin proteasome system 
(56).  
Collectively, the work presented here and studies in yeast and mammals, 
suggest a conserved outcome for sumoylation of SNF1/AMPK/SnRK1 catalytic 
subunits, in targeting these protein kinases for proteasomal degradation. 
Specific SNF1/AMPK/SnRK1 complexes, attained through multiple 
combinations of catalytic and regulatory subunits, may determine the interaction 
with different molecular players and diversify the downstream consequences of 
sumoylation. For instance, the suggested interdependence between SnRK1"1 
sumoylation and its degradation may rely on the interaction with STUbLs, 
whereas sumoylated SnRK1"2 may recruit other interacting proteins that do not 
affect its stability. How sumoylation of specific individual subunits integrates with 
the dynamics of the whole complex regulation requires further investigation. 
Furthermore, specific cellular and environmental stimuli may determine the pool 
of protein that is sumoylated at a given moment and/or allocate the regulation 
through sumoylation to specific loci within the cell. 
In an attempt to unravel the functional relevance of SnRK1 sumoylation at 
the whole plant level we analyzed the loss of SnRK1 (SIZ1-dependent) 
sumoylation using the siz1-2 mutant. We hypothesized that some phenotypic 
traits observed in siz1-2 could be due to the overaccumulation of SnRK1!1 in 
this background. However, SnRK1!1 did not mediate both sugar and ABA 
hypersensitivity in siz1-2, due to their persistence in the siz1-2 snrk1!1-3 double 
mutant (Figure 3.8). Additional components may contribute to these 
phenotypes, underpinning the pervasive consequences of blocking SIZ1-
dependent sumoylation at the whole plant level. Future studies to decipher the 
functional and biological implications of SIZ1-dependent sumoylation of SnRK1 
in planta will make use of SnRK1!1-OEsiz1-2 and SnRK1!1-SUMO-OE plants 
(Figure 3.9). Whole plant studies of the biological role of SnRK1 sumoylation 
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may also be facilitated by the identification of the components involved in the 
intermediary steps of the sumoylation-ubiquitylation-degradation cycle (e.g. E4 





3.4 | Materials and Methods 
A list of all primers, cloning steps, and constructs used in this study, is 
provided in Appendix Table 1. 
 
 
3.4.1 | Plant Material, Growth Conditions, Transformation, and Early 
Seedling Development Assays 
 
Unless otherwise specified, plants were grown in soil under a 12h light 
(100µE), 22°C/12h dark, 18°C regime. Arabidopsis thaliana plants used in this 
study are in the Columbia (Col-0) background. The siz1-2 (SALK_065397) (35, 
36) and SnRK1!1-OE lines (12) have been previously described. The siz1-2 
snrk1!1-3 double mutant was generated by crossing siz1-2 and snrk1!1-3 
(GABI-KAT: 579E09) parent lines, and genotyped for the presence of an 
insertion in both alleles for each gene. SnRK1!1-SUMO-OE, or GFP-SUMO-
OE, transgenic lines were generated by transformation of the snrk1!1-3 mutant 
by the floral dip method (57), with Agrobacterium tumefaciens (GV3101) 
containing the pCB302-derived minibinary expression vector (58) with the 
coding sequence of SnRK1!1 (At3g01090.1), or GFP, fused with the coding 
sequence of a non-conjugatable mature SUMO1 (At4g26840) or mature 
SUMO3 (At5g55170). SUMO fusion constructs were generated in both 
orientations (Appendix Table 1). BASTA-resistant transformants were selected 
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based on their segregation ratio (T2) and homozygosity (T3). Homozygous T3 
lines were analyzed regarding the presence of SnRK1!1-SUMO variants.  
For phenotypical analyses, siz1-2, snrk1!1-3, siz1-2 snrk1!1-3, SnRK1!1-
OE, or Col-0 plants were grown in horizontal plates with 0.5xMS media with 
0.2% glucose (control), or with the indicated concentrations of glucose or 
sorbitol, and ABA in a 16h light (100µE), 22°C/8h dark, 18°C regime. 




3.4.2 | Antibodies and Protein Expression Analyses 
 
The SnRK1!1 (1/500, anti-AKIN10, AS10919), SnRK1"1 (1/500, anti-
AKINB1, AS09460), SnRK1"2 (1/500, anti-AKINB2, AS09 462), and SnRK1# 
(1/2000, anti-AKING1, AS09613) were purchased from Agrisera. Phospho-
SnRK1!1/2 (T175/176) was detected with an anti–phosphoT172-AMPK! 
antibody (1/1000 in 5% BSA-TBS-Tween, referred to as P-AMPK; #2535, Cell 
Signaling). SUMO1 (1/5000, ab5316, Abcam) and Ubiquitin11 (1/10000, 
AS08307, Agrisera) antibodies were used to detect the respective protein 
modifications. Anti-HA (1/1000, Roche, #11867423001) antibody was used to 
detect the corresponding tagged proteins. 
For immunoblotting, all primary antibodies were diluted in 1% non-fat Milk in 
TBS (unless otherwise stated) and incubated with the membrane under gentle 
shaking for 12h at 4°C. Secondary antibodies (Jackson ImmunoResearch Lab, 
inc) were used at 1/10000 in 1% non-fat Milk in TBS for 1h at RT. In the case of 
immunoprecipitated samples, secondary antibodies subsequently used in the 
immunodetection were against the light chain of IgG. 
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3.4.3 | Protoplast Transient Expression Assays 
 
Protoplasts from Col-0 and siz1-2 plants were isolated and transfected as 
already described (59). All effector constructs (Appendix Table 1) were 
generated by cloning the corresponding coding sequences into a pHBT95 
vector harboring a C-terminal HA (59), except for the SnRK1-SUMO construct 
that has no tag. The indicated mutations were introduced by site-directed 
mutagenesis and verified by sequencing. For protein expression analyses, 
protoplasts were directly resuspended in 4X Laemmli solubilization buffer (60)  
and boiled for 5min at 95°C. Cyclohexamide (Biochemica, A0879/0001; Ethanol 
stock) and MG132 (Sigma, C2211; DMSO stock) solutions were used at a final 
concentration of 2-M and 50-M, respectively.  
 
 
3.4.4 | Gene Expression Analyses 
 
Fully expanded rosettes of 4-5-week old Col-0 and siz1-2 plants were 
incubated on sterile MilliQ water in Petri dishes under control (3h Light, 100µE) 
or SnRK1 signaling activating conditions (3h Dark). The treatment was always 
initiated 3h after the onset of the light period. Total RNA was extracted using 
TRIzol reagent (Life Technologies), treated with RNase-Free DNase (Promega), 
and reverse transcribed (1µg) using SuperScriptIII Reverse Transcriptase (Life 
Technologies), as previously described (14). Quantitative real-time RT-PCR 
(qPCR) analyses were performed using a CFX384TM Real-Time System (Bio-
Rad), the iTaqTM Universal SYBR® Green Supermix (BioRad), and the 2-..Ct 
method for relative quantification (61). Expression values of SnRK1 target 
genes were normalized using the CT values obtained for the ACT2 reference 
gene. 
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3.4.5 | Quantification of immunoblot results 
 
Membranes were analyzed by immunoblotting and then stained with 
Coomassie Brilliant Blue R250. Band intensity was quantified using Image J 
(http://imagej.nih.gov/ij/) and Gel Quant Net  
(http://biochemlabsolutions.com/GelQuantNET.html) softwares. The immunoblot 
intensities were normalized to the Coomassie staining intensity (referred as 
“loading”). Quantifications were normalized to the t=0 of each kinetics or to 




3.4.6 | Statistical Analyses 
 
All statistical analyses were performed with the GraphPad Prism 6 software 
(GraphPad softwares). For analyses of qPCR data, the statistical significance of 
the indicated changes was assessed employing log2-transformed relative 
expression values (61, 62). 
 
 
3.4.7 | GFP, SnRK1!1-GFP and SnRK1!1$KA1-GFP 
Immunoprecipitation  
 
Proteins from 5-week-old SnRK1!1-GFP, SnRK1!1"KA1-GFP, or 35S-GFP 
plant leaves were extracted with immunoprecipitation (IP) buffer [50mM Tris-HCl 
pH8.0, 50mM NaCl, 1% (V/V) Igepal CA-630, 0.5% (w/V) Sodium deoxycholate, 
0.1% (w/V) SDS, 1mM EDTA pH8.0, 50µM MG132, 50mM N-Ethylmaleimide 
and cOmplete protease inhibitor cocktail (one tablet/10mL)]. After clearing 
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samples by centrifugation (6,785g, 2°C, 10min), 800µL of supernatant were 
supplemented with fresh MG132 (50µM) and incubated at 4°C for 1h with 40µL 
of -MACS Anti-GFP MicroBeads (-MACS GFP Isolation Kit, Miltenyi, 130-091-
125). Samples were thereafter loaded in -Columns (Miltenyi, 130-042-701) pre-
equilibrated with 1ml of IP buffer, and allowed to flow through. Columns were 
washed four times with 200-L of IP buffer and proteins eluted with 80-L of 
Elution Buffer (Miltenyi, 130-091-125) at 95°C. "-Mercapto-Ethanol (2%) was 
added to the eluates prior to boiling for 5 min at 95°C. Proteins were resolved by 
SDS-PAGE, wet-transferred to a PVDF membrane (30V, 16h at 4°C), and 
analyzed by immunoblotting with anti-SnRK1!1 and anti-Ubiquitin11 antibodies. 
For each GFP immunoprecipitation experiment, immunodetection with different 
antibodies was done using equal loading on independent membranes. 
 
 
3.4.8 | SnRK1!1 Immunoprecipitation and in vitro Kinase Assays 
 
 
For measurements of endogenous SnRK1!1 activity, SnRK1!1 was 
immunoprecipitated from leaves of 5-week-old Col-0 or siz1-2 plants. Plant 
material (1g) was extracted in 2 volumes of Buffer C [50mM Hepes, pH7.25, 
150mM NaCl, 1mM EDTA, 0.05% Triton X-100, cOmplete protease inhibitor 
cocktail (one tablet/50mL, Roche 11697498001) and 1/500 (v/v) phosphatase 
inhibitor 2 (Sigma P5726) and 3 (Sigma P0044)]. After two successive 
centrifugations (20,000g, 4°C, 10min), the supernatant was recovered, and 1 
mg of total protein was incubated with gentle shaking for 3h at 4°C with 15µL 
beads of protein A–antibody complex prepared as follows. For each 
immunoprecipitation, 15µL (bed volume) of protein A–agarose (Roche 
#11719408001) was equilibrated in 1XPBS (Sigma-Aldrich P5493) and 
incubated with 1.5µg of anti-SnRK1!1 antibody (anti-AKIN10) in 500µL of 1X 
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PBS for 1h at room temperature with gentle shaking. After three washes in 
buffer C, the beads were used for immunoprecipitation. After incubation for 3h at 
4°C under shaking, the beads were washed five times with buffer C, and one-
third (5µL) was kept for immunoblot analyses with anti-SnRK1!1 antibody. The 
remaining 10µL were used to determine the specific activity of SnRK1 in 30µL of 
kinase buffer (50mM Hepes-NaOH, pH7.25, 20mM MgCl2, 0.5mM DTT and 
100mM ATP) with His-%C ABF2 (1µg) for 1 h at 30°C in the presence of 2µCi of 
#32P-ATP. The reaction products were resolved by 12% SDS-PAGE and 




3.4.9 | Recombinant Protein Production and Purification 
 
 
Recombinant His-%C ABF2 (residues 1–173) was produced and purified as 
previously described (14). Successful protein production and purification was 
verified by immunoblotting with an anti-T7 antibody. 
 
 
3.4.10 | Y2H Assays 
 
 
Y2H assays were performed as described (63). The full-length (FL) coding 
sequence of SnRK1!1 was cloned in pGBKT7 and co-transfected with FL 
SnRK1!1 in pGADT7. The empty vectors were used as negative controls. The 
growth of transformed AH109 yeast cells was assessed in permissive (-Leucine, 
-Tryptophan) or selective (-Leucine, -Tryptophan, -Histidine, -Adenine) media. 
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3.4.11 | Accession Numbers 
 
Sequence data can be found in the Arabidopsis Genome Initiative database 
under the following accession numbers: SnRK1!1, At3g01090; SnRK1#1, 
At5g21170; SnRK1#2, At4g16360; SnRK1$, At3g48530; GBF5, At2g18160; 
SCE1, At3g57870; SIZ1, At5g60410; HPY2, At3g15150; SUMO1, At4g26840; 
SUMO3, At5g55170; DIN6, At3g47340; AXP, At2g33830; TPS8, At1g70290; 




Supplemental Data includes Appendix Table 1 and Appendix Figure 1.  
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The Snf1-Related protein Kinase 1 (SnRK1) is a central component of the 
plant stress response that promotes catabolism and represses anabolism, in 
order to restore energy homeostasis upon energy deprivation conditions (1, 2). 
However, both SnRK1 overexpression and its downregulation impact plant 
growth and developmental transitions (1). Hence, a tight regulation of the 
SnRK1 signaling pathway is required for a responsive and accurate system, 
though preventing its excessive activation.  
Sumoylation is implied in the regulation of several protein kinases where 
there is often interplay between SUMO and other posttranslational modifications 
(3-5). We have previously shown that SnRK1 sumoylation triggers its 
ubiquitylation and subsequent proteasomal degradation (Chapter 3). Here we 
show that the inactive SnRK1 variants SnRK1K48M and SnRK1T175A (impaired in 
ATP binding and T-loop phosphorylation, respectively) accumulate to a greater 
extent and are more stable than the active WT SnRK1 protein. Importantly, 
inactive SnRK1K48M and SnRK1T175A can be destabilized if co-transfected with 
active SnRK1!1 or if expressed as a translational protein fusion with SUMO1, 
further supporting that kinase activity is essential for its degradation and 
suggesting the impaired turnover of inactive SnRK1!1 variants is caused by 
lack of sumoylation. We suggest that SUMO-dependent SnRK1 degradation is 
triggered by SnRK1 activity as part of a negative feedback loop to prevent 
deleterious effects derived from overly high SnRK1 signaling. Furthermore, we 
show SnRK1 phosphorylates the E3 SUMO ligase SIZ1 in vitro, and 
hypothesize that such mechanism may couple stress and SnRK1 activation to 




CHAPTER 4 | 
! 200 
 
4.1 | Introduction 
 
 
The activity of protein kinases can be regulated at the expression level and 
also through swift posttranslational modifications (PTMs) such as 
phosphorylation, acetylation and ubiquitylation, amongst many others. The 
binding of activating subunits, inhibitor proteins or metabolites can adjust the 
kinase response to specific cues, and kinase modulation is also achieved 
through oligomerization, intracellular translocation or protein cleavage (6). 
Furthermore, the possible interconnection between different modes of regulation 
expands the system versatility. Most of the kinase regulatory mechanisms, 
either positive or negative, are reversible (e.g. phosphorylation/ 
dephosphorylation, or binding of protein regulators), but an irreversible 
downregulation (e.g. through ubiquitin-mediated proteasomal degradation) can 
dictate signal termination. The commitment to degradation is most often 
triggered by an active kinase, especially if the activity is sustained (6).  
Sumoylation is implied in the regulation of several protein kinases. Protein 
kinase sumoylation can be phosphorylation-dependent, when the negative 
charges added by phospho groups increase the affinity of phospho-dependent 
sumoylation motifs (PDSMs) to the positively charged patch of SCE1 (7). 
Another mechanism of phosphorylation-dependent sumoylation may rely on 
SUMO-SIM non-covalent interactions. Phosphorylated serine and threonine 
residues associated with SUMO interacting motifs (SIMs) have higher affinity 
towards a positive patch on SUMO, and may modulate the proximity between 
SUMO machinery and potential substrate proteins. Besides the cooperative 
interplay between phosphorylation and sumoylation, these PTMs can impose 
opposite fates on a substrate. For instance, phosphorylation stabilizes the 
human transcription factor Sp1, whereas sumoylation recruits the ubiquitin 
ligase RNF4, which induces ubiquitin-dependent proteasomal degradation of 
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Sp1 (4, 8). The plant transcription factor ABI5 is phosphorylated and activated 
by SnRK2.2 and SnRK2.3 kinases in response to ABA, whereas SIZ1-mediated 
sumoylation renders ABI5 inactive, probably by interfering with its 
phosphorylation (9). On the other hand, sumoylation can modulate protein 
kinase function without affecting its phosphorylation status. For instance, the 
insulin/IGF-1 activated protein kinase Akt is regulated by phosphorylation, 
ubiquitylation, acetylation and sumoylation. Akt sumoylation is Akt 
phosphorylation-dependent and sumoylation increases Akt kinase activity 
without affecting its phosphorylation level (10, 11).  
Since SUMO itself and the SUMO machinery are also regulated by 
phosphorylation, protein kinases can be involved in sumoylation-
phosphorylation regulatory feedback loops to better adjust the response of 
specific systems towards the cellular and whole organism demands.  
The Snf1-Related protein Kinase 1 (SnRK1) is a central component that 
participates in plant developmental decisions as well as in the response to 
environmental stresses, to balance energy levels upon energy deprivation 
conditions (1, 2). Such central metabolic regulator needs to be tightly 
coordinated, promoting a concerted and timely activation of the pathway, though 
preventing its excessive activation, in accordance with the environmental and 
organism demands. The work described in this chapter integrates SnRK1 
pathway activation and protein turnover in response to activating conditions. 
Furthermore, it suggests SnRK1 sumoylation is an intermediary step of a 
negative feedback loop to restrain SnRK1 signaling, preventing excessive 
activation and allowing an accurate response to energy deprivation. We 
hypothesize that a putative SnRK1-dependent phosphorylation of SIZ1 in planta 
may convey SnRK1 activation to the SUMO machinery, with a possible impact 
on SnRK1 and global sumoylation. 
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4.2 | Results 
 
 
4.2.1 | SnRK1 activity triggers its degradation  
 
We previously observed that inactive SnRK1!1 variants, such as 
SnRK1!1K48M (K48 is responsible for the phosphotransfer activity) and the T-
loop phosphomutant SnRK1!1T175A, accumulate to higher levels than the WT 
SnRK1!1 protein (1) (Figure 4.1A), suggesting a connection between kinase 
activity and stability. By measuring protein half-life in the presence of 
cycloheximide in Col-0 cells, we found that the reason for overaccumulation of 
both inactive variants (SnRK1!1K48M and SnRK1!1T175A) was the lack of protein 
degradation, in comparison to the WT version of SnRK1!1 (Figure 4.1B). We 
next reasoned that SnRK1 degradation might be selectively induced or 
enhanced upon SnRK1 pathway activation. To evaluate this we determined the 
turnover of WT, SnRK1!1K48M and SnRK1!1T175A variants (all HA tagged 
constructs) when co-transfected with control DNA or with an active untagged 
SnRK1!1 construct in Col-0 cells. Importantly, SnRK1 pathway activation 
triggered by expression of untagged SnRK1!1 [Figure 3.1 and (1, 12)] but not 
by control DNA, induced degradation of inactive SnRK1!1K48M and 
SnRK1!1T175A proteins. This suggests that SnRK1 activity and/or SnRK1 
pathway activation promotes SnRK1!1 turnover, possibly by acting in trans on 
the total SnRK1!1 pool (Figure 4.1C).  






Figure 4.1 | SnRK1 activity triggers its degradation. 
A. Inactive SnRK1!1 variants accumulate to higher levels than the WT protein. Accumulation 
of WT SnRK1!1 and of two inactive SnRK1!1T175A and SnRK1!1K48M mutants transiently 
expressed in Col-0 protoplasts, analyzed by Western-blot (WB) with anti-SnRK1!1 antibody. B. 
Only active SnRK1!1 undergoes degradation. WT (squares) or inactive (circles) SnRK1!1 
variants were expressed in Col-0 protoplasts. Protoplasts were thereafter treated with 
cycloheximide (CHX), samples were harvested at the indicated time points, and analyzed by 
Western-blot (WB) with anti-SnRK1!1 antibody. The signal was quantified and normalized to the 
t=0 for each kinetics. C. As in B but HA-tagged SnRK1!1 variants (WT, squares; T175A, red 
triangles, K48M, blue circles) were co-expressed with a WT untagged variant (empty symbols) or 
with control plasmid (filled symbols). Data plotted are means (n(3) and error bars are SEM. 
Statistical difference between kinetics at the different time points were analyzed through two-way 
ANOVA with Tukey’s multiple comparison (*p<0.05, **p<0.01; ***p<0.001). 
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4.2.2 | Sumoylation restores degradation of inactive SnRK1!1 variants 
 
Given the previously found interdependence between SnRK1!1 sumoylation 
and its ubiquitylation-mediated proteasomal degradation (Chapter 3), we 
hypothesized that the impaired turnover of inactive SnRK1!1 variants, observed 
in Figure 4.1B, was caused by a lack of sumoylation or, in the case sumoylation 
is occurring, by the absence of ubiquitylation-mediated proteasomal degradation 
downstream of sumoylation. To be able to distinguish between these two 
scenarios, we tested if we could restore a normal degradation of SnRK1!1 
inactive variants by artificially providing the “SUMO signal”. We expressed WT, 
SnRK1!1K48M, and SnRK1!1T175A variants as translational SUMO1 fusions 
(“SUMO mimetics”, as in Figure 3.4F) in Col-0 cells, and determined their 
turnover. Interestingly, fusion of SUMO1 to inactive SnRK1!1 variants restored 
the degradation profile observed with active SnRK1!1, whilst a GFP-SUMO1 
protein (control) was stable overtime, demonstrating a specific effect of the 
SUMO mimetic on SnRK1!1 stability (Figure 4.2A). This result suggests that 
the impaired turnover of inactive SnRK1!1 variants is caused by lack of 
sumoylation and that SnRK1!1 activity and/or SnRK1 pathway activation are a 
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Figure 4.2 | Sumoylation restores degradation of inactive SnRK1!1 variants. 
A. Inactive SnRK1!1 variants undergo degradation when expressed as SUMO-mimetics. 
SnRK1!1-mature SUMO1 (mS1) fusions (WT, squares; T175A, red circles, K48M, blue circles) or 
GFP fused to mS1 (green triangles, negative control) were expressed in Col-0 protoplasts. 
Protoplasts were thereafter treated with cycloheximide (CHX), samples were harvested at the 
indicated time points, and analyzed by Western-blot (WB) using anti-SnRK1!1 or anti-GFP 
antibodies. The signal was quantified and normalized to the t=0 for each kinetics. Stars denote 
statistical significance, as determined by two-way ANOVA with Tukey’s multiple comparison (n(3; 
error bars=SEM; *p<0.05, **p<0.01; ***p<0.001).  
 
 
4.2.3 | Preliminary approaches to monitor endogenous SnRK1 protein 
turnover in energy deprivation (SnRK1 activation) conditions 
 
Given that SnRK1 signaling is activated by energy deprivation [Figure 3.2A, 
(1, 12)] and that SnRK1 activation appears to trigger its own degradation 
(Figure 4.1), we decided to monitor the turnover of endogenous SnRK1, under 
control and activation conditions. The underlying hypothesis was that 
endogenous SnRK1 would be less stable under activating conditions due to 
increased sumoylation. To test this, we treated Col-0 and siz1-2 protoplasts with 
control (2h light) or energy stress (2h darkness) conditions, and subsequently 
measured endogenous SnRK1!1 half-life in the presence of cycloheximide, the 
proteasome inhibitor MG132, or DMSO (mock) (Figure 4.3A). Despite the 
variability in SnRK1 degradation profile, we could sometimes visualize a small 
decrease of endogenous SnRK1!1 protein in dark-treated cells (Figure 4.3A), 
presumably as a result of SnRK1 activation by this stress (Figure 3.2A), and in 
accordance with the differential stability of active and inactive SnRK1!1 variants 
(Figure 4.1B). Furthermore, SnRK1!1 degradation in response to darkness was 
mostly diminished in the siz1-2 mutant (Figure 4.3A), suggesting sumoylation 
could be a signal derived from SnRK1 activity that triggered its degradation. 
However, we failed to reproduce the differences regarding endogenous 
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SnRK1!1 protein accumulation in a consistent manner. Moreover, we also used 
a wide range of time points (to ensure detection of potentially transient 
changes), as well as detached leaves or liquid cultures of Arabidopsis 
seedlings, incubated with cyclohexamide and subjected to light and dark 
conditions, but no clear differences could be observed in SnRK1!1 protein 
accumulation overtime (not shown). 
In order to determine if activation of the SnRK1 pathway would result into an 
increased accumulation of SnRK1$1-SUMO conjugates, we undertook two 
approaches. On one hand, we used Col-0 plants subjected to light (6h; control) 
or extended night (1h or 6h; energy stress) treatments to analyze SnRK1$1 
accumulation and size profile in the corresponding nuclear extracts. Samples 
were processed to enrich for nuclear fractions since SUMO, the sumoylation 
machinery, and SUMO conjugates are particularly enriched in the nuclear 
compartment (13). Immunoblot analyses with anti-SnRK1$1 antibody revealed 
the accumulation of a high Molecular Weight (hMW) band in the nuclear 
fraction, relative to unmodified SnRK1!1, in response to energy stress (Figure 
4.3B). The intensity of this band was stronger in the first hour of dark treatment 
while it was absent in control conditions (light), supporting the notion it could 
correspond to sumoylated SnRK1!1 (Figure 4.3B). However, the identity of 
SnRK1$1 hMW band should be specifically addressed. For instance, its 
disappearance in siz1-2 nuclear fractions would suggest it corresponds indeed 
to SnRK1$1-SUMO conjugates. If further confirmed, this preliminary result may 
support the connection between SnRK1$1 activation in response to darkness 
and increased SnRK1$1 sumoylation, in the same energy stress conditions.  
On the other hand, we treated SnRK1%1-GFP plants under light (control) and 
dark (energy stress) conditions, and performed GFP immunoprecipitations (IPs) 
to evaluate potential changes in the amount of SUMO1 conjugates associated 
with SnRK1$1-GFP immunoprecipitates. However, these experiments were not 
conclusive, as even though an accumulation of hMW SnRK1$1 forms and 
SUMO1 conjugates could sometimes be observed in response to dark stress 
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(D) as exemplified in Figure 4.3C, we failed to reproduce this observation in a 
consistent manner. Seedlings and leaf discs from SnRK1%1-GFP plants were 
also incubated in energy deprivation conditions, and in the presence of the 
proteasome inhibitor MG132, and subjected to GFP IPs. However, the plant 
material obtained with such approaches was much less abundant then the one 
retrieved with full rosettes, thereby hindering a reliable immunodetection of 
hMW SnRK1$1 forms and SUMO1 conjugates (not shown). Further attempts, 
perhaps employing stronger conditions to activate SnRK1 signaling (e.g. 
herbicide treatment, hypoxia, or the combination of both), specific cellular 
fractions (e.g. nucleus), different time points, and proteasome inhibitors may be 
required to tackle the accumulation of SnRK1$1-SUMO conjugates in response 
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Figure 4.3 | SnRK1 activity triggers its sumoylation and turnover. 
A. Following isolation, Col-0 and siz1-2 protoplasts were rested for 1h under light, exposed to 
2h of Light or Dark treatment, and subsequently treated with cyclohexamide (CHX), MG132 (MG) 
or DMSO (mock control). Samples were harvested at the indicated time points, and analyzed by 
Western-blot (WB) using anti-SnRK1!1 antibody. The signal was quantified and normalized to the 
t=0 for each kinetics.! Data plotted are means and stars denote statistical significance, as 
determined by multiple t-tests using the Holm-Sidak method (n=4; error bars=SEM; *p<0.05). B. 
Full rosettes (~30 leaves) of 6-week-old Col-0 plants subjected to 1 or 6 hours of night extension 
(NE1h, NE6h; SnRK1!1 activating conditions), or to 6 hours of light (L6h; control), were used to 
separate soluble (S) and nuclei-enriched (N) fractions. These fractions were subsequently 
analyzed by SDS-PAGE and immunodetection with antibodies against SnRK1!1 and CYP37, a 
protein localized in the chloroplast that should be absent in the nuclear fraction. Green arrowhead 
indicates CYP37 protein, only present in "Soluble", black arrowhead indicates SnRK1!1 main 
band, and grey arrowhead, SnRK1!1 hMW bands. The panel on the right evidences nuclear 
enrichment in "N", through the immunodetection of Histone3 (His3) in this fraction, and a 
predominant presence of Rubisco in the "S" fraction, using the same protocol but in a parallel 
nuclear enrichment experiment. C. SnRK1$1-GFP was immunoprecipitated (IP) from leaf crude 
extracts of SnRK1%1-GFP plants treated with 3h of dark (D) or 3h of light (L), and analyzed by 




4.2.4 | SnRK1%1 phosphorylates SIZ1  
 
 
Our previous results suggest that SnRK1 activation may trigger its 
sumoylation and subsequent turnover. However, how the SUMO machinery 
recognizes active SnRK1$1 is not yet understood. We hypothesized that the 
active kinase could phosphorylate a component of the SUMO pathway and 
thereby induce its own sumoylation. We searched for the presence of SnRK1 
phosphorylation consensus motifs (14, 15) in the E3 ligase SIZ1 that confers 
specificity to SnRK1 sumoylation in planta, as previously shown (Chapter 2 and 
3).  We could detect seven SnRK1 phosphorylation motifs in SIZ1 (Appendix 
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Figure 2) and therefore decided to evaluate first if SnRK1 could phosphorylate 
SIZ1 to induce its own sumoylation. To this end, we performed in vitro kinase 
assays using recombinant SIZ1, SnRK1$1, and SnRK1 activating kinase 2 
(SnAK2). SnAK2 was incubated with recombinant SnRK1$1 to promote its 
activation and, in agreement with previous reports, SnRK1$1 and SnAK2 
crossphosphorylated [(16), Figure 4.4A]. A higher band corresponding to SIZ1 
phosphorylation was detected when the three proteins were incubated together 
but not when SIZ1 was incubated alone or just with SnAK2 (Figure 4.4A). 
Similarly, recombinant SIZ1 was phosphorylated in the presence of SnRK1$1 
immunoprecipitated from dark-treated 35S-SnRK1%1-HA plants (1) (Figure 
4.4B). The observed autophosphorylation of (active) immunoprecipitated 
SnRK1$1 has been previously reported (12, 17). These results support the 
hypothesis that SnRK1 may transduce its activation status through SIZ1 

















CHAPTER 4 | 
! 210 
Figure 4.4 | SnRK1 phosphorylates SIZ1 in vitro. 
A. Recombinant His-T7-SnRK1$1 (2µg) and GST-SnAK2-GST (0.2µg) were purified, and 
incubated in kinase activity buffer supplemented with #-32P-ATP in the presence of His-T7-SIZ1 
(3ug) for 2h30m at 30ºC. Samples were then submitted to SDS-PAGE and autoradiography. The 
positions of phosphorylated SIZ1 (P-SIZ1), SnRK1$1 (P-SnRK1$1) and SnAK2 (P-SnAK2) are 
indicated. B. SnRK1$1-HA was immunoprecipitated from dark-treated 35S-SnRK1%1-HA plants, 
and incubated in kinase activity buffer supplemented with #-32P-ATP for 1h at 30°C in the 
presence or absence of His-T7-SIZ1.1 (6ug). Samples were then submitted to SDS-PAGE and 




To address the functional outcome of SIZ1 phosphorylation in SnRK1 
sumoylation and SnRK1 pathway activation, we first aimed at identifying the 
residue(s) phosphorylated in SIZ1 in the in vitro kinase assays by mass 
spectrometry (MS). However, despite several attempts, we failed to detect SIZ1 
phosphopeptides in our MS analyses, presumably due to the low 
phosphorylation signal together with a poor coverage of the protein in these 
analyses. As an alternative approach we generated SIZ1 variants harboring S/T 
to A (phosphomutant) or to D (phosphomimetic) mutations in putative SnRK1-
dependent phosphorylation sites, in other SIZ1 phosphoresidues previously 
identified by MS (18-22), or in possible phosphorylation sites not covered in the 
MS analyses (Appendix Figure 2). These variants were then compared to WT 
SIZ1 for their ability to restore normal pDIN6::LUC reporter induction by 
transfected SnRK1$1 in siz1-2, as explained in Figure 3.1C. However, no clear 
differences were observed between WT or phosphomutant/ mimetic SIZ1 
variants in a preliminary assay (Figure 4.5A), which may suggest that at least 
the targeted residues are not important for the repressive effect of SIZ1 on 
SnRK1$1 signaling. Further experiments are required to rule out SIZ1 
phosphorylation as a possible mechanism connecting SnRK1 activity to its 
sumoylation. Additional replicates are needed and several possible SIZ1 
phosphoresidues were not covered in this assay. The in vitro kinase assay 
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should also be used to test the abrogation of SnRK1-dependent phosphorylation 
of SIZ1 variants mutated in possible phosphoresidues (alone or in combination). 
We also did preliminary assays to test if SnRK1$1 could phosphorylate other 
components of the SUMO pathway in Arabidopsis. For this purpose, we 
expressed in Col-0 cells various HA-tagged SUMO pathway components (E1 
SUMO activating enzyme SAE1b, SAE2, or E2 SUMO conjugating enzyme 
SCE1) in the presence or absence of SnRK1$1. Proteins were thereafter 
resolved by Phos-Tag SDS-PAGE and immunodetected with a HA-antibody. 
Phos-Tag selectively retards phosphorylated proteins (23), allowing a clear 
separation between phosphorylated and non-phosphorylated forms of a given 
protein. However, no clear differences were observed in the migration pattern of 
SUMO machinery components in the presence or absence of SnRK1$1 (Figure 
4.5B). 
Finally, we reasoned that a putative regulation of the SUMO machinery by 
SnRK1 could have a broader impact on global sumoylation beyond the effect on 
SnRK1 itself. To test this, we induced transient systemic snrk1 knockdown using 
virus-induced gene silencing (VIGS) (1, 24) of SnRK1%2 in snrk1!1-3 knockout 
seedlings (hereafter referred as snrk1%1 snrk1%2 double mutant for simplicity), 
to circumvent the experimental limitation of obtaining snrk1% double loss-of-
function mutants (25-27). Global SUMO1 profiles of control (Col-0), siz1-2, 
snrk1%1 GFP (VIGS against GFP in snrk1%1-3 plants as a control for VIGS), and 
snrk1%1 snrk1%2 double mutant plants were analyzed after treatment of 
detached rosettes with several types of stress (darkness, heat, oxidative, 
ethanol, and salt) (28-31), or control conditions, and processing in 2X Laemmli 
solubilization buffer. Whereas no major differences were observed in the 
accumulation of SUMO1 conjugates in plants with diminished SnRK1 activity, 
siz1-2 plants accumulated much less SUMO1 conjugates in stress conditions 
(Figure 4.5C), as previously described for this mutant (32-36). 
 
 


























Figure 4.5 | SnRK1-dependent phosphorylation of SUMO pathway components and possible 
outcome. 
 A. Expression of SnRK1$1 triggers an overinduction of SnRK1 signaling in siz1-2 that is 
rescued by the E3 ligase activity of SIZ1 (WT), but not by a catalytically inactive SIZ1 (C379A) 
variant. Several phosphomutant and phosphomimetic variants of SIZ1 were tested. B. HA tagged 
SUMO machinery components SAE1b, SAE2 and SCE1 were expressed alone or in combination 
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with SnRK1$1 in Col-0 protoplasts. Samples were then resolved through regular SDS-PAGE or 
Phos-tag SDS-PAGE and immunodetected with anti-HA antibody. C. Detached rosettes of WT 
(Col-0), siz1-2, snrk1%1 GFP, and snrk1%1 snrk1%2 were incubated in control conditions or 
subjected to Dark, Heat (37ºC), oxidative (50mM H2O2), Ethanol (10%), or salt (150mM NaCl) 
stress for 1h. Samples were processed in 2X Laemmli buffer and analyzed by Western-blot (WB) 




4.3 | Discussion 
 
The activation of protein kinases is commonly coupled to their 
downregulation via the ubiquitin/proteasome system (6). Indeed, we provide 
evidence that SUMO-mediated degradation of SnRK1 is dependent on SnRK1 
kinase activity. First, inactive SnRK1!1 variants are not degraded (Figure 4.1B) 
and therefore accumulate to higher levels than the active kinase (1) (Figure 
4.1A). Nevertheless, upon SnRK1 pathway activation, attained by co-expression 
of an active SnRK1!1, the inactive SnRK1!1 variants recovered normal 
turnover (Figure 4.1C). Second, when expressed as SnRK1!1-SUMO1 fusions 
("SUMO mimetics"), inactive SnRK1!1 variants are degraded like the WT 
SnRK1!1 (Figure 4.2A), suggesting that the reason for their impaired 
degradation is the lack of sumoylation. Finally, the turnover of active SnRK1!1 
seems to be impaired in the siz1-2 mutant (Figure 4.3A), suggesting that 
sumoylation may be an intermediate step between SnRK1 activity and its 
degradation. Collectively, these results suggest that SnRK1 activation initiates 
its downregulation through sumoylation-dependent ubiquitylation and 
proteasomal degradation. The prediction from this model would be that under 
conditions of high SnRK1 signaling activity such as dark stress, SnRK1 
sumoylation and consequent degradation would be increased. Some of our 
preliminary experiments support such model, showing that destabilization of 
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endogenous SnRK1!1 occurs in cells subjected to energy stress (darkness), 
presumably as a result of SnRK1 activation (Figure 4.3A). We have also 
preliminary data that suggests an increase in SnRK1!1-SUMO conjugates upon 
energy deprivation (Figure 4.3B-C). However, the obtained differences are 
often subtle and prone to high variability, and hence our results on the 
endogenous protein are not yet conclusive. Probably there were technical 
limitations due to the quantification of small variations in protein amount, and to 
the degradation of untransfected protoplasts over long incubation times. A more 
sensitive loading control, with immunodetection of an endogenous and stable 
protein should be employed in future attempts. On the other hand, it is also 
possible that an increased rate of sumoylation, turnover and replenishment of 
SnRK1 protein does not result in the differential accumulation of SnRK1-SUMO 
conjugates, detected in a given time point. Further studies are needed to 
acquire a better temporal resolution (checking shorter and longer time points) of 
SnRK1 turnover, and upon different stress treatments (regarding the nature of 
the stress, but also the intensity and duration of the perturbation). For instance, 
a sensitive and dynamic pulse-chase labeling using SNAP-tag (37, 38) could be 
used to assess differences in SnRK1 turnover in living cells (Col-0 and siz1-2), 
and upon different stimuli. 
Interestingly, SnRK1! is degraded in response to ABA in wheat roots (39). 
Given that ABA activates SnRK1 signaling (12) this suggests that SnRK1 
degradation might be a general mechanism to reset SnRK1 signaling upon 
activation by different stimuli, preventing pathway overactivation, which might be 
deleterious for plant growth.  
Activated kinases can be recognized for ubiquitylation and degradation by 
different mechanisms, often involving the generation of recognition motifs 
through phosphorylation, or their exposure through conformational changes (6). 
We show that sumoylation of active SnRK1!1 seems to be an intermediary step 
for its turnover, and that the active kinase phosphorylates SIZ1 in vitro (Figure 
4.3A-B). This raises the possibility that the latter mechanism is used for 
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recognition of active SnRK1 by the SUMO machinery. Different SIZ1 
phosphopeptides have been retrieved in phosphoproteomic studies (18-22), but 
the role of differentially phosphorylated SIZ1 remains unclear in plants. In other 
systems, phosphorylation was shown to directly modulate activity (40) or 
possibly localization (41, 42) of E3 SUMO ligases. Although not conclusively, we 
failed to show a clear impact of phosphorylation of specific SIZ1 residues in 
SnRK1!1 signaling pathway activation (Figure 4.5A), or of SnRK1-dependent 
phosphorylation on global sumoylation, in response to several types of stresses 
(Figure 4.5C). Further studies are required to address SnRK1-dependent SIZ1 
phosphorylation in planta, and to clarify the functional outcome of this 
modification, namely on SnRK1 sumoylation and/or global sumoylation. 
Additionally, it is also possible that SnRK1 pathway activation is conveyed 
through SnRK1-dependent phosphorylation of other SUMO machinery 
components. Our preliminary tests showed unmodified SAE1b, SAE2 and 
SCE1, in the presence or absence of SnRK1!1 (Figure 4.5B). SnRK1 
phosphorylation motifs can also be found in other SUMO pathway components 
such as SUMO proteases and SUMO itself (not shown), and further 
experiments should be made to clarify a possible regulation of sumoylation via 
SnRK1-dependent phosphorylation. 
Recently, the insulin/IGF-1 activated protein kinase Akt was shown to be 
sumoylated, and this modification further enhanced kinase activity. Furthermore, 
active Akt phosphorylates SUMO1 and the SUMO conjugating enzyme Ubc9, 
and through both mechanisms regulates global sumoylation, including Akt and 
Ubc9 sumoylation, as well as substrate sumoylation specificity. The specific 
downstream sumoylation of phosphatase and tensin homolog (PTEN) serves as 
an endogenous mechanism to stop the positive feedback loop resulting from Akt 
activation and sumoylation (10, 11). Another interesting example of regulation 
through phosphorylation of SUMO pathway components, involves the 
phosphorylation of the E3 SUMO ligase Pc2 by its substrate, homeodomain 
interacting protein kinase 2 (HIPK2). HIPK2-dependent phosphorylation of Pc2 
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enhances its SUMO ligase activity towards HIPK2, creating a feedback 
regulatory mechanism (40). In a different case, phosphorylation of the E3 ligase 
PIAS1 requires, but does not seem to impact, its E3 ligase activity (42, 43). 
Besides the abovementioned mechanisms to convey SnRK1 kinase activity, 
phosphorylated residues on active SnRK1 or conformational changes 
associated with kinase activity, may create or expose a recognition motif for the 
SUMO machinery. Several phospho-residues were identified on catalytic 
SnRK1! subunits in phosphoproteomic studies, besides conserved T-loop 
phosphorylation (T175/T176) (18-22, 44). Phosphorylated residues on SnRK1!1 
such as S176, S179 or Y182 (in the kinase domain), or S364 an S367 (in the 
regulatory domain), await functional characterization and may be eventually 
implied in a phosphorylation-dependent sumoylation of SnRK1. Similarly, 
identified phosphorylated residues on SnRK1 regulatory subunits ("1, "2 and 
"#) (18-22) may putatively contribute to an interplay between phosphorylation 
and SnRK1 complex sumoylation. Another option may also include the 
downstream phosphorylation of SnRK1 targets that in turn could regulate the 
sumoylation pathway. For instance, the serine/arginine-rich (SR) splicing protein 
SF2/ASF was shown to stimulate SUMO conjugation of specific substrates in 
mammals (45). The Arabidopsis SR45 splicing protein interacts with the SUMO 
machinery in Y2H, but does not seem to be modified by sumoylation (46), 
suggesting it may rather have a role as a co-factor in sumoylation regulation. 
Furthermore, the SR45 splicing factor modulates SnRK1 stability (Carvalho, 
RF., submitted) but whether this depends on SnRK1 sumoylation and/or on 
SnRK1-dependent phosphorylation of SR45 remains to be tested. Finally, it is 
also possible that SnRK1 sumoylation is not directly induced by its activation 
status, but that is rather a consequence of the physical proximity between active 
SnRK1 and SUMO machinery, upon given stimuli (e.g. co-localization in the 
nucleus).  
As previously addressed in Chapter 2 and Chapter 3 [see respective 
Discussion(s)], sumoylation has been described for SnRK1 orthologs in yeast 
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(SNF1) and mammals (AMPK). In AMPK, both catalytic (!1/!2) subunits are 
within a list of ~1600 human proteins found to be sumoylated using high-
resolution MS (47). AMPK!1 sumoylation was detected in control samples and 
was significantly increased in response to heat shock, proteasome inhibition and 
SUMO protease inhibition treatments. It is known that several environmental 
stresses such as heat, oxidative stress and hypoxia result in ATP depletion and 
in the consequent activation of AMPK (48). Thus, similarly to SnRK1, AMPK!1 
activation seems to enhance its sumoylation (upon heat stress) and is intimately 
connected to kinase turnover, as suggested by the enrichment of AMPK!1-
SUMO conjugates upon proteasome inhibition. Sumoylation of the catalytic 
subunit AMPK!2 had a low intensity signal and was only detected upon MG132 
treatment (47), suggesting it may similarly regulate kinase turnover and signal 
termination. In the case of SNF1, the Snf1 catalytic subunit was reported to be 
sumoylated and degraded in response to Snf1 inactivating conditions (glucose 
treatment) (49). Even though the authors conclude that sumoylation is important 
to reduce SNF1 levels when cells do no longer need SNF1 activity, the fact that 
the Mms21 SUMO ligase mutants also accumulate higher Snf1 levels under low 
glucose suggests that, as in the case of SnRK1 and AMPK, sumoylation of 
SNF1 catalytic subunit may also operate under activating conditions as a way to 
promote signal termination and prevent deleterious pathway overactivation. 
However, distinct layers of regulation and functional outcomes may be 
attained through sumoylation of specific regulatory subunits or specific 
SNF1/AMPK/SnRK1 complexes. AMPK"2 sumoylation was reported to 
enhance AMPK activity by increasing its phosphorylation (50). Furthermore, 
AMPK"2 sumoylation and ubiquitylation appeared to be antagonistic, and 
possibly the same occurs with the SnRK1 regulatory subunit, SnRK1"2. On the 
other hand, SnRK1"1 and SnRK1"2 are differentially accumulated in the siz1-2 
mutant (Figure 3.4D), possibly due to distinct consequences of SUMO 
attachment.  
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Given the common downregulation of SNF1/AMPK/SnRK1 catalytic subunits 
by sumoylation, it is challenging to integrate diverse functional outcomes of 
individual regulatory subunits and whole complex sumoylation. One potential 
scenario is that complex composition influences its sumoylation, as the SUMO 
machinery may have different affinities towards distinct SNF1/AMPK/SnRK1 
complexes and this might be partially due to their differential distribution within 
the cell. Alternatively, sumoylation may per se selectively determine 
SNF1/AMPK/SnRK1 complex composition in response to specific signaling 
cues, activating distinct complexes and consequently triggering their 
degradation.  
In summary, the work here described has uncovered a negative feedback 
loop by which SnRK1 activity triggers its own SUMO-mediated proteasomal 
degradation. Furthermore, this feedback regulation allows to reset SnRK1 
signaling to equilibrium, and to restrain stress responses over growth and 
developmental demands (2, 51), possibly taking into account the intensity and 
duration of stress signals. Such an intimate connection between kinase activity 
and turnover may be required for an accurate response to energy deprivation 
conditions, and seems to be evolutionarily conserved amongst 
SNF1/AMPK/SnRK1 kinases.  
 
 
4.4 | Materials and Methods 
A list of all primers, cloning steps and constructs used in this study is 
provided in Appendix Table 1. 
 
 
4.4.1 | Plant Material, Growth Conditions and Virus-induced gene 
silencing (VIGS) 
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Unless otherwise specified, plants were grown in soil under a 12h light 
(100µE), 22°C/12h dark, 18°C regime. Arabidopsis thaliana plants used in this 
study are in the Columbia (Col-0) background such as Col-0 (WT), siz1-2 
(SALK_065397) (52, 53), and snrk1!1-3 (described in Chapter 2), or in the 
Landsberg erecta (Ler) background for 35S-SnRK1!1-HA (1), and have been 
previously described.!Virus-induced gene silencing (VIGS) of SnRK1!2 or GFP 
(control) was performed in the snrk1!1-3 background to generate snrk1!1 
snrk1!2 (SnRK1!2 VIGS) or snrk1!1 GFP (GFP VIGS) plants. Virus-induced 
gene silencing (VIGS) was done as previously described (24). pTRV RNA1 and 
pTRV RNA2 (the latter containing gene specific fragments of -SnRK1!2 or -
GFP) were introduced into Agrobacterium tumefaciens strain GV3101 and a 
5mL culture was grown overnight at 28ºC in 50 mg/L gentamycin and 50 mg/L 
kanamycin. The culture was inoculated into 50mL LB medium containing 
antibiotics, 10mM MES, and 20µM acetosyringone and grown overnight in a 
28ºC shaker. A. tumefaciens cells were harvested and resuspended in 
infiltration media (10mM MgCl2, 10mM MES, and 200µM acetosyringone), 
adjusted to an OD600nm of 1.5, and left at room temperature for 3 to 4 h. Two- to 
three true-leaf seedlings of snrk1!1-3 plants with approximately 2 weeks were 
used for VIGS. Agroinfiltration was performed after mixing 1:1 RNA1 and RNA2 
Agrocultures, and infiltrating the entire leaf with a needleless 1mL syringe, into 
two leaves of each seedling. Plants were used for stress treatments at the age 
of 4-5 weeks. 
 
 
4.4.2 | Antibodies and Protein Expression Analyses 
 
The SnRK1!1 (1/500, anti-AKIN10, AS10919), Rubisco (1/5000, anti-RbcL, 
AS03037), Histone 3 (1/1000, anti-H3, AS10710) and CYP37 (1/2000, anti-
PPIase CYP37, AS101589) antibodies were purchased from Agrisera. Anti-HA 
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(1/1000, Roche, #11867423001) and anti-GFP (1/500, A01388, GeneScript) 
antibodies were used to detect the corresponding tagged proteins, whereas 
anti-GST (1/2000, Sigma, #G7781) and anti-T7 (1/10000, #69522-3, Novagen) 
were used to immunoprecipitate the corresponding tagged proteins. 
For immunoblotting all primary antibodies were diluted in 1% non-fat Milk in 
TBS (unless otherwise stated) and incubated with the membrane under gentle 
shaking for 12h at 4°C. Secondary antibodies (Jackson ImmunoResearch Lab, 
inc) were used at 1/10000 in 1% non-fat Milk in TBS for 1h at RT.  
 
 
4.4.3 | Protoplast Transient Expression Assays 
 
Protoplasts from Col-0 or siz1-2 plants were isolated and transfected as 
already described (54). All effector constructs (Appendix Table 1) were 
generated by cloning the corresponding coding sequences into a pHBT95 
vector harboring a C-terminal HA (54), except for the "SUMO mimetics" 
constructs that have no tag. The indicated mutations were introduced by site-
directed mutagenesis and verified by sequencing. For endogenous protein 
quantifications (Figure 4.2B), protoplasts were incubated without transfection 
and collected at the described times. Cyclohexamide (Biochemica, A0879/0001; 
Ethanol stock) and MG132 (Sigma, C2211; DMSO stock) solutions were used at 
a final concentration of 100-M and 50-M, respectively. 
For protein expression analyses, protoplasts were directly ressuspended in 
4X Laemmli solubilization buffer (55) and boiled for 5min at 95°C. Samples were 
analyzed by SDS-PAGE or Phos-Tag SDS-PAGE, in which the Phos-Tag ligand 
selectively retards phosphorylated proteins [50 -M Phos-Tag ligand (Wako 
Chemicals GmbH, AAL-107, 304-93521) and 100 -M MnCl2) (23)]. 
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4.4.4 | Nuclear enrichment  
 
Full rosettes from 6-week-old Col-0 plants were ground in liquid nitrogen and 
extracted with 15ml/rosette of Nuclear Enrichment Extraction buffer (EB) [20mM 
Tris-HCl pH6.8, 25% Glycerol (V/V), 1% Triton-X (V/V), 2.5mM MgCl2, 20mM 
KCl, 2mM EDTA, 8.8% Sucrose (w/V), 0.5mM Spermidine, 30mM "-Mercapto-
Ethanol, cOmplete protease inhibitor cocktail (one tablet/25mL), 1/500 (v/v) 
phosphatase inhibitor 2 (Sigma P5726) and 3 (Sigma P0044), 10mM NEM]. 
Liquid and homogenous plant extracts were filtered through four layers of 
Miracloth and kept on ice for 15-20min. Samples were thereafter cleared by 
centrifugation using a swing-out rotor (1000g, 4ºC, 10min). The supernatant, 
containing the "soluble fraction" was frozen (15-20µl of supernatant loaded per 
gel), and the pellet containing the nuclei was gently washed three times with 3ml 
of Nuclei Resuspension buffer (RB) [20mM Tris-HCl pH6.8, 25% Glycerol (V/V), 
2.5mM MgCl2, 0.5mM Spermidine, 30mM "-Mercapto-Ethanol, cOmplete 
protease inhibitor cocktail (one tablet/25mL), 1/500 (v/v) phosphatase inhibitor 2 
(Sigma P5726) and 3 (Sigma P0044), 10mM NEM], and resuspended in 60ul of 
RB (20µl of nuclei enriched fraction loaded per gel). Prior to SDS-PAGE 
analysis, samples were boiled for 5min at 95°C with 4X Laemmli solubilization 
buffer (55). 
 
4.4.5 | Plant Stress treatments 
 
Detached rosettes of Col-0 (WT), siz1-2, snrk1!1 snrk1!2, or snrk1!1 GFP 
plants with 4 to 5 weeks, were incubated in small petri dishes with 10ml of MilliQ 
water and subjected to control or stress treatments for 1 hour. The following 
stresses were applied: darkness, heat (37ºC), oxidative stress (H2O2, 50mM), 
ethanol (10%), or salt stress (NaCl 150mM) (28-31). Plant material was frozen 
and subsequently processed in 2X Laemmli buffer with 8% "-Mercapto-Ethanol 
CHAPTER 4 | 
! 222 
and 50mM N-Ethylmaleimide (NEM), and boiled for 5min at 95°C. Samples 
were analyzed through SDS-PAGE and immunoblotting against SUMO1. 
Membranes were afterwards stained with Coomassie Brilliant Blue R250, and 
the loading of each lane was compared with the correspondent SUMO1 profile 
previously obtained. 
 
4.4.6 | Quantification of immunoblot results 
 
Membranes were analyzed by immunoblotting and then stained with 
Coomassie Brilliant Blue R250. Band intensity was quantified using Image J 
(http://imagej.nih.gov/ij/) and Gel Quant Net  
(http://biochemlabsolutions.com/GelQuantNET.html) softwares. The immunoblot 
intensities were normalized to the Coomassie staining intensity (referred as 
“loading”). Quantifications were normalized to the t=0 of each kinetics. 
 
 
4.4.7 | Statistical Analyses 
 




4.4.8 | Recombinant Protein Production and Purification 
 
Recombinant SnAK2-GST protein was purified from E. coli extracts using 
glutathione-agarose affinity chromatography (G4510; Sigma-Aldrich), according 
to the manufacturer’s instructions and as previously described (16). SnRK1!1.1 
and SIZ1.1 were cloned into pET28a (Novagen). Recombinant proteins were 
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produced in E. coli (BL21 rosetta) and purified using immobilized metal ion 
affinity chromatography (Ni-NTA, Qiagen) following the manufacturer’s 
instructions and as previously described (12). Successful protein production and 




4.4.9 | SnRK1!1 Immunoprecipitation and in vitro Kinase Assays 
 
SnRK1!1 was immunoprecipitated from leaves of 35S-SnRK1.1-HA plants 
treated for 1h in darkness. Plant material (1g) was extracted in 3 volumes of 
1xPBS supplemented with 1mM EDTA, 0.05% Triton X-100, and 1/500 (v/v) 
plant-specific protease inhibitor cocktail (Sigma) and phosphatase inhibitor 
cocktail (Sigma). After centrifugation (20,000g, 4°C, 15min), the supernatant 
was recovered, and 1mg of total protein was incubated 2h at 4°C with 30µL of 
anti-HA affinity matrix. The matrix was washed three times with extraction buffer 
and resuspended in kinase assay buffer, of which one third was used for each 
reaction as follows.  
For in vitro kinase assays, recombinant His-T7-SIZ1 (3µg) was incubated 
alone or with His-T7-SnRK1!1 (2µg) and/or GST-SnAK2 (0.2µg), for 2h at 30°C 
in kinase assay media [50mM Hepes-NaOH pH7.25, 10mM MgCl2, 1mM DTT, 
1/500 (v/v) plant-specific protease inhibitor cocktail (Sigma), 1/500 (v/v) 
phosphatase inhibitor 2 (Sigma P5726) and 3 (Sigma P0044), 100-M cold ATP 
and complemented with 2-Ci of #-32P-ATP]. Immunoprecipitated SnRK1!1 was 
directly incubated (or not) with recombinant SIZ1 in kinase assay buffer, with 
100-M cold ATP and 2-Ci of #-32P-ATP, for 1h at 30°C.  Reactions were 
stopped by addition of Laemmli buffer, and then boiled for 5 min at 95ºC. 
Proteins were resolved in an 8% SDS-PAGE gel, and detected using a 
phosphor image system (STORM 860; GE Healthcare). 




4.4.10 | Accession Numbers 
 
Sequence data can be found in the Arabidopsis Genome Initiative database 
under the following accession numbers: SnRK1!1, At3g01090; SIZ1, 
At5g60410; SAE1b, At5g50580; SAE2, At2g21470; SCE1, At3g57870; SUMO1, 
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Plants are subjected to diverse environmental changes throughout their life 
cycle. Although stress responses are crucial for withstanding these changes, 
they may also compromise plant growth and influence development. Hence, 
limited resources should be adequately allocated in accordance with the internal 
and external demands. This delicate balance relies on accurate sensing of 
environmental cues and on complex signaling pathways, and is mediated by the 
crosstalk of several hormones, sugars and other metabolite effectors (1). 
The plant Snf1-Related protein Kinase 1 (SnRK1) is a central kinase that 
senses and signals the energy levels of the cell, and is activated in response to 
starvation and energy depletion conditions (2, 3). Furthermore, SnRK1 has a 
privileged position at the interface of several stresses, hormonal, and metabolic 
signaling pathways at the whole organism level, and impacts plant growth and 
developmental decisions (2-4). The importance and centrality of SnRK1 is 
highlighted by its conservation across eukaryotes and by the fact that, in most 
organisms, the SnRK1 pathway is essential for viability (2, 5-7). 
Yeast, mammalian and plant SNF1/AMPK/SnRK1 kinases are heterotrimeric 
complexes composed of an !-catalytic and "- and #-regulatory subunits. 
Conservation of these complexes at the structural level overlays with common 
functionalities, and their regulation occurs through multiple mechanisms that 
impact kinase activity, stability, and/or subcellular localization. Such broad 
regulation confers flexibility to the SNF1/AMPK/SnRK1 kinases providing tissue, 
developmental, metabolic and/or environmental specificities (8). However, some 
of the members of this kinase group display very specific features that probably 
reflect divergent evolutionary outcomes, such as atypical subunits (9-11), 
allosteric regulation (12), or interaction with carbohydrates (10, 13, 14), amongst 
many others. In contrast to its mammalian and yeast orthologs, the plant 
SnRK1! T-loop phosphorylation/ dephosphorylation seems to be required but 
insufficient to determine its activation under stress, and subsequent inactivation 
once homeostasis is restored (2, 15-17). Furthermore, intrinsic SnRK1 kinase 
CHAPTER 5 | 
! 232 
activity appears unchanged under conditions that induce SnRK1 signaling as 
well as in pp2c mutants that display deficient repression of the SnRK1 pathway 
(2, 15, 17).  
The work described in this thesis aimed at deciphering additional 
posttranslational regulatory mechanisms of the SnRK1 kinase that could explain 
its regulation in response to activating conditions. We focused on the 
modification of SnRK1 by the Small Ubiquitin-like modifier (SUMO), due to the 
presence of high probability SUMO attachment site (hpSAS) motifs on the 
SnRK1!1 catalytic subunit, and to the observation of high molecular weight 
(hMW) SnRK1!1 forms that could correspond to SnRK1!1-SUMO conjugates. 
Furthermore, SUMO pathway and SnRK1 signaling have important roles in the 
plant response to various biotic and abiotic stresses (2, 4, 18-22). Thus, we 
hypothesized that SUMO and SnRK1 could be entwined in the plant stress 
response, through sumoylation of the SnRK1 kinase, and possibly through 
SnRK1-dependent phosphorylation of SUMO pathway components.  
Using several approaches we were able to determine that SnRK1 is 
sumoylated. SnRK1!1 interacts with the essential E2 SUMO conjugating 
enzyme (SCE1) in yeast two-hybrid assays (Y2H) and is sumoylated with 
SUMO1 and SUMO3 in several domains and multiple residues, in a system that 
reconstitutes the Arabidopsis SUMO pathway in E. coli. We also determined 
that other regulatory subunits of the SnRK1 complex (SnRK1"1 and SnRK1"2, 
but not SnRK1"#) are similarly sumoylated in the E. coli system, raising the 
possibility that in planta protein group sumoylation targets the entire SnRK1 
complex. Sumoylation of the SnRK1 subunits SnRK1!2 and SnRK1"3 remains 
to be determined, whereas the probably divergent and non-established SnRK1# 
subunit was sumoylated in the E.coli system.  
We were able to show that SnRK1!1 is sumoylated in planta. In GFP 
immunoprecipitates from SnRK1!1-GFP plants, SnRK1!1 hMW bands partially 
matched with SUMO1 bands in the same samples. Importantly, GFP 
immunoprecipitates from SnRK1!1-GFPsiz1-2 plants, which lack the E3 ligase 
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SIZ1 determinant for sumoylation specificity in vivo, were completely depleted of 
SUMO1 conjugates. In the same conditions SnRK1!1 hMW bands were 
strongly diminished, supporting their identity as SnRK1!1-SUMO1 conjugates. 
Thus, these data strongly suggest a SIZ1-dependent sumoylation of SnRK1!1 
by SUMO1 in planta. For the in vivo detection of sumoylation we ground plant 
material in a mild denaturing buffer, through the usage of ionic detergents, to 
enable the subsequent immunoprecipitation (IP) step. The presence of the 
alkylating agent N-Ethylmaleimide (NEM) and of the proteasome inhibitor 
MG132 was crucial to enrich for the scarce and labile SnRK1!1-SUMO 
conjugates. However, such mild conditions allow protein non-covalent 
interactions and the co-immunoprecipitation of several SnRK1!1 interacting 
proteins, which may also be sumoylated. Indeed, we could assign a significant 
contribution to the SUMO1 signal in SnRK1!1-GFP IPs to SnRK1!1 interacting 
proteins, namely SnRK1"1 and SnRK1"2 regulatory subunits, which similarly to 
SnRK1!1 exhibit hMW bands and are likely sumoylated in planta. In 
SnRK1!1%KA1-GFP immunoprecipitates, SUMO1 signal intensity and 
SnRK1!1 hMW bands are strongly diminished but still present to some extent, 
evidencing that sumoylation still occurs in the remaining catalytic subunit. 
Removal of the KA1 domain of SnRK1!1 abrogates the interaction with 
regulatory subunits and probably with several other SnRK1!1 interacting 
proteins, but also one crucial lysine residue (K390) of SUMO attachment on 
SnRK1!1 is lost. The SUMO1 signal associated with SnRK1!1-GFP IPs can 
also result from non-covalent interactions between sumoylated proteins and 
putative SUMO interacting motifs (SUMO-SIM interactions) on SnRK1!1, or 
conversely by the interaction of SUMO moieties covalently attached to 
SnRK1!1 with SIMs in other (sumoylated) proteins. We could not detect SIM 
motifs in the SnRK1!1 subunit using a stringent search for SIMs type SIMa, 
SIMb or SIMr (23) or for the SIM motifs described by Sun and Hunter (24). 
However, additional bona fide SIM motif features await characterization and the 
SIM motifs present in the co-purified SnRK1 regulatory subunits (namely 
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SnRK1"#) may be sufficient to convey SUMO-SIM non-covalent interactions, 
and contribute to the intensity of the SUMO1 signal obtained.  
As previously mentioned, to unequivocally demonstrate sumoylation of a 
particular SnRK1 subunit, future analyses should employ plants expressing His-
tagged SUMO1 or SUMO3 (21, 25) to perform SUMO pulldowns under 
denaturing conditions followed by immunoblots for the protein of interest. This 
would retrieve only components covalently bound to SUMO (as opposed to 
components interacting through non-covalent protein-protein interactions).  
In any case, the extraction buffer used and the presence of both type of 
covalent and non-covalent protein interactions allowed a global insight into the 
massive SUMO1 signal associated with SnRK1!1 subunit in planta. Our results 
reinforce the idea that SUMO may act as a "glue", promoting or stabilizing 
interactions amongst groups of proteins and even establishing functional 
networks between sumoylated proteins and their noncovalent interactors (26-
30). It will be extremely interesting to compare the SnRK1!1 interactome in the 
presence or absence of sumoylation (e.g. from SnRK1!1-GFP versus 
SnRK1!1-GFPsiz1-2 plants). Since SUMO can promote interactions but also act 
as a "repellent", the amount and identity of SnRK1!1 interacting proteins should 
vary in both backgrounds. Such knowledge should clarify our understanding of 
the functional and biological outcomes of SnRK1 sumoylation in planta. 
Surprisingly, our preliminary results suggest sumoylation influences SnRK1 
complex composition and its putative oligomerization. SnRK1 signaling is 
overactivated in siz1-2 plants in response to energy stress and it will be 
interesting to correlate this overactivation with SnRK1 interacting partners, 
complex composition and oligomerization state in this mutant background. 
Here we show a SIZ1-dependent sumoylation of SnRK1 by SUMO1, but we 
cannot exclude a possible sumoylation of SnRK1 by SUMO3 or SUMO5 in 
planta, due to the lack of good antibody tools, neither a role for the E3 ligase 
HPY2. Notwithstanding, the SUMO1 signal associated with SnRK1!1 can be 
fully attributed to the SIZ1 ligase activity in the conditions tested, as suggested 
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by its disappearance in immunoprecipitates from SnRK1!1-GFPsiz1-2 plants. As 
previously reported, the increase in SUMO1/SUMO2 conjugates associated with 
stress responses is mainly conveyed through the E3 SUMO ligase SIZ1 in 
plants (18, 31).  
Similarly to the recently described sumoylation of yeast SNF1 and 
mammalian AMPK, our data suggest a possible sumoylation of the SNF1A 
Drosophila counterpart, and SnRK1 complex sumoylation in planta. Thus, the 
Small Ubiquitin-like modifier (SUMO) seems to have an expanding role in the 
regulation of the SNF1/AMPK1/SnRK1 family of protein kinases, conserved 
amongst eukaryotes. 
Importantly, we determined that SIZ1-dependent sumoylation of SnRK1 by 
SUMO1 has a negative impact on SnRK1 pathway activation. Co-expression of 
SnRK1!1, SUMO1 and SIZ1 diminished the ability of SnRK1!1 to induce 
SnRK1 signaling. SnRK1 pathway was overactivated in siz1-2 plants, as 
determined by qRT-PCR analysis of SnRK1 marker genes in response to dark 
treatment, as well as in the protoplast assay using siz1-2 cells. We could 
observe that the negative impact of sumoylation occurred at the kinase level, 
since SnRK1 pathway activation induced by the downstream transcription factor 
GBF5 was not affected by SIZ1-dependent sumoylation. Furthermore, we show 
that the E3 SUMO ligase activity of SIZ1 is required to rescue the overactivation 
of SnRK1 signaling in siz1-2, which seems to be independent of the salicylic 
acid (SA) accumulation observed in this mutant. 
We determined that SnRK1!1 intrinsic kinase activity was unchanged 
between WT and siz1-2 plants, and that SnRK1 signaling overactivation in siz1-
2 could be attributed to the accumulation of SnRK1!1 protein in this 
background. Importantly, T-loop phosphorylation was increased proportionally to 
SnRK1!1 protein accumulation. Whereas SnRK1 subunits SnRK1!2 and 
SnRK1"1 also accumulated in siz1-2, the SnRK1"2 subunit did not, despite all 
of these being likely sumoylated in planta. Future studies should address the 
sumoylation of each SnRK1 complex subunit and its specific biochemical and 
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functional outcome in planta. This knowledge will contribute to integrate 
individual subunit regulation with regulation of the whole SnRK1 complex. 
Furthermore, specific features associated with the modulation of specific SnRK1 
complexes may be clarified with such studies. 
We observed that SnRK1!1 protein turnover was impaired in siz1-2, 
explaining protein kinase accumulation and signaling pathway overactivation in 
this mutant background. Importantly, a SUMO mimetic of SnRK1!1 restored a 
WT degradation profile to SnRK1!1 in siz1-2, supporting a connection between 
SnRK1!1 sumoylation and its degradation.  
An increasing number of reports highlight the interplay between sumoylation 
and ubiquitylation (32-36), and we next assessed if SnRK1 sumoylation could 
be promoting its ubiquitylation and subsequent proteasomal degradation. 
Interestingly, ubiquitin conjugates co-purified with SUMO1 conjugates in 
immunoprecipitates from SnRK1!1-GFP plants, but were strongly diminished in 
SnRK1!1-GFPsiz1-2 IPs. This result suggests that SIZ1 sets a sumoylation-
dependent ubiquitylation of SnRK1, possible through the action of SUMO-
targeted ubiquitin ligases (STUbLs). Furthermore, as previously reported, we 
could also show that SnRK1!1 degradation occurs via the proteasome. One of 
the reasons why detection of SnRK1 sumoylation in planta was so challenging 
is probably due to the functional outcome of this modification in targeting 
SnRK1!1 to degradation. Besides the strategies employed to block SUMO 
proteases and enrich for the scarce SUMO conjugates, the utilization of MG132 
revealed to be crucial to counteract proteasomal degradation of sumoylated and 
ubiquitylated SnRK1!1.  
STUbLs bind sumoylated proteins via SUMO-SIM non-covalent interactions 
and further conjugate the sumoylated substrate with ubiquitin modifiers. In large-
scale Y2H screens of Arabidopsis SUMO interacting proteins, six proteins were 
identified as the evolutionary and functional homologs of yeast STUbLs (37). 
Arabidopsis STUbLs (1-6) complemented to various degrees the 
Schizosaccharomyces pombe STUbL mutant rfp1/rfp2, evidencing partially non-
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redundant functions that should be further dissected. Besides, plant-specific 
features were reported for STUbL4 (37). It will be interesting to address the role 
of STUbLs in SnRK1 sumoylation-mediated ubiquitylation. Mutant stubl plants 
should be analyzed regarding SnRK1 pathway activation and SnRK1 protein 
stability. These readouts should be correlated with the ubiquitylation and 
sumoylation profiles of SnRK1 in the respective mutants.  
However, the role of other players in SnRK1 sumoylation should also be 
considered. The interaction between SnRK1!1 and the SUMO protease Early in 
short days 4 (ESD4) (38, 39) was reported in a Y2H screen (40). Future studies 
on SnRK1 sumoylation should also take into account such SUMO machinery 
component and explore, for instance, a possible accumulation of SnRK1-SUMO 
conjugates in esd4 mutants and address its molecular and functional 
consequences. A delicate balance between the activity of SUMO proteases and 
STUbLs may exist at the level of SnRK1 sumoylation, since both molecular 
players may counteract the accumulation of sumoylated SnRK1. However, a 
putative SUMO protease and STUbL acting on SnRK1 may have antagonistic 
outcomes, since SnRK1 may be degraded through the action of a putative 
STUbL, and a SUMO protease may stabilize SnRK1 by antagonizing STUbLs 
action. 
Furthermore, the E4 SUMO ligases PIAL1 and PIAL2, recently characterized 
to promote SUMO-chain formation in Arabidopsis (28, 41), may have a role in 
SUMO chain assembly on sumoylated SnRK1!1. Using the E4 SUMO ligase 
double mutant pial1pial2 (41) may allow us to distinguish between multi- and 
polysumoylation as a requirement to putatively recruit STUbLs and 
subsequently ubiquitylate sumoylated SnRK1 in planta.  
Whether SUMO conjugated to SnRK1 could fulfill other biological functions 
prior to SUMO targeted ubiquitylation and signal termination, remains an open 
question. If affirmative, the discrimination between both outcomes could be 
based on the (putative) length and/or topology of the attached SUMO chains 
(42). We could use the protoplast cell assay to block specific SUMO proteases 
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and STUbLs, and manipulate the E3 SIZ1 ligase and possibly E4 PIAL ligases, 
promoting SnRK1!1 sumoylation but preventing its proteolytic outcome. SnRK1 
molecular and functional features should be addressed in such scenario.  
A SUMO variant with mutated lysines could be a helpful tool to prevent 
SUMO chain extension or to modulate SUMO chain topology. Either alone or in 
fusion with SnRK1!1 (SUMO mimetic), this SUMO variant could be used to 
better dissect and characterize functional outcomes of SnRK1 sumoylation. 
Our approach to block SnRK1!1 sumoylation through mutation of several 
lysine residues at the target level produced no effect regarding SnRK1 signaling 
activation and SnRK1 protein stability in planta. Probably, sumoylation at the 
whole SnRK1 complex level impairs such an approach, as similarly reported for 
other cases, and seemingly a characteristic feature of the SUMO pathway (30, 
43, 44). Still, other readouts of SnRK1 activity beyond reporter gene activation 
remain to be assessed using the mutated lysine variants, for instance the 
phosphorylation level of direct targets of SnRK1 in planta (45). 
We analyzed the loss of SnRK1 (SIZ1-dependent) sumoylation and its 
functional consequences using the siz1-2 mutant. In another attempt to assess 
the functional relevance of this molecular mechanism in planta, we will analyze 
SnRK1!1-OE plant lines in the siz1-2 background (SnRK1!1-OEsiz1-2).  Since 
one of the endogenous mechanisms to repress SnRK1 signaling is lost in the 
siz1-2 mutant, we expect SnRK1!1 overexpression in SnRK1!1-OEsiz1-2 to be 
further enhanced in comparison to SnRK1!1-OE, in the Col-0 background. 
Accordingly, a true SnRK1!1 overexpressor in SnRK1!1-OEsiz1-2 should exhibit 
higher severity of SnRK1-OE related phenotypes than the SnRK1!1-OE plants.  
Conversely, in order to mimic SnRK1!1 sumoylation in planta we generated 
SnRK1!1-SUMO-OE plants. SnRK1!1 protein turnover and accumulation, 
SnRK1 pathway activation, and SnRK1!1-OE associated phenotypes will be 
compared in SnRK1!1-OE and SnRK1!1-SUMO-OE plants, with the 
expectation that SnRK1!1-SUMO-OE will behave as a weak overexpressor of 
SnRK1!1 due to the repressive effect associated with SnRK1!1 sumoylation.  
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Still, additional studies may be required to decipher the functional and 
biological implications of SIZ1-dependent sumoylation of SnRK1 in planta. 
The fact that ubiquitylation is diminished but still present in the absence of 
SnRK1 sumoylation evidences that multiple E3 ubiquitin ligases may 
cooperatively regulate SnRK1 protein turnover and terminate kinase action, 
probably acting in accordance with distinct stimuli or other specificities (46).   
Sumoylation also negatively regulates the stability of yeast Snf1 (47) and 
mammalian AMPK! (48), pointing to a conserved outcome of this 
posttranslational modification in the regulation of SNF1/AMPK/SnRK1 catalytic 
subunits. 
Besides SnRK1 kinase stability, and consequent impact on SnRK1 signaling 
activation, it is also possible that sumoylation affects or is affected (see below) 
by kinase subcellular localization. Our preliminary studies suggest an 
enrichment of SnRK1!1 hMW forms in nuclear fractions, and further attempts 
should clarify if they correspond indeed to SnRK1!1-SUMO conjugates. Making 
use of SnRK1!1-GFP and SnRK1!1-GFPsiz1-2 plants, we can assess the impact 
of sumoylation on SnRK1!1 localization through microscopy techniques. 
Furthermore, the distribution of SnRK1!1 protein in siz1-2 and WT backgrounds 
can be compared using subcellular fractionation protocols.  
Importantly, we were able to show that SnRK1 kinase activity is intimately 
connected to its sumoylation, and subsequent ubiquitylation and protein 
turnover. Inactive SnRK1!1 mutants accumulate to a higher extent than the 
active form due to impaired turnover. However, their degradation rate can be 
restored to WT levels when co-expressed with active SnRK1!1, either due to a 
direct regulation in trans by the active kinase, or through an indirect effect 
derived from SnRK1 signaling activation. To be able to distinguish between 
these two scenarios we could test, for instance, the degradation rate of the 
inactive SnRK1!1 variants when the pathway is activated downstream of the 
SnRK1 kinase, through overexpression of the GBF5 transcription factor. 
Furthermore, fusion of SUMO1 to inactive SnRK1!1 mutants (SUMO mimetic) 
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restores a WT degradation profile, suggesting the impaired turnover is due to 
absence of sumoylation in inactive SnRK1!1 variants.  
Endogenous SnRK1!1 protein degradation seems to be increased in 
response to dark-stress conditions, but further experiments are required to 
support this observation. Sumoylation could be one intermediary step in this 
process, since SnRK1!1 dark-induced turnover seems to be impaired in siz1-2 
cells. Future work should dissect the impact of different types of stress that 
converge as energy deprivation conditions, in active SnRK1 kinase turnover.  
In protoplasts, the high induction of SnRK1 signaling upon SnRK1!1 
transfection, in which sumoylated SnRK1 should get rapidly degraded, probably 
explains why we could not detect SnRK1!1-SUMO conjugates in this system. 
Maybe, when expressing SnRK1!1 in protoplasts of a yet to be determined 
STUbL mutant background, in the presence of the proteasome inhibitor MG132, 
and of a SUMO protease dominant negative version to block reversion of 
sumoylation, we could clearly see SnRK1!1 hMW bands in this system. 
Moreover, further attempts should be made to analyze the differential 
accumulation of SnRK1!1-SUMO conjugates and SnRK1!1-ubiquitin 
conjugates upon SnRK1 signaling activation. We could not detect a clear 
difference in the accumulation of SUMO conjugates in GFP immunoprecipitates 
of SnRK1!1-GFP plants from light and sudden dark conditions. However, the 
detection of SnRK1!1 hMW bands after nuclear enrichment revealed an 
accumulation of these forms in SnRK1 activating conditions (extended dark) and 
their absence in SnRK1 repressing conditions (light). Combined strategies of 
enrichment and purification steps (e.g. nuclear fractionation followed by 
SnRK1!1 immunoprecipitation) might improve the detection of variable amounts 
of SnRK1!1-SUMO conjugates in response to different stimuli. Ideally, a 
quantitative approach could provide information on the stoichiometry and 
kinetics of SnRK1 sumoylation in different conditions, for instance through the 
combination of labeling methods, enrichment strategies and mass spectrometry 
analyses (49). As an example, Miller et al. recently used a quantitative 
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methodology with isobaric tag for relative and absolute quantification (iTRAQ) 
mass spectrometry, in conjunction with SUMO enrichment strategies, to quantify 
sumoylated proteins after heat stress in plants (50). 
Interestingly, we could observe that active SnRK1!1 phosphorylates the E3 
SUMO ligase SIZ1 in vitro and hypothesize this could be a way to signal SnRK1 
pathway activation towards the SUMO machinery, promoting its sumoylation 
and subsequent turnover. How this modification affects SIZ1 ligase activity, and 
if it impacts SnRK1 or global sumoylation, remains to be determined. Additional 
studies are required to decipher the functional and biological implications of 
SnRK1-dependent phosphorylation of SIZ1 in planta. For instance, a thorough 
analysis of SIZ1 phosphomutants and phosphomimetics should give insights 
regarding the role of SIZ1 phosphorylation, and downstream consequences in 
planta. On the other hand, whether sumoylation depends or not on SnRK1 
subcellular localization, could be assessed by monitoring SnRK1 sumoylation 
and/or stability in SnRK1 variants with distinct subcellular localization (e.g. 
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Figure 5.1 | Model of SnRK1 turnover mediated by sumoylation. 
Upon energy stress, active SnRK1 regulates processes that promote energy homeostasis. As 
a consequence of its activity, possibly due to a SnRK1-mediated phosphorylation of SIZ1 and/or 
of other SUMO machinery components, SnRK1 is sumoylated on several subunits in a SIZ1-
dependent manner. SIZ1 phosphorylation by SnRK1 may affect global sumoylation and substrate 
specificity. SnRK1 sumoylation can occur on multiple residues (multisumoylation) and possibly 
with the formation of SUMO chains (polysumoylation) mediated by the Arabidopsis E4 SUMO 
ligases PIALs. Sumoylated SnRK1 becomes ubiquitylated, possibly through the recruitment and 
activity of SUMO-Targeted Ubiquitin Ligases (STUbLs), and is degraded by the 26S proteasome. 
Sumoylation and ubiquitylation are reversible processes and thus specific SUMO proteases and 
deubiquitylases (DUBs) may counteract the attachment of the respective modifiers to SnRK1. 
Similarly, SnRK1-dependent phosphorylation of SIZ1 may be reverted by specific Protein 
Phosphatases (PP). The tight coupling between SnRK1 activity and its turnover may contribute to 
optimize the balance between stress/defense responses and biosynthetic growth-related 
processes in plants. Continuous or dashed lines represent molecular mechanisms and/or 
components identified or to be determined, respectively.  In red, reversal of sumoylation (by 




Overall, our aim to dissect a possible regulation of SnRK1 by sumoylation 
was based on the hypothesis that SnRK1 and SUMO could be entwined in the 
plant stress response, with the underlying idea that sumoylation could be a 
switch towards SnRK1 activation in energy-deprivation conditions. Surprisingly, 
we have unraveled an endogenous mechanism by which sumoylation represses 
SnRK1 signaling in the plant stress response. In many systems, protein kinase 
activity initiates signal termination through negative feedback loops and other 
mechanisms, in order to prevent deleterious effects derived from pathway 
overactivation. Likewise, sustained SnRK1 pathway activation may compromise 
growth and developmental transitions due to a metabolic switch towards 
catabolism and energy saving processes, with a deleterious impact on plant 
fitness and productivity. The work described in this thesis reveals SnRK1 activity 
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initiates its proteasomal-mediated degradation and adds yet another layer to the 
complex regulation of SnRK1 in the plant stress response. 
Such molecular mechanism of signal termination, triggered by kinase 
activation-dependent sumoylation, may be conserved in yeast SNF1 and 
mammalian AMPK systems. The activation of AMPK pathway by heat stress 
correlates with an increment of AMPK!1-SUMO conjugates, which are mostly 
increased upon proteasome inhibition, suggesting their proteolytic fate (48). 
Furthermore, proteasome inhibition was recently shown to trigger AMPK 
activation (51, 52). In the yeast system, Snf1 sumoylation increases when cells 
are shifted from energy-deprivation (2% galactose, Snf1 activation) to energy 
replenishing (2% glucose, Snf1 inactivation) conditions. However, sumoylation-
mediated turnover of Snf1 is also clearly important in Snf1 activating conditions, 
since yeast cells deficient on the SUMO ligase MMS21 accumulate more Snf1 
when grown on 2% galactose (47). Collectively, sumoylation seems to terminate 
SNF1/AMPK/SnRK1-dependent energy signaling. 
Whereas deleterious overactivation of the SnRK1 pathway seems to be 
counteracted by its sumoylation-mediated turnover in energy deficiency 
conditions, it will be important to clarify a possible role of sumoylation for the full 
clearance of SnRK1 signaling once homeostasis is restored. The dynamics of 
SnRK1 sumoylation upon reversal of the energy deficit should be analyzed, for 
instance, in plants switched from dark to light conditions, or after 
supplementation with sugars (energy) while still in the presence of the original 
stress (e.g. dark). As previously mentioned, a quantitative approach would be 
ideal to address the role of SnRK1 sumoylation in response to environmental 
and endogenous energy transitions.  
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Appendix- Figure 1 
 




K- sumoylated residues 




Arabidopsis  Moss Human Drosophila Yeast 
 
SnRK1!1  Snf1a AMPK!1 SNF1A  Snf1 




SnRK1!2         -----------------------------------MDHSSNRFGNNGVESILPNYKLGKT 25 
SnRK1!1         -----------------------------------MDGSGTGS-RSGVESILPNYKLGRT 24 
Snf1a           -----------------------------------MEAGGRPMGPATAEYYLPNYKLGKT 25 
Snf1b           -----------------------------------MDSGGRPVAPVAVEYYLPNYKMGKT 25 
AMPK!1          ---------------------------MRRLSSWRKMATAEKQKHDG-RVKIGHYILGDT 32 
AMPK!2          --------------------------------------MAEKQKHDG-RVKIGHYVLGDT 21 
DmSNF1A         ---------------------------MPQMRAAAAEAVAAGSANGQPLVKIGHYLLGAT 33 
ScSnf1          MSSNNNTNTAPANANSSHHHHHHHHHHHHHGHGGSNSTLNNPKSSLADGAHIGNYQIVKT 60 
                                                                   : :* :  * 
 
SnRK1!2.1       LGIGSFGKVKIAEHVVTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRQYE 85 
SnRK1!1.1       LGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84 
Snf1a           LGIGSFGKVKVAEHSPTGHKVAIKILNRRKVKMMDMEEKVRREIKILRLFMHPHIIRLYE 85 
Snf1b           LGIGSFGKVKVAEHTPTGHKVAIKILNRRKVKSMDMEEKVRREIKILRLFMHPHIIRLYE 85 
AMPK!1          LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 92 
AMPK!2          LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 81 
Dm              LGTGTFGKVKIGEHQITRVKVAVKILNRQKIKSLDVVGKIRREIQNLKLFRHPHIIKLYQ 93 
Sc              LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 120 
                ** *:**:**:. *  *  ***:**:*:: :   ::  ::.***. *:*: *****: *: 
 
SnRK1!2.1       VIETTSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 145 
SnRK1!1.1       VIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 
Snf1a           VIETPADIFVVMEYVKSGELFDYIVEKGRLGEHEARRFFQQIVSGVEYCHRNMVVHRDLK 145 
Snf1b           VIETPTDIFVVMEYVKSGELFDYIVEKQRLGEDEARRFFQQIVSGVEYCHRNMVVHRDLK 145 
AMPK!1          VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 152 
AMPK!2          VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 141 
Dm              VISTPSDIFMIMEYVSGGELFDYIVKHGKLQEHQARRFFQQIISGVDYCHRHMIVHRDLK 153 
Sc              VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 179 
                **.:  :: :::**. . ****** :. :: * ::*.:****:*.*:****: :****** 
 
SnRK1!2.1       PENLLLDSRCNIKIADFGLSNVMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 205 
SnRK1!1.1       PENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 204 
Snf1a           PENLLLDSKSNVKIADFGLSNVMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 205 
Snf1b           PENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 205 
AMPK!1          PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG 212 
AMPK!2          PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 201 
Dm              PENLLLDHNMHVKIADFGLSNMMLDGEFLRTSCGSPNYAAPEVISGKLYAGPEVDIWSCG 213 
Sc              PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 239 
                ***:*** . : *********:* **.**:****************:********:**.* 
 
SnRK1!2.1       VILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSSEARDLIPRMLIVDPVKRITIPE 265 
SnRK1!1.1       VILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLVVDPMKRVTIPE 264 
Snf1a           VILYALLCGSLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLLVDPMKRVTIPE 265 
Snf1b           VILYALLCGSLPFDDENIPNLFRKIKGGIYTLPSHLSPGARDLIPRMLLVDPMKRVTIPE 265 
AMPK!1          VILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKD 272 
AMPK!2          VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKD 261 
Dm              VILYALLCGTLPFDDEHVPTLFRKIKSGIFPIPEYLNKQVVNLVCQMLQVDPLKRANIEE 273 
Sc              VILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHE 299 
                ****.:**  *****: :* **::* .*::  *..*.  .  *: :** *:*::* .* : 
 
SnRK1!2.1       IRQHRWFQTHLPRYLAVSPPDTVEQAK----------------KINEEIVQEVVN-MGFD 308 




Snf1a           IRQHPWFLNHLPRYLAVPPPDTTQQAK----------------RIDEEILERVVA-LNFD 308 
Snf1b           IRQHPWFLNHLPRYLAVPPPDTLQQAK----------------RIDEEILERVVA-LNFD 308 
AMPK!1          IREHEWFKQDLPKYLFPE--DPSYSST----------------MIDDEALKEVCEKFECS 314 
AMPK!2          IREHEWFKQDLPSYLFPE--DPSYDAN----------------VIDDEAVKEVCEKFECT 303 
Dm              IKKHEWFQKDLPAYLFPS--SIEQDSN----------------VIDTYAVAEVCTKFGVK 315 
Sc              IMQDDWFKVDLPEYLLPPDLKPHPEEENENNDSKKDGSSPDNDEIDDNLVNILSSTMGYE 359 
                * :. **  .** **     .   .                   *:   :  :   :    
 
SnRK1!2.1       RNQVLESLRNR----TQNDATVTYYLLLDNRFRVPSGY------------LESEFQE--- 349 
SnRK1!1.1       RNHLIESLRNR----TQNDGTVTYYLILDNRFRASSGY------------LGAEFQE--- 348 
Snf1a           RDLLIDSLLNR----VQNKATVAYYLMLDNRRRLSNGY------------LCSEFNE--- 349 
Snf1b           RVHLIESLLNR----VQNKATVAYYLMLDNRRRLSNGY------------LGSEFDE--- 349 
AMPK!1          EEEVLSCLYNRN---HQDPLAVAYHLIIDNRRIMNEAK---------DFYLATSPPD--- 359 
AMPK!2          ESEVMNSLYSGD---PQDQLAVAYHLIIDNRRIMNQAS---------EFYLASSPPSG-- 349 
Dm              ETEVHNSLLSGD---PHDQLAIAYHLIIDNKRFADDAAN--QINEINNFFVAGSPPPPPP 370 
Sc              KDEIYESLESSEDTPAFNEIRDAYMLIKENKSLIKDMKANKSVSDELDTFLSQSPPTFQQ 419 
                .  : ..* .       :    :* *: :*:    .              :  .       
 
SnRK1!2.1       -----TTDSGSNPMRT---------------------------------PEAGASPVGHW 371 
SnRK1!1.1       -----TMEG-TPRMHP---------------------------------AESVASPVSHR 369 
Snf1a           -----GKEHLMSPMD-----------------------------------AFNGTPRSGY 369 
Snf1b           -----GKEQSLSPMSPY--------------------------------GAHGGTPRSTY 372 
AMPK!1          -----SFLDDHHLTR---------------------------------PHPERVPFLVAE 381 
AMPK!2          -----SFMDDSAMHIPPGL----------------------------KPHPERMPPLIAD 376 
Dm              PPVPQSSMDHQAPLATVTVGGGTSASSGTATPVPPVAGGTPSSTIPIRPHPERIAPMRDR 430 
Sc              ----QSKSHQKSQVDHETAKQHARRMASAITQQRTYHQSPFMDQYKEEDSTVSILPTSLP 475 
                                                                             
 
 
SnRK1!2.1       IPAHVDHYGLGARSQVP--------VDRKWALGLQSHAHPREIMNEVLKALQELNVCWKK 423 
SnRK1!1.1       LPGLMEYQGVGLRSQYP--------VERKWALGLQSRAHPREIMTEVLKALQDLNVCWKK 421 
Snf1a           PRTLTHMSSMDRRSASPSGLQHRVVAERKWVLGLQLRSHPKEIMNDVLKTLRDLGINWKK 429 
Snf1b           PRSLIRTPSMDRRGSSSSVLQHRVVAERKWALGVQLRSHPKEIMSDVLDTLRKCDINWKK 432 
AMPK!1          --TPRARHTLDELNPQKSKH--QGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKV 437 
AMPK!2          --SPKARCPLDALNTTKPKS--LAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKV 432 
Dm              QLAMSVQTSGGGAFPEKTARGGTPIKRAKWHLGIRSQSKPNDIMLEVYRAMKALSYEWKI 490 
Sc              QIHRANMLAQGSPAASKISPLVTKKSKTRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAK 535 
                          .                 :* :*:: :: * ::* ::  :::  .  *   
 
SnRK1!2.1       IG---HYNMKCRWVPG-------------LADGQNT-MVNNQL--HFRDESSIIEDDCAM 464 
SnRK1!1.1       IG---HYNMKCRWVPNS------------SADGMLSNSMHDNN--YFGDESSIIENEAAV 464 
Snf1a           TG---AYNLKCRWVAPGQNSNDTTAENHSLPDSPMAGSMPRASSCRWSSEQHGVSGSVAA 486 
Snf1b           TG---AYNLKCRWVAPNQHLNDRASEHRGIPDSPMAGTTPRVSSGRWSSEQQGISGSVAS 489 
AMPK!1          VN---PYYLRVRRKNPVTSTYSKMSLQLYQVDSRTYLLDFRSIDDEITEAKSGTATPQRS 494 
AMPK!2          VN---AYHLRVRRKNPVTGNYVKMSLQLYLVDNRSYLLDFKSIDDEVVEQRSGSSTPQRS 489 
Dm              IN---PYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQ--GDDVIMES 545 
Sc              PSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFKFDGWESSYGD 595 
                 .    : :: *                   .                             
 
SnRK1!2.1       TS-----------------PTVIKFELQLYKAREEKYLLDIQR-VNGPQFLFLDLCAAFL 506 
SnRK1!1.1       KS-----------------PNVVKFEIQLYKTRDDKYLLDLQR-VQGPQFLFLDLCAAFL 506 
Snf1a           GNRDN---------ESGVESNVLKFELQLFKLREEKYLLDLQR-VVGPTYLFLDLCAAFL 536 
Snf1b           GNKDD---------ESGVESNVLKFELQLFKMREEKYLLDLQR-VEGPTYLFLDLFSAFL 539 
AMPK!1          GSVSNYRSCQRSDSDAEAQGKSSEVSLTSSVTSLDSSPVDLTPRPGSHTIEFFEMCANLI 554 
AMPK!2          CSAAGLHRPRSSFDSTTAESHSLSGSLTGSLT--GSTLSSVSPRLGSHTMDFFEMCASLI 547 
Dm              LTPP-------------------PLSVSGVMP--------LQP-TGHHTMEFFEMCAALI 577 
Sc              DTTVS---------------NISEDEMSTFSA-----------------YPFLHLTTKLI 623 
                 .                       .:                        *:.: : :: 
 
SnRK1!2.1       TELRVI---- 512 
SnRK1!1.1       AQLRVL---- 512 
Snf1a           AELRVL---- 542 
Snf1b           IELRVA---- 545 
AMPK!1          KILAQ----- 559 
AMPK!2          TTLAR----- 552 
Dm              IQLAR----- 582 
Sc              MELAVNSQSN 633 






Appendix-Figure 1. Protein Alignment of SnRK1!1 homologs. Arabidopsis thaliana (Arabidopsis) 
SnRK1!1 and SnRK1!2, Physcomitrella patens patens (Moss) Snf1a (Q6V8Y5) and Snf1b 
(Q6V8Y3), Homo sapiens (Human) AMPK!1 (Q13131) and AMPK!2 (P54646), Drosophila 
melanogaster (Drosophila, Dm) SNF1A (O18645) and Saccharomyces cerevisae (Yeast, Sc) Snf1 
(P06782) protein sequences, were analyzed using the Clustal W2 multiple sequence alignment 
tool (http://www.ebi.ac.uk/Tools/msa/clustalw2/). Sequences were retrieved from UniprotKB 
Protein knowledgebase database (http://www.uniprot.org/uniprot), except for Arabidopsis proteins, 
whose sequence was retrieved from TAIR (www.arabidopsis.org). In the sequences, red 
underlined K(s) represent hpSAS >91%, blue underlined K(s) represent pSAS <91%, bold red 
K(s) represent sumoylated residues, bold red K(s) highlighted in yellow represent sumoylated 
residues crucial for SnRK1!1 sumoylation in E. coli. Blue italic underlined residues represent 
SIM1 and yellow italic underlined residues represent SIM2 motifs identified in yeast Snf1, in green 
italic underlined are the overlapped residues of both motifs. Below the alignment, asterisks (*) 
indicate amino acid residues conserved in all aligned sequences, colon (:) indicates conservation 
between groups of strongly similar properties, and period (.) indicates conservation between 





Appendix- Figure 2 
 







Phosphorylated residues are in bold type and underlined; basic residues at are 






















Appendix- Figure 2 | Predicted SnRK1 phosphorylation motifs, and phosphorylated residues 
retrieved from phosphoproteomics studies, in SIZ1.1 protein. Underlined are the predicted SnRK1 
phosphorylation motifs encompassing T24, T94, S182, T307, S366, S410, S453 (putative 
phosphorylated residues are in bold, black). In red, bold, phosphorylated residues retrieved in 
several phosphoproteomic studies that include S79, S86, S346, S348, S493, and S870 (2-6). 
Functional domains of SIZ1 encompass the following residues: SAP (11-45), PD (112-168), PINIT 
(273-276), SP-RING (348-425), and SXS (604-606). 
 
! !
Appendix Table 1       
Name Number AGI Insert information (numbers of the corresponding primers) Vector (Tag) Description / usage Reference 
       
Clones used in this study      
       
Constructs for expression in protoplasts 
SnRK1!1 pEBG1 At3g01090.1 Previously described, see reference [CDS cloned into pHBT95 (498/709)] pHBT95 (C-HA) Expression of SnRK1!1 in protoplasts (7) 
SnRK1!1T175A pEBG2 At3g01090.1 Previously described, see reference [mutagenesis of pEBG1 (1444/1445)] pHBT95 (C-HA) Expression of SnRK1!1
T175A in protoplasts (7) 
SnRK1!1K48M pEBG3 At3g01090.1 Previously described, see reference [mutagenesis of pEBG1 (1377/1378)] pHBT95 (C-HA) Expression of SnRK1!1
K48M in protoplasts (7) 
SnRK1!13K pPC54 At3g01090.1 Cloned from pPC55 (706/709) pHBT95 (C-HA) Expression of SnRK1!1
K34R/K63R/K390R in 
protoplasts  
SnRK1!18K pPC135 At3g01090.1 Cloned from pPC92 (706/709) pHBT95 (C-HA) 
Expression of 
SnRK1!1K20R/K34R/K44R/K56R/K63R/K69R/K390R/K421
R in protoplasts  
mSUMO1 pLD24 At4g26840.1 CDS cloned into pHBT95 (759/440) pHBT95 (N-Flag) 
Expression of mature SUMO1 in 
protoplasts  
mSUMO3 pLD25 At5g55170.1 CDS cloned into pHBT95 (443/444) pHBT95 (N- Flag) 
Expression of mature SUMO3 in 
protoplasts  
mSUMO1AA pLD89 At4g26840.1 Cloned from pLD24 (759/835) pHBT95 (N- Flag) 
Intermediary step to generate SnRK1!1-
mSUMO1AA  
mSUMO1Q90A pLD92 At4g26840.1 Mutagenesis of pLD24 (833/834) pHBT95 (N-Flag) 





At4g26840.1 Cloned from pLD24 (759/835) to pEBG1 pHBT95 





At4g26840.1 Mutagenesis of pLD87 (1444/1445) pHBT95 
Expression of SnRK1!1T175A-mSUMO1AA 




At4g26840.1 Mutagenesis of pLD87 (1377/1378) pHBT95 
Expression of SnRK1!1K48M-mSUMO1AA in 
protoplasts  
GFP-mSUMO1AA pPC134 GFP / At4g26840.1 Subcloned GFP from pHBT-GFP-HA (plasmid 77 in Li et al., 2013, see reference) to pLD87 pHBT95 
Expression of GFP-mSUMO1AA in 
protoplasts (8) 
SIZ1 pLD28 At5g60410.1 CDS cloned into pHBT95 (495/496) pHBT95 (C-HA) Expression of SIZ1.1 in protoplasts  
SIZ1C379A pLD127 At5g60410.1 Mutagenesis of pLD28 (1382/1383) pHBT95 (C-HA) Expression of SIZ1.1C379A in protoplasts  
SCE1 pLD27 At3g57870.1 CDS cloned into pHBT95 (489/490) pHBT95 (C-HA) Expression of SCE1 in protoplasts  
SnRK1!1-SCE1 pLD91 At3g01090.1/At3g57870.1 SCE1 StuI/StuI (809/490) cloned in frame with SnRK1!1 in pEBG1 pHBT95 (C-HA) 
Expression of SnRK1!1-SCE1 in 
protoplasts  
SCE1-SnRK1!1 pLD93 At3g57870.1/At3g01090.1 SnRK1!1 StuI/StuI (649/709) cloned in frame with SCE1 in pLD27 pHBT95 (C-HA) 






SnRK1!1"KA1 StuI/StuI (649/708) cloned in frame with SCE1 in 
pLD27 pHBT95 (C-HA) 
Expression of SCE1-SnRK1!1"KA1 in 
protoplasts  
! !
Name Number AGI Insert information (numbers of the corresponding primers) Vector (Tag) Description / usage Reference 




pLD103 At3g01090.1/At3g57870.1 Mutagenesis of pLD91 (912/913 and 973/974) pHBT95 (C-HA) 





90.1 Mutagenesis of pLD93 (912/913 and 973/974) pHBT95 (C-HA) 





90.1 Mutagenesis of pLD84 (912/913 and 973/974) pHBT95 (C-HA) 
Expression of SCE1K15/154R-SnRK1!1"KA1 
in protoplasts  
HPY2 pEBG7 AT3G15150.1 CDS cloned into pHBT95 (BamHI/StuI) pHBT95 (C-HA) Expression of HPY2 in protoplasts  
GBF5 pEBG5 At2g18160.1 Previously described, see reference [CDS cloned into pHBT95 (GBF5_BamHI_F/GBF5_StuI_R) pHBT95 (C-HA) Expression of GBF5 in protoplasts (7) 
pDIN6::LUC pEBG4 At3g47340 Previously described, see reference  pHBT95 Reporter gene construct (pDIN6::LUC) for following SnRK1 signaling in protoplasts (7) 
pUbq::GUS   Previously described, see reference  pHBT95 
Control for protoplasts transfection 
efficiency (pUbq::GUS) (9) 
mER7 (Control 
DNA)   Previously described, see reference  pHBT95 
Negative control for protoplast transfection 
(truncated GUS which is not expressed) (10)  
       
Constructs for E. coli assay - targets 
His-T7-SnRK1!1 pLD20 At3g01090.1 Cloned from pEBG1 (400/401) pET28a Expression of SnRK1!1 in the E. coli SUMOylation assay  
His-T7-
SnRK1!1K144/471R pRB4 At3g01090.1 Mutagenesis of pLD20 (1013/1014 and 314/315) pET28a 
Expression of SnRK1!1K144R/K471R in the E. 
coli SUMOylation assay  
His-T7-SnRK1!1-
KD pRB3 At3g01090.1 Cloned from pEBG1 (400/593) pET28a 
Expression of SnRK1!1 Kinase Domain in 
the E. coli SUMOylation assay  
His-T7-SnRK1!1-
KDK34/63R pPC38 At3g01090.1 Mutagenesis of pRB3 (738/739 and 740/741) pET28a 
Expression of SnRK1!1 Kinase Domain-
K34R/K63R in the E. coli SUMOylation assay  
His-T7-SnRK1!1-
RD pRB1 At3g01090.1 Cloned from pEBG1 (736/401) pET28a 
Expression of SnRK1!1 Regulatory 
Domain in the E. coli SUMOylation assay  
His-T7-SnRK1!1-
RDK390R pPC16 At3g01090.1 Mutagenesis of pRB1 (718/719) pET28a 
Expression of SnRK1!1 Regulatory 
Domain-K390R in the E. coli SUMOylation 
assay  
His-T7-SnRK1!13K pPC55 At3g01090.1 Mutagenesis of pLD20 (738/739; 740/741 and 718/719) pET28a Expression of SnRK1!1
K34R/K63R/K390R in the 
E. coli SUMOylation assay  
His-T7-SnRK1!18K pPC92 At3g01090.1 Mutagenesis of pPC55 (1138/1139; 1140/1141; 1142/1143; 1144/1145 and 720/721) pET28a 
Expression of SnRK1!1 
K20R/K34R/K44R/K56R/K63R/K69R/K390R/K421R   
His-T7-SnRK1#1 pPC104 At5g21170.1 Subcloned from pGBKT7::SnRK1#1 (from Martine Thomas) to pET28a pET28a 
Expression of SnRK1#1 in the E. coli 
SUMOylation assay (11) 
His-T7-SnRK1#2 pPC105 At4g16360.3 Subcloned from pGBKT7::SnRK1#2 (from Martine Thomas) to pET28a pET28a 
Expression of SnRK1#2 in the E. coli 
SUMOylation assay (11) 
His-T7-SnRK1$ pPC107 At3g48530.1 Subcloned from pGBKT7::SnRK1$  (from Martine Thomas) to pET28a pET28a 
Expression of SnRK1$ in the E. coli 
SUMOylation assay (11) 
His-T7-SnRK1#$ pPC108 At1g09020.1 Subcloned from pGBKT7::SnRK1#$  (from Martine Thomas) to pET28a pET28a 
Expression of SnRK1#$ in the E. coli 
SUMOylation assay (12) 
! !
Name Number AGI Insert information (numbers of the corresponding primers) Vector (Tag) Description / usage Reference 
His-T7-SNF1A-KD pLD64  - -  Cloned from pLD39 (548/710) pET28a Expression of SNF1A Kinase Domain in the E. coli SUMOylation assay  
His-T7-SNF1A-RD pLD68  - - Cloned from pLD39 (727/549) pET28a Expression of SNF1A Regulatory Domain in the E. coli SUMOylation assay  
       
Constructs for E. coli assay - machinery 
SAE2 + SAE1A pTK978 At2g21470.1 / At4g24940.1 pACYCDuetTM-1 Expression of the machinery (E1) in the E. coli SUMOylation assay (13) 
SUMO1GG + SCE1 pTK973 At4g26840.1 / At3g57870.1 AtSUMO1
GG / AtSCE1 pCDFDuetTM-1 
Expression of the machinery (E2 + 
SUMO1GG) in the E. coli SUMOylation 
assay 
(13) 
SUMO1AA + SCE1 pTK1017 At4g26840.1 / At3g57870.1 AtSUMO1
AA / AtSCE1 pCDFDuetTM-1 
Expression of the machinery (E2 + 
SUMO1AA) in the E. coli SUMOylation 
assay 
(13) 
SUMO1RGG + SCE1 mS1-RGG At4g26840.1 / At3g57870.1 AtSUMO1
RGG / AtSCE1 pCDFDuetTM-1 
Expression of the machinery (E2 + 
SUMO1RGG) in the E. coli SUMOylation 
assay 
(13) 
SUMO3GG + SCE1 pTK975 At5g55170.1 / At3g57870.1 AtSUMO3
GG / AtSCE1 pCDFDuetTM-1 
Expression of the machinery (E2 + 
SUMO3GG) in the E. coli SUMOylation 
assay 
(13) 
SUMO3AA + SCE1 pTK1788 At5g55170.1 / At3g57870.1 AtSUMO3
AA / AtSCE1 pCDFDuetTM-1 
Expression of the machinery (E2 + 
SUMO3AA) in the E. coli SUMOylation 
assay 
(13) 
SUMO3RGG + SCE1 pKT1037 At5g55170.1 / At3g57870.1 AtSUMO3
RGG / AtSCE1 pCDFDuetTM-1 
Expression of the machinery (E2 + 
SUMO3RGG) in the E. coli SUMOylation 
assay 
(13) 
Constructs for plant transformation   !PROM-5'UTR 
SnRK1!1 pLD40 At3g01090 Amplified from genomic DNA (557/558) 
pDONR221 P1-
P4 
Entry clone with the promoter (2kb 
upstream of the ATG) of SnRK1!1   
gSnRK1!1.2-GFP pLD33 At3g01090.2 Amplified from genomic DNA (664/709) pHBT95 (C-GFP) 
Intermediary clone for having the genomic 
sequence of SnRK1!1.2-GFP   
gSnRK1!1.2-GFP-
att pLD36 At3g01090.2 Cloned from pLD33 (546/547) pDONR221 
Entry clone with the genomic sequence of 
SnRK1!1 in frame with the CDS of the 
GFP   
3'UTR-TERM 
SnRK1!1 pLD41 At3g01090 Amplified from genomic DNA (559/560) 
pDONR221 
P4r-P3r 
Entry clone with the terminator (1kb 
downsteam of the last codon) of SnRK1!1   
prom-gSnRK1!1-







GFP pLD66 At3g01090.1 Cloned from pEBG1 (498/708) 
pHBT95 (C-ter 
GFP) 
Intermediary clone for having the CDS of SnRK1!1-
DKA1-GFP  
! !
Name Number AGI Insert information (numbers of the corresponding primers) Vector (Tag) Description / usage Reference 
       
SnRK1!1"KA1-
GFP-att pAE28 At3g01090.1 Cloned from pLD66 (279/547) pDONR221 
Entry clone with the CDS of  
SnRK1!1"KA1-GFP   
prom-SnRK1!1-
"KA1-GFP-ter pAE34 At3g01090.1 Multiple Site Gateway Recombination of pLD40, pAE28 and pLD41 pBm43GW0 
Generation of pSnRK1!1::SnRK1!1"KA1-





mSumo1AA BamHI/StuI (837/838) +N-GFP-SnRK1!1 BamHI/StuI as 
backbone pHBT95 






mSumo3AA BamHI/StuI (838/840) +N-GFP-SnRK1!1 BamHI/StuI as 
backbone pHBT95 






SnRK1!1-HA StuI/PstI as backbone + mSumo3AA StuI/PstI 
(443/836) pHBT95 






subcloned from pLD85a with BamHI/PstI and inserted in pCB302 
plasmid BamHI/PstI pCB302  






subcloned from pLD86b with BamHI/PstI and inserted in pCB302 
plasmid BamHI/PstI pCB302  






subcloned from pLD87a with BamHI/PstI and inserted in pCB302 
plasmid BamHI/PstI pCB302  






subcloned from pLD88a with BamHI/PstI and inserted in pCB302 
plasmid BamHI/PstI pCB302  
Generation of SnRK1!1-mSUMO3-OE 
plants  
mSUMO1AA-GFP pLD123 At4g26840.1+GFP subcloned from pLD107 with StuI/PstI and inserted GFP StuI/PstI in this pCB302 pLD107 plasmid StuI/PstI 
pCB302 (C-
GFP) Generation of mSUMO1-GFP-OE plants  
mSUMO3AA-GFP pLD124 At5g55170.1+GFP subcloned from pLD108 with StuI/PstI and inserted GFP StuI/PstI in pCB302 pLD108 plasmid StuI/PstI 
pCB302 (C-
GFP) Generation of mSUMO3-GFP-OE plants  
GFP-mSumo1AA pLD125 GFP+At3g57870.1 subcloned from pLD109 with BamHI/StuI  and inserted GFP  BamHI/StuI in pCB302 pLD109 plasmid  BamHI/StuI 
pCB302 (N-
GFP) Generation of GFP-mSUMO1-OE plants  
GFP-mSumo3AA pLD126 GFP+At5g55170.1 subcloned from pLD110 with BamHI/StuI and inserted GFP  BamHI/StuIin pCB302 pLD110 plasmid BamHI/StuI 
pCB302 (N-
GFP) Generation of GFP-mSUMO3-OE plants  
       
Constructs for Yeast-Two-Hybrid     
SCE1 pLD26 At3g57870.1 Cloned from pTK973 (491/490) pGBKT7 Expression of GAL4 BD-SCE for Y2H  
SnRK1!1 pLD35 At3g01090.1 Cloned from pEBG1 (402/403) pGADT7 Expression of GAL4 AD-SnRK1!1 full-length for Y2H  
SnRK1!1-KD pLD49 At3g01090.1 Cloned from pEBG1 (402/561) pGADT7 Expression of GAL4 AD-SnRK1!1 KD for Y2H  
SnRK1!1-RD pLD34 At3g01090.1 Cloned from pEBG1 (447/403) pGADT7 Expression of GAL4 AD-SnRK1!1 RD for Y2H  
SnRK1!1-RD"KA1 pLD58 At3g01090.1 Cloned from pLD34 (447/672) pGADT7 Expression of GAL4 AD-SnRK1!1 RD"KA1 for Y2H  
SNF1A pLD39  - - Cloned from Drosophila cDNA (548/549) pGADT7 Expression of GAL4 AD-SNF1A for Y2H  
SnRK1!1 - - At3g01090.1 Previously described, see reference  pGBKT7 Expression of GAL4 BD-SnRK1!1 full-length for Y2H (14) 
       
! !
Name Number AGI Sequence    
 
 
Primers used in this study      
Restriction or att sites introduced by PCR are marked in blue    
 
      
Cloning primers        
SnRK1!1"KA1-GFP attB1 
Fw 279 At3g01090.1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTAATGGATGGATCAGGCACAGGCAG   
SnRK1!1-ATG BamHI Fw  400 At3g01090.1 CGGGATCCGATGGATCAGGCACAGGCAG    
SnRK1!1 EcoRI Rv 401 At3g01090.1 CGGAATTCTCAGAGGACTCGGAGCTGAG    
SnRK1!1 EcoRI Fw  402 At3g01090.1 CCGGAATTCATGGATGGATCAGGCACAGGC    
SnRK1!1 BamHI Rv 403 At3g01090.1 CGCGGATCCGAGGACTCGGAGCTGAGCAAG    
mSUMO1 PstI Rv 440 At4g26840.1 AAAACTGCAGTCAGCCACCAGTCTGATGG    
mSUMO1 StuI Fw 759 At4g26840.1 AAGGCCTTCTGCAAACCAGGAGGAAG    
mSUMO1AA PstI Rv 835 At4g26840.1 AAAACTGCAGTCAAGCAGCAGTCTGATGG    
mSUMO3_StuI 443 At5g55170.1 AAGGCCTTCTAACCCTCAAGATGAC    
mSUMO3_PstI 444 At5g55170.1 AAAACTGCAGTCAACCACCACTCATCGC    
SnRK1!1 RD EcoRI Fw  447 At3g01090.1 CCGGAATTCGACGAGGAGATTCTCCAAG    
SCE1_FP_Nco1 489 At3g57870.1 CATGCCATGGCTAGTGGAATCGCTCG    
SCE1 StuI Rv 490 At3g57870.1 AAGGCCTGACAAGAGCAGGATACTGC    
SCE1 EcoRI Fw 491 At3g57870.1 CGGAATTCGCTAGTGGAATCGCTCG    
SCE1_StuI_Fw-ATG 809 At3g57870.1 AAGGCCTGCTAGTGGAATCGCTCG    
SIZ1.1 NcoI Fw 495 At5g60410.1 CATGCCATGGATTTGGAAGCTAATTG    
SIZ1.1 StuI Rv 496 At5g60410.1 AAGGCCTCTCAGAATCCGAGTCAATGG    
SnRK1!1 BamHI Fw a 498 At3g01090.1 CGGGATCCATGGATGGATCAGGCACAGG    
gSnRK1!1-GFP attB1 Fw 546 At3g01090.2 GGGGACAAGTTTGTACAAAAAAGCAGGCTTAATGTTCAAACGAGTAGATG   
gSnRK1!1-GFP attB2 Rv 547 At3g01090.2 GGGGACCACTTTGTACAAGAAAGCTGGGTTTTACTTGTACAGCTCGTCC   
SnRK1!1"KA1-GFP attB2 
Rv 547 At3g01090.1 GGGGACCACTTTGTACAAGAAAGCTGGGTTTTACTTGTACAGCTCGTCC   
PROM-5'UTR_gSnRK1!1 
attB4 Fw 557 At3g01090.1 GGGGACAACTTTGTATAGAAAAGTTGTTTTAATCTTTGGTGTAGGCATCG   
PROM-5'UTR_gSnRK1!1 
attB1r Rv 558 At3g01090.1 GGGGACTGCTTTTTTGTACAAACTTGTGAGAATTTAGCGAGAATTAGG   
TERM-3'UTR_gSnRK1!1 
attB2r Fw 559 At3g01090.1 GGGGACAGCTTTCTTGTACAAAGTGGTTATACTAAACCGGACCTCTTC   
TERM-3'UTR_gSnRK1!1 
attB3 Rv 560 At3g01090.1 GGGGACAACTTTGTATAATAAAGTTGTACGAATCTTGGGGCGAATCCG   
SnRK1!1 KD EcoRI Rv 561 At3g01090.1 CCGGAATTCAATCTTTTTTGCCTGTTGC    
                     SnRK1!1 I293 EcoRI Rv   593  At3g01090.1     CCGGAATTCTCAAATCTTTTTTGCCTGTTGC 
! !
Name Number AGI Sequence    
gSnRK1!1 BamHI Fw 664 At3g01090.2 CGGGATCCATGTTCAAACGAGTAGATG    
SnRK1!1 BamHI Fw b 706 At3g01090.1 CGGGATCCGGATGGATGGATCAGGCACAGG    
SnRK1!1"KA1 StuI Rv  708 At3g01090.1 AAGGCCTTCTCTCAACAGGGTATTG    
SnRK1!1D389_BamHI_Rv 672 At3g01090.1 CGCGGATCCTCTCTCAACAGGGTATTG    
SnRK1!1 StuI Rv 709 At3g01090.1 AAGGCCTGAGGACTCGGAGCTGAGC    
SnRK1!1 D294 BamHI Fw  736 At3g01090.1 CGCGGATCCGACGAGGAGATTCTCCAAGAAG    
SNF1A_EcoR1_Fw 548  - - CCGGAATTCCCCCAGATGAGGGCTGCG    
SNF1A_EcoR1_Rp 549  - - CCGGAATTCGCGAGCCAGTTGAATGATC    
SNF1A-I300-XhoI-Rv 710  - - CCGCTCGAGGATCACATTGGAGTCCTG    
SNF1A-D301-BamHI-Fw 727  - - CGGGATCCGACACCTACGCTGTGGCAG    
   
 
   
GBF5_BamHI_F  At2g18160.1 CGGGATCCATGGCGTCATCTAGCAGCAC    
GBF5_StuI_R  At2g18160.1 AAGGCCTATACATATTGATATCATTAG    
SnRK1#$_BamHI_F  At1g09020.1 CGGGATCCATGTTTGGTTCTACATTGG    
SnRK1#$ _StuI_R  At1g09020.1 AAGGCCTAAGACCGAGCAGGAATTGG    
       
Mutagenesis primers       
       
SnRK1!1-K48M Fw 1377 At3g01090.1 TAAGGTTGCTATCATGATCCTCAATCGTCGC    
SnRK1!1-K48M Rv 1378 At3g01090.1 GCGACGATTGAGGATCATGATAGCAACCTTA    
       
SnRK1!1-T175A Fw 1444 At3g01090.1 GGTCATTTTTTGAAGGCAAGTTGTGGAAGT    
SnRK1!1-T175A Rv 1445 At3g01090.1 ACTTCCACAACTTGCCTTCAAAAAATGACC    
       
SnRK1!1-K20R Fw 1138 At3g01090.1 TCTACCAAATTACAGGCTTGGGAGAACTCTT    
SnRK1!1-K20R Rv 1139 At3g01090.1 AAGAGTTCTCCCAAGCCTGTAATTTGGTAGA    
       
SnRK1!1-K34R Fw 738 At3g01090.1 CCTTTGGTAGGGTGAGGATAGCTGAGCATGC    
SnRK1!1-K34R Rv 739 At3g01090.1 GCATGCTCAGCTATCCTCACCCTACCAAAGG    
       
SnRK1!1-K44R Fw 1140 At3g01090.1 ATTGACAGGACATAGGGTTGCTATCAAGATC    
SnRK1!1-K44R Rv 1141 At3g01090.1 GATCTTGATAGCAACCCTATGTCCTGTCAAT    
       
SnRK1!1-K56R Fw 1142 At3g01090.1 TCGTCGCAAAATCAGGAACATGGAGATGGAG    
SnRK1!1-K56R Rv 1143 At3g01090.1 CTCCATCTCCATGTTCCTGATTTTGCGACGA    
! !
Name Number AGI Sequence    
 
SnRK1!1-K63R Fw 740 At3g01090.1 TGGAGATGGAGGAGAGAGTGAGGAGAGAGAT    
SnRK1!1-K63R Rv 741 At3g01090.1 ATCTCTCTCCTCACTCTCTCCTCCATCTCCA    
       
SnRK1!1-K69R Fw 1144 At3g01090.1 GAGGAGAGAGATCAGAATCTTGAGACTATTT    
SnRK1!1-K69R Rv 1145 At3g01090.1 AAATAGTCTCAAGATTCTGATCTCTCTCCTC    
       
SnRK1!1-K144R Fw 1013 At3g01090.1 TCACAGAGACCTCAGGCCTGAAAACTTGC    
SnRK1!1-K144R Rv 1014 At3g01090.1 GCAAGTTTTCAGGCCTGAGGTCTCTGTGA    
       
SnRK1!1-K390R Fw 718 At3g01090.1 CCCTGTTGAGAGAAGATGGGCTCTTGGAC    
SnRK1!1-K390R Rv 719 At3g01090.1 GTCCAAGAGCCCATCTTCTCTCAACAGGG    
       
SnRK1!1-K421R Fw 720 At3g01090.1 TGTATGTTGGAAGAGGATAGGGCACTACA    
SnRK1!1-K421R Rv 721 At3g01090.1 TGTAGTGCCCTATCCTCTTCCAACATACA    
       
SnRK1!1-K471R Fw 314 At3g01090.1 AAGTCGCCCAATGTTGTCCGTTTTGAAATTCAGTTGTAT    
SnRK1!1-K471R Rv 315 At3g01090.1 ATACAACTGAATTTCAAAACGGACAACATTGGGCGACTT    
       
SIZ1.1_C379A Fw 1382 At5g60410.1 GCTGGGAGATTTTTACCCGCTGTGCACATGGGCTGTTTTG    
SIZ1.1_C379A Rv 1383 At5g60410.1 CAAAACAGCCCATGTGCACAGCGGGTAAAAATCTCCCAGC    
       
MUT_mSUMO1Q90A_Fw 833 At4g26840.1 GATCGATGCGATGCTCCATGCGACTGGTGGCTGACTGCAG    
MUT_mSUMO1Q90A_Rp 834 At4g26840.1 CTGCAGTCAGCCACCAGTCGCATGGAGCATCGCATCGATC    
       
Genotyping primers       
SnRK1!1-GABIa (LP) 374 At3g01090 CCAGCATAATAGAGAACGAAGC    
SnRK1!1-GABIb (RP) 375 At3g01090 GTCCGGTTTAGTATTCAGAGG    
GABI-08409-LB 722 -- ATATTGACCATCATACTCATTGC    
       
SnRK1!1-seqF Fw 534 At3g01090 GAGATCCGGCAACACCCTTG    
GABI1-RB-seq Rv 832 At3g01090 CATGTGTTGAGCATATAAGAAACC    
       
SIZ1.1_Gen_RP 1568 AT5G60410.1 CACGACAGATGAAGCATTGTG    
SIZ1.1_Gen_LP 1569 AT5G60410.1 GAGCTGAAGCATCTGGTTTTG    
SALK LBb1 T-DNA primer 373  -- GCGTGGACCGCTTGCTGCAACT    
 
!
Name Number AGI Sequence    
IMS2-Fw 828 At5g23020 GAGGAGAATCTCTGATGGATGG    
IMS2-Rv 829 At5g23020 GATTTCAGCACCGTTCACCAC    
       
       
qPCR primers       
AXP Fw 63 At2g33830 CTTCGACAAGCCTTCTCACC    
AXP Rv 64 At2g33830 TCGTCGCTGTATAGCCAATC    
       
DIN6 Fw 53 At3g47340 AACTTGTCGCCAGATCAAGG    
DIN6 Rv 54 At3g47340 GGAACACGTGCCTCTAGTCC    
       
TPS8 Fw 89 At1g70290 CCACAAGGTGTAAGCAAAGG    
TPS8 Rv 90 At1g70290 CGCGTTCTACCATTTCTCG    
       
ACT2 Fw 555 At3g18780 TTTGCAGGAGATGATGCTCCC    
ACT2 Rv 556 At3g18780 GTCTTTGAGGTTTCCATCTCC    
       
       
       
Virus Induced Gene Silencing (VIGS) primers    
 
KIN11VIGS-A At3g29160 GGAATTCGTTTCTGTATATTTCTTCGCTC    
KIN11VIGS-B   At3g29160 CGGGATCCAGTACTCTACACCAGATATTAT    
       
GFPVIGS-A  --  CGGAATTCCCATCCTGGTCGAGCTGGAC    
GFPVIGS-B  --  GGGGTACCCGTTGGGGTCTTTGCTCAGG    
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